<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:746.2pt;left:44.8pt;line-height:7.0pt"><i><span style="font-family:Lato,serif;font-size:7.0pt">J Neurosci Res. </span></i><span style="font-family:Lato,serif;font-size:7.0pt">2021;99:573&#x2013;603. </span></p>
<p style="top:746.2pt;left:245.4pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">wileyonlinelibrary.com/journal/jnr </span></p>
<p style="top:746.2pt;left:520.7pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt"> </span><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:9.0pt">|</span><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; 573</span></b></p>
<p style="top:746.2pt;left:428.1pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">&#xa9; 2020 Wiley Periodicals LLC</span></p>
<p style="top:619.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;INTRODUCTION</span></b></p>
<p style="top:647.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Traumatic brain injury (TBI) has been referred to as a silent epidemic, </span></p>
<p style="top:660.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with an estimated age standardized global incidence rate of 369 per </span></p>
<p style="top:673.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">100,000 person-years and an estimated incidence of 27 million new </span></p>
<p style="top:686.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBIs per year (James et al., 2019; Rusnak, 2013). The true incidence </span></p>
<p style="top:699.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of TBI may be even higher due to reporting and recording limitations </span></p>
<p style="top:621.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Barker-Collo et al., 2016). Injury burden is undeniable; yet due to intri-</span></p>
<p style="top:634.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cate TBI pathophysiology, clinical strategies to attenuate damage and </span></p>
<p style="top:647.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">assist recovery across the TBI spectrum remain elusive. Mild, mod-</span></p>
<p style="top:660.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">erate, and severe TBIs are characterized by a primary biomechanical </span></p>
<p style="top:673.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">event wherein force is transmitted, injuring the brain as a consequence </span></p>
<p style="top:686.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of events such as a fall, motor vehicle accident (MVA), assault, blast ex-</span></p>
<p style="top:699.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">posure, or sport-related activity (Gardner &amp; Zafonte, 2016). TBI sever-</span></p>
<p style="top:712.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ity is primarily determined using the Glasgow Coma Score (assessment </span></p>
<p style="top:725.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of level of consciousness). Additionally, moderate and severe TBIs are </span></p>
<p style="top:1.1pt;left:44.8pt;line-height:12.0pt"><span style="font-family:STIX,serif;font-size:12.0pt"> </span></p>
<p style="top:29.2pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Received: 22 June 2020&#x2003;</span><span style="font-family:Lato,serif;font-size:9.6pt"> |</span><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; Revised: 2 October 2020&#x2003;</span><span style="font-family:Lato,serif;font-size:9.6pt"> |</span><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003; Accepted: 7 October 2020</span></p>
<p style="top:43.7pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">DOI: 10.1002/jnr.24746  </span></p>
<p style="top:69.2pt;left:44.8pt;line-height:9.0pt"><b><span style="font-family:Lato,serif;font-size:9.0pt">R E V I E W</span></b></p>
<p style="top:109.0pt;left:44.8pt;line-height:18.0pt"><b><span style="font-family:Lato,serif;font-size:18.0pt">Nutritional interventions to improve </span></b></p>
<p style="top:132.0pt;left:44.8pt;line-height:18.0pt"><b><span style="font-family:Lato,serif;font-size:18.0pt">neurophysiological impairments following </span></b></p>
<p style="top:155.0pt;left:44.8pt;line-height:18.0pt"><b><span style="font-family:Lato,serif;font-size:18.0pt">traumatic brain injury: A systematic review</span></b></p>
<p style="top:198.8pt;left:44.8pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">Joshua P. McGeown</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">1,2</span></b></sup></p>
<p style="top:198.8pt;left:179.0pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">   Patria A. Hume</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">1,2,3</span></b></sup></p>
<p style="top:198.8pt;left:315.4pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">   Alice Theadom</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">2,3</span></b></sup><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">    </span></b></p>
<p style="top:216.8pt;left:44.8pt;line-height:12.0pt"><b><span style="font-family:Lato,serif;font-size:12.0pt">Kenneth L. Quarrie</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">4</span></b></sup><b><span style="font-family:Lato,serif;font-size:12.0pt">&#x2003;</span></b><span style="font-family:Lato,serif;font-size:12.0pt">|</span><b><span style="font-family:Lato,serif;font-size:12.0pt">   Robert Borotkanics</span></b><sup><b><span style="font-family:Lato,serif;font-size:8.4pt">1</span></b></sup></p>
<img style="position:absolute;transform:matrix(.31967376,0,-0,.31957907,486.2572,-82.371128)" src="data:image/png;base64,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">
<p style="top:726.9pt;left:44.8pt;line-height:6.0pt"><span style="font-family:Lato,serif;font-size:6.0pt">Edited by Martin Doughty. Reviewed by Bridget Hawkins. </span></p>
<p style="top:253.9pt;left:44.8pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">1</span><span style="font-family:Lato,serif;font-size:7.0pt">Sports Performance Research Institute </span></p>
<p style="top:265.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">New Zealand (SPRINZ), Faculty of Health </span></p>
<p style="top:275.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">and Environmental Science, Auckland </span></p>
<p style="top:285.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">University of Technology, Auckland, New </span></p>
<p style="top:295.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Zealand</span></p>
<p style="top:306.9pt;left:44.8pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">2</span><span style="font-family:Lato,serif;font-size:7.0pt">Traumatic Brain Injury Network, Auckland </span></p>
<p style="top:318.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">University of Technology, Auckland, New </span></p>
<p style="top:328.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Zealand</span></p>
<p style="top:339.9pt;left:44.8pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">3</span><span style="font-family:Lato,serif;font-size:7.0pt">National Institute of Stroke and Applied </span></p>
<p style="top:351.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Neuroscience (NISAN), Faculty of Health </span></p>
<p style="top:361.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">and Environmental Science, Auckland </span></p>
<p style="top:371.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">University of Technology, Auckland, New </span></p>
<p style="top:381.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Zealand</span></p>
<p style="top:392.9pt;left:44.8pt;line-height:4.9pt"><span style="font-family:Lato,serif;font-size:4.9pt">4</span><span style="font-family:Lato,serif;font-size:7.0pt">New Zealand Rugby, Wellington, New </span></p>
<p style="top:404.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Zealand</span></p>
<p style="top:424.4pt;left:44.8pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">Correspondence</span></b></p>
<p style="top:434.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Joshua P. McGeown, Sports Performance </span></p>
<p style="top:444.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Research Institute New Zealand, Auckland </span></p>
<p style="top:454.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">University of Technology, Private Bag </span></p>
<p style="top:464.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">92006, Auckland 1142, New Zealand.</span></p>
<p style="top:474.4pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato,serif;font-size:7.0pt">Email: josh.mcgeown@aut.ac.nz</span></p>
<p style="top:260.4pt;left:207.1pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">Abstract</span></b></p>
<p style="top:276.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">Traumatic brain injury (TBI) accounts for significant global health burden. Effects of </span></p>
<p style="top:291.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">TBI can become chronic even following mild injury. There is a need to develop effec-</span></p>
<p style="top:306.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">tive therapies to attenuate the damaging effects of TBI and improve recovery out-</span></p>
<p style="top:321.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">comes. This literature review using a priori criteria (PROSPERO; CRD42018100623) </span></p>
<p style="top:336.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">summarized 43 studies between January 1998 and July 2019 that investigated nutri</span><span style="font-family:Lato,serif;font-size:9.0pt">-</span></p>
<p style="top:351.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">tional interventions (NUT) delivered with the objective of altering neurophysiological </span></p>
<p style="top:366.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">(NP) outcomes following TBI. Risk of bias was assessed for included studies, and NP </span></p>
<p style="top:381.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">outcomes recorded. The systematic search resulted in 43 of 3,748 identified studies </span></p>
<p style="top:396.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">met inclusion criteria. No studies evaluated the effect of a NUT on NP outcomes of </span></p>
<p style="top:411.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">TBI in humans. Biomarkers of morphological changes and apoptosis, oxidative stress, </span></p>
<p style="top:426.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">and plasticity, neurogenesis, and neurotransmission were the most evaluated NP out-</span></p>
<p style="top:441.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">comes across the 43 studies that used 2,897 animals. The risk of bias was unclear in </span></p>
<p style="top:456.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">all reviewed studies due to poorly detailed methodology sections. Taking these limi-</span></p>
<p style="top:471.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">tations into account, anti-oxidants, branched chain amino acids, and </span><span style="font-family:STIX,serif;font-size:9.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:9.0pt">-3 polyunsatu-</span></p>
<p style="top:486.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">rated fatty acids have shown the most promising pre-clinical results for altering NP </span></p>
<p style="top:501.2pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">outcomes following TBI. Refinement of pre-clinical methodologies used to evaluate </span></p>
<p style="top:516.3pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">effects of interventions on secondary damage of TBI would improve the likelihood of </span></p>
<p style="top:531.3pt;left:207.1pt;line-height:9.0pt"><span style="font-family:Lato,serif;font-size:9.0pt">translation to clinical populations.</span></p>
<p style="top:556.7pt;left:207.1pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">K E Y W O R D S</span></b></p>
<p style="top:569.9pt;left:207.1pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">animal models, biomarker, clinical, nutrition, rehabilitation, supplementation</span></p>
<img style="position:absolute;transform:matrix(.44444449,0,-0,.44444449,629.04006,-11.997314)" src="data:image/png;base64,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">
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">574&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">typically associated with skull fracture and/or positive neuroimaging </span></p>
<p style="top:62.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">findings indicating structural damage (Saatman et al., 2008; K. Wang </span></p>
<p style="top:75.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2016). Mild TBI (mTBI) represents the majority (95%) of TBIs and </span></p>
<p style="top:88.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">is generally classified based on a Glasgow Coma Score between 13 and </span></p>
<p style="top:101.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">15, symptom complaints, and the absence of both skull fracture and </span></p>
<p style="top:114.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">positive neuroimaging (Feigin et al., 2013; Saatman et al., 2008; Wang, </span></p>
<p style="top:127.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cui, et al., 2016). Within minutes of the traumatic event (primary in-</span></p>
<p style="top:140.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">jury) neurological homeostasis is disrupted representing the second-</span></p>
<p style="top:153.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ary injury phase of TBI. Neurophysiological (NP) consequences of TBI </span></p>
<p style="top:166.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">can include: ionic and neurometabolic dysregulation; neurovascular </span></p>
<p style="top:179.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and autonomic uncoupling; axonal and cytoskeletal damage; impaired </span></p>
<p style="top:192.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">synaptic plasticity; neuroinflammation; disrupted blood&#x2013;brain barrier </span></p>
<p style="top:205.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(BBB) permeability and damaged cell membranes; impaired synaptic </span></p>
<p style="top:218.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">plasticity; and neuronal apoptosis (see Romeu-Mejia et al., 2019 for a </span></p>
<p style="top:231.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">recent review detailing TBI pathophysiology).</span></p>
<p style="top:244.4pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Improved understanding of NP consequences of TBI provides </span></p>
<p style="top:257.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">targets for therapeutic interventions to improve recovery outcomes </span></p>
<p style="top:270.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Romeu-Mejia et al., 2019; Wang, Cui, et al., 2016). On this basis, </span></p>
<p style="top:283.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">targeted exercise prescription has been shown to be an effective in-</span></p>
<p style="top:296.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tervention to address symptom burden and functional deficits that </span></p>
<p style="top:309.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">commonly occur as a consequence of TBI (Alsalaheen et al., 2010; </span></p>
<p style="top:322.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Archer et al., 2012; Baker et al., 2012; Ellis, Cordingley, et al., 2015; Ellis </span></p>
<p style="top:335.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2016; Ellis, Leddy, et al., 2015; Fernandes et al., 2017; Gomez-</span></p>
<p style="top:348.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Pinilla et al., 2008; Griesbach et al., 2004, 2009; Leddy et al., 2007, </span></p>
<p style="top:361.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2013, 2016; Storey et al., 2018). Some symptoms such as headache </span></p>
<p style="top:374.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">complaints, sleep disruption, and/or mood disorders, that can occur </span></p>
<p style="top:387.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">secondary to TBI, have been managed with prescription pharmaceuti-</span></p>
<p style="top:400.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cals (although greater clarity regarding efficacy of these approaches is </span></p>
<p style="top:413.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">needed) (Bhatnagar et al., 2016; Liu et al., 2019; Meehan, 2011; Miller </span></p>
<p style="top:426.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Phillips &amp; Reddy, 2016; Plantier &amp; Luaut&#xe9;, 2016). However, there is no </span></p>
<p style="top:439.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">intervention to proactively target the secondary injury phase of TBI in </span></p>
<p style="top:452.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a manner that promotes earlier resolution of a range of symptom com-</span></p>
<p style="top:465.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">plaints and deficits observed clinically (Mohamadpour et al., 2019).</span></p>
<p style="top:478.4pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Lifestyle factors such as diet and nutrition play crucial roles in </span></p>
<p style="top:491.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">maintaining neurological function and overall brain health (Gomez-</span></p>
<p style="top:504.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Pinilla, 2011). In this regard, modification of dietary intake and/or nu-</span></p>
<p style="top:517.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tritional supplementation post-TBI demonstrate potential to attenuate </span></p>
<p style="top:530.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">damaging effects of secondary injury following TBI by simultaneously </span></p>
<p style="top:543.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">acting upon multiple NP pathways. An advantage of nutritional inter-</span></p>
<p style="top:556.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ventions (NUT) is the &#x201c;over-the-counter&#x201d; accessibility of affordable </span></p>
<p style="top:569.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">food and supplements which could potentially benefit patients post-</span></p>
<p style="top:582.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI to alter the secondary damage of TBI when availability of medical </span></p>
<p style="top:595.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">services may be limited. Modifying nutrition is potentially useful for </span></p>
<p style="top:608.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">enhancing resilience to the damaging effects of TBI for at risk pop-</span></p>
<p style="top:621.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ulations (i.e., military personnel and athletes participating in high-risk </span></p>
<p style="top:634.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sports) (Chakraborty et al., 2016; Oliver et al., 2018). Due to scalability </span></p>
<p style="top:647.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and implementation limitations, the preventative role of nutrition is be-</span></p>
<p style="top:660.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">yond the scope of the current review.</span></p>
<p style="top:673.4pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cellular damage and dysfunction that characterizes the second-</span></p>
<p style="top:686.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ary injury phase of TBI manifest clinically as an array of functional and </span></p>
<p style="top:699.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neurobehavioral deficits (Giza &amp; Hovda, 2014; Kenzie et al., 2018). </span></p>
<p style="top:712.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Previous reviews in the field of TBI have not summarized relevant </span></p>
<p style="top:309.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUT literature both comprehensively and systematically, or have </span></p>
<p style="top:322.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">focussed on interventions that target observable clinical symptoms </span></p>
<p style="top:335.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Ashbaugh &amp; McGrew, 2016; Bothe &amp; Stover, 2015; Davies, 2018; </span></p>
<p style="top:348.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Lewis, 2016; Lukaski &amp; Hardy, 2013; McDougall et al., 2018; Sharma </span></p>
<p style="top:361.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Trojian et al., 2017; White &amp; Venkatesh, 2011). This re</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:374.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">view evaluated the evidence for treatments to reduce the physiolog-</span></p>
<p style="top:387.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ical causes of these clinical symptoms through exploring the effect </span></p>
<p style="top:400.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of NUTs on NP outcomes.</span></p>
<p style="top:437.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">1.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Aim</span></b></p>
<p style="top:465.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">This review aimed to systematically consolidate evidence from ani-</span></p>
<p style="top:478.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mal and human studies, evaluating NUTs administered post-TBI and </span></p>
<p style="top:491.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">their subsequent effects on NP outcomes.</span></p>
<p style="top:528.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;METHODS</span></b></p>
<p style="top:556.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">We conducted this review according to Preferred Reporting Items </span></p>
<p style="top:569.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for Systematic Reviews and Meta-Analyses (PRISMA) guidelines </span></p>
<p style="top:582.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and followed clear a priori criteria registered with the International </span></p>
<p style="top:595.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Prospective </span></p>
<p style="top:595.4pt;left:359.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Register </span></p>
<p style="top:595.4pt;left:399.1pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of </span></p>
<p style="top:595.4pt;left:416.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Systematic </span></p>
<p style="top:595.4pt;left:464.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Reviews </span></p>
<p style="top:595.4pt;left:504.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(PROSPERO; </span></p>
<p style="top:608.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">CRD42018100623). Review methodology was developed accord</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:621.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing to Population, Intervention, Comparator, and Outcome (P.I.C.O.) </span></p>
<p style="top:634.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">guidelines (Table 1).</span></p>
<p style="top:671.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">2.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Search strategy and study selection criteria</span></b></p>
<p style="top:699.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Table 1 outlines search terms to identify studies investigating the in-</span></p>
<p style="top:712.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">fluence of nutritional and dietary manipulation interventions on NP </span></p>
<p style="top:66.3pt;left:324.5pt;line-height:9.0pt"><b><span style="font-family:Lato,serif;font-size:9.0pt">Significance</span></b></p>
<p style="top:83.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cellular damage and impaired neurophysiological function </span></p>
<p style="top:96.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">are the hallmarks of traumatic brain injury (TBI) patho-</span></p>
<p style="top:109.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">physiology. Over the last 20 years, nutritional interven</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:122.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tions have demonstrated potential to blunt these damaging </span></p>
<p style="top:135.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">effects in a manner that may improve recovery outcomes, </span></p>
<p style="top:148.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">however, this literature has never been systematically </span></p>
<p style="top:161.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">consolidated. This review sought to identify nutritional </span></p>
<p style="top:174.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">interventions with &#x201c;over-the-counter&#x201d; potential to benefit </span></p>
<p style="top:187.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical patients with TBI. This study is significant in iden-</span></p>
<p style="top:200.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tifying that the relationship between nutritional interven-</span></p>
<p style="top:213.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tions and TBI pathophysiology has only been evaluated in </span></p>
<p style="top:226.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">animal studies; and many studies have considerable meth-</span></p>
<p style="top:239.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">odological limitations that threaten the likelihood of trans-</span></p>
<p style="top:252.1pt;left:324.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">lation to clinical populations.</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;575</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:569.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes post-TBI. We filtered titles and abstracts for nutritional </span></p>
<p style="top:582.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and diet-related terms within 10 words either side of TBI-related </span></p>
<p style="top:595.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">keywords. When permitted by database functionality, additional fil-</span></p>
<p style="top:608.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ters were applied to limit search results to peer-reviewed studies, </span></p>
<p style="top:621.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">available in full-text, and published in English. Our systematic data</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:634.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">base search identified 4,148 articles (Figure 1) available online and </span></p>
<p style="top:647.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">published between January 1998 and July 2019 through MEDLINE </span></p>
<p style="top:660.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">[EBSCO] (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 652), Web of Science (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 608), Scopus (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 639), </span></p>
<p style="top:673.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">CINAHL [EBSCO] (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 451), SportDiscus [EBSCO] (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 245), </span></p>
<p style="top:686.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">PsycINFO [OVID] (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 1,489), and Cochrane Library [Wiley] (</span><i><span style="font-family:Lato,serif;font-size:8.0pt">n</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:STIX,serif;font-size:8.0pt">=</span><span style="font-family:Lato,serif;font-size:8.0pt"> 62). </span></p>
<p style="top:699.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Reference lists of included articles were reviewed but did not iden-</span></p>
<p style="top:712.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tify any additional results. Once duplicate references were removed, </span></p>
<p style="top:725.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">screening for eligibility by JM of titles, abstracts, and full-texts of </span></p>
<p style="top:569.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">3,748 studies was completed. A 10% random check of references </span></p>
<p style="top:582.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was performed at each screening stage by PH. Table 1 provides de-</span></p>
<p style="top:595.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tailed inclusion and exclusion criteria used to guide study selection.</span></p>
<p style="top:632.8pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">2.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Quality assessment</span></b></p>
<p style="top:660.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Only pre-clinical animal studies met all inclusion criteria for this </span></p>
<p style="top:673.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">review, so quality and risk of bias (RoB) was assessed for included </span></p>
<p style="top:686.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies using the Systematic Review Centre for Laboratory Animal </span></p>
<p style="top:699.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Experimentation (SYRCLE) RoB tool (Hooijmans et al., 2014). The </span></p>
<p style="top:712.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">SYRCLE RoB tool adapted the Cochrane Collaboration RoB tool </span></p>
<p style="top:725.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Higgins et al., 2011) for randomized controlled trials (RCTs) using </span></p>
<p style="top:47.7pt;left:44.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">Search strategy and study eligibility criteria</span></p>
<p style="top:66.8pt;left:50.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Systematic search strategy</span></b></p>
<p style="top:83.0pt;left:50.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI-related search terms</span></p>
<p style="top:83.0pt;left:226.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Postconcussion or &#x201c;post-concussion&#x201d; or concussion or tbi or mtbi or &#x201c;traumatic brain injur*&#x201d; or </span></p>
<p style="top:93.5pt;left:230.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;cortical impact&#x201d; or &#x201c;fluid percussion&#x201d; or &#x201c;acceleration injury&#x201d;</span></p>
<p style="top:107.6pt;left:50.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">The nutrition- and diet-related search terms below were queried within 10 words before or after TBI-related search terms</span></i></p>
<p style="top:121.6pt;left:50.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nutrition- and diet-related search terms</span></p>
<p style="top:121.6pt;left:226.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Diet* or supplement* or &#x201c;neuroprotective agent*&#x201d; or creatine or antioxidant* or &#x201c;anti-</span></p>
<p style="top:132.1pt;left:230.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oxidant*&#x201d; or &#x201c;fatty acid*&#x201d; or vitamin* or nutri* or nutraceutical or keto* or &#x201c;amino acid*&#x201d; or </span></p>
<p style="top:142.6pt;left:230.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;complementary and integrative medicine&#x201d; or &#x201c;complementary and alternative medicine&#x201d;</span></p>
<p style="top:159.3pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">P.I.C.O. framework and study selection criteria</span></b></p>
<p style="top:177.6pt;left:166.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Exclusion criteria</span></b></p>
<p style="top:177.6pt;left:358.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Inclusion criteria</span></b></p>
<p style="top:193.6pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Participants/population</span></b></p>
<p style="top:193.6pt;left:166.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">In vitro</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> models of brain/neuronal/axonal injury</span></p>
<p style="top:193.6pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mild, moderate, and severe TBI</span></p>
<p style="top:207.6pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Humans and/or mammals that </span></p>
<p style="top:218.1pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">have sustained TBI</span></p>
<p style="top:207.6pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Spinal cord injury</span></p>
<p style="top:207.6pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Single or repetitive impacts/injuries</span></p>
<p style="top:221.6pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Human subjects with TBI on life support, in a </span></p>
<p style="top:232.1pt;left:170.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">comatose state, and/or subjects that are paralysed</span></p>
<p style="top:221.6pt;left:358.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">In vivo</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> investigations including:</span></p>
<p style="top:232.1pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1. Clinical studies with human subjects and/or</span></p>
<p style="top:242.6pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2. Pre-clinical studies on animal models of TBI</span></p>
<p style="top:256.7pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:256.7pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nutrition/dietary interventions administered pre-TBI</span></p>
<p style="top:256.7pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nutrition and/or dietary manipulation interventions </span></p>
<p style="top:267.2pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">administered non-invasively* post-TBI</span></p>
<p style="top:270.7pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nutrition and/or dietary </span></p>
<p style="top:281.2pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">manipulation interventions </span></p>
<p style="top:291.7pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">administered </span><i><span style="font-family:Lato,serif;font-size:7.5pt">post-injury</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> with </span></p>
<p style="top:302.2pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the aim to attenuate impaired </span></p>
<p style="top:312.7pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurophysiological functions </span></p>
<p style="top:323.2pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">due to TBI</span></p>
<p style="top:270.7pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Acute lifesaving interventions</span></p>
<p style="top:284.7pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Administration of nutrition supplement via invasive </span></p>
<p style="top:295.2pt;left:170.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">means such as intravenous, intraperitoneal, </span></p>
<p style="top:305.7pt;left:170.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">intrathecal, or intracerebroventricular/intracerebral </span></p>
<p style="top:316.2pt;left:170.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injections</span></p>
<p style="top:330.3pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nutrition/dietary interventions targeting the gut/</span></p>
<p style="top:340.8pt;left:170.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">intestines after severe TBI</span></p>
<p style="top:330.3pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">*Exception made for nutrients/supplements delivered </span></p>
<p style="top:340.8pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage to animal models to ensure dosage </span></p>
<p style="top:351.3pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">compliance</span></p>
<p style="top:354.8pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Enteral feeding for paralysed/comatose subjects</span></p>
<p style="top:368.9pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pharmaceutical/drug/hormone interventions</span></p>
<p style="top:382.9pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Comparators/controls</span></b></p>
<p style="top:382.9pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Absence of comparison group</span></p>
<p style="top:382.9pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Presence of comparison group</span></p>
<p style="top:396.9pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-injury baseline measures, </span></p>
<p style="top:407.4pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">current best practice, regular </span></p>
<p style="top:417.9pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet, no treatment, sham </span></p>
<p style="top:428.4pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury, control, or placebo </span></p>
<p style="top:438.9pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">group</span></p>
<p style="top:453.0pt;left:49.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Outcomes</span></b></p>
<p style="top:453.0pt;left:166.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Neurocognitive, neuropsychological, behavioral, or </span></p>
<p style="top:463.5pt;left:170.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">clinical outcome measures only</span></p>
<p style="top:453.0pt;left:358.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Minimum of one objective outcome measure to </span></p>
<p style="top:463.5pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">quantify neurophysiological outcomes and/or </span></p>
<p style="top:474.0pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">consequences of TBI including: morphological </span></p>
<p style="top:484.5pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">changes, cell death/apoptosis/cell survival, energy </span></p>
<p style="top:495.0pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">metabolism, mitochondrial function, oxidative </span></p>
<p style="top:505.5pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stress, glial activation, immune response, BBB </span></p>
<p style="top:516.0pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">integrity, cell membrane homeostasis, plasticity, </span></p>
<p style="top:526.5pt;left:362.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and/or neurogenesis</span></p>
<p style="top:467.0pt;left:49.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Measures of </span></p>
<p style="top:477.5pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurophysiological function </span></p>
<p style="top:488.0pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">related to secondary injury </span></p>
<p style="top:498.5pt;left:53.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">phase of TBI</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">576&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">human subjects adjusting for aspects of bias within animal studies. </span></p>
<p style="top:62.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The 10 signaling questions used within SYRCLE&#x2019;s RoB tool, and re-</span></p>
<p style="top:75.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">spective results for included studies are presented in Table 2. Quality </span></p>
<p style="top:88.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">assessment of all included studies was performed by JM with a 10% </span></p>
<p style="top:101.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">random check by PH.</span></p>
<p style="top:138.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">2.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Data extraction and synthesis</span></b></p>
<p style="top:166.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Studies meeting inclusion criteria were recorded and curated for: </span></p>
<p style="top:179.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">study characteristics (study type, number of study groups, method </span></p>
<p style="top:192.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of TBI induction, TBI severity, and mortality rate); animal charac-</span></p>
<p style="top:205.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">teristics (species, sample size, sex, age, and weight); intervention </span></p>
<p style="top:218.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">details (type of intervention, controls used, timing of initiation of </span></p>
<p style="top:231.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">intervention, intervention dosage, and duration of intervention); and </span></p>
<p style="top:244.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes (NP outcomes evaluated, biomarkers used, and behavio-</span></p>
<p style="top:257.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ral/neurocognitive outcomes). Efforts were made to contact study </span></p>
<p style="top:270.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">authors to acquire any key information that was missing or unclear </span></p>
<p style="top:283.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in published articles. A summary of study characteristics (Table 3), </span></p>
<p style="top:49.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">summary of NP outcomes (Table 4), and details of NP and behavioral </span></p>
<p style="top:62.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes (Table S1) are provided.</span></p>
<p style="top:75.4pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">We qualitatively appraised studies, aggregating evidence to identify </span></p>
<p style="top:88.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">strengths, weaknesses, and trends suggesting preliminary positive inter-</span></p>
<p style="top:101.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vention effects from animal studies within this review while identifying </span></p>
<p style="top:114.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gaps in knowledge. Through identifying these trends we can begin to </span></p>
<p style="top:127.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">develop explanatory theories about how NUTs may facilitate improved </span></p>
<p style="top:140.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">recovery outcomes post-TBI; while generating hypotheses to justify and </span></p>
<p style="top:153.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">inform the feasibility of translating this evidence to clinical patients (de </span></p>
<p style="top:166.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Vries et al., 2014; Snilstveit et al., 2012).</span></p>
<p style="top:203.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;RESULTS</span></b></p>
<p style="top:229.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Article selection and quality assessment</span></b></p>
<p style="top:257.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Application of inclusion and exclusion criteria to titles and abstracts </span></p>
<p style="top:270.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of search resulted in 201 full-text articles that were screened for eli-</span></p>
<p style="top:283.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gibility; 43 journal articles (Bailes &amp; Mills, 2010; Cheng et al., 2016; </span></p>
<p style="top:733.4pt;left:46.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">FI G U R E 1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">PRISMA flowchart [Color figure can be viewed at wileyonlinelibrary.com]</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;577</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Cole et al., 2010; Davis et al., 2008; Deng-Bryant et al., 2011; Elliott </span></p>
<p style="top:62.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Gerbatin et al., 2019; Greco et al., 2016; Hu, Wang, </span></p>
<p style="top:75.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Jin, et al., 2009; Hu, Wang, Qiao, et al., 2009; Itoh et al., 2013; Ji </span></p>
<p style="top:88.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2017; Jiang et al., 2017; Krishna et al., 2019; Kumar et al., 2014; </span></p>
<p style="top:101.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Lim et al., 2013; Liu et al., 2017; Mills et al., 2011; Ozbal et al., 2015; </span></p>
<p style="top:114.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&#xd6;zevren et al., 2018; Prins et al., 2005; Prins &amp; Hovda, 2009; </span></p>
<p style="top:127.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Rubovitch et al., 2019; Saraiva et al., 2012; Schober et al., 2016; </span></p>
<p style="top:140.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Schwartzkroin et al., 2010; Sharma et al., 2010; Shin &amp; Dixon, 2011; </span></p>
<p style="top:153.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Su et al., 2016; Thau-Zuchman et al., 2019; Toklu et al., 2009; Wang </span></p>
<p style="top:166.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Wang, Li, et al., 2016; Wang, Zhang, et al., 2016; Wei </span></p>
<p style="top:179.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2015; Wu et al., 2011, 2014; Xie et al., 2018; Xing et al., 2016; </span></p>
<p style="top:192.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Xu et al., 2017; Zhang et al., 2018; Zhao et al., 2014; Zhu et al., 2017) </span></p>
<p style="top:205.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">met all eligibility criteria. Most studies (28/43) were conducted since </span></p>
<p style="top:218.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2013, with four to seven new studies being released each year since </span></p>
<p style="top:231.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2016. All studies were pre-clinical animal studies with 27/43 stud</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:244.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ies clearly stating that randomization took place. RoB was generally </span></p>
<p style="top:257.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">unclear across all studies (Table 2) due to limited methodological de-</span></p>
<p style="top:270.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tail, which failed to address several criteria within the SYRCLE RoB </span></p>
<p style="top:283.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tool such as: &#x201c;5) Were the caregivers and/or investigators blinded </span></p>
<p style="top:296.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">from knowledge which intervention each animal received during the </span></p>
<p style="top:309.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">experiment?&#x201d; (unclear in 40 of 43 studies); and &#x201c;6) Were the animals </span></p>
<p style="top:322.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">selected at random for outcome assessment?&#x201d; (unclear in 30 of 43 </span></p>
<p style="top:335.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies).</span></p>
<p style="top:372.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;TBI induction and animal characteristics</span></b></p>
<p style="top:398.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.2.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;TBI induction</span></b></p>
<p style="top:426.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Across the 43 included studies (Table 3), TBIs were produced in </span></p>
<p style="top:439.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2,897 animals (more animals were used but the sample size in sev</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:452.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">eral studies was unclear) using controlled cortical impact (16 CCI </span></p>
<p style="top:465.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies), fluid percussion injury (12 FPI studies), or weight drop tech-</span></p>
<p style="top:478.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">niques (15 studies). Generally, Feeney&apos;s weight drop model (5/15) </span></p>
<p style="top:491.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and CCI are implemented to mimic a mainly focal brain injury that </span></p>
<p style="top:504.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">might occur after a fall, MVA, or sport-related TBI (Ma et al., 2019). </span></p>
<p style="top:517.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Marmarou&apos;s weight drop model (6/15) produced mainly diffuse brain </span></p>
<p style="top:530.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">injury like that following a fall or MVA. To achieve mixed brain in-</span></p>
<p style="top:543.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">jury (with focal and diffuse consequences) FPI is commonly deliv-</span></p>
<p style="top:556.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ered (Ma et al., 2019). No studies used a blast wave model which </span></p>
<p style="top:569.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">would mimic TBI commonly suffered by deployed military personnel </span></p>
<p style="top:582.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Ma et al., 2019; Xiong et al., 2013). Animals were anesthetized in </span></p>
<p style="top:595.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">42 studies prior to delivery of TBI. Craniotomy or skull surgical al</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:608.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">teration occurred in 34/43 studies. The head of animals was secured </span></p>
<p style="top:621.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">during TBI induction in 15/43 studies, while freedom of head move</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:634.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ment was unclear or not reported in 27/43 studies (9 CCI, 10 FPI, 8 </span></p>
<p style="top:647.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">weight drop).</span></p>
<p style="top:684.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.2.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;TBI severity</span></b></p>
<p style="top:712.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI induction methods (Table 3) inflicted mTBI in nine studies (five </span></p>
<p style="top:725.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">FPI, four weight drop), moderate TBI in nine studies (one CCI, six </span></p>
<p style="top:49.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">FPI, two weight drop), and severe TBI in four studies (one CCI, three </span></p>
<p style="top:62.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">weight drop). In 23 studies TBI severity was not clearly described </span></p>
<p style="top:75.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(15 CCI, 2 FPI, 6 weight drop). Given TBI severity was a key vari-</span></p>
<p style="top:88.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">able of interest, study authors were contacted for information, or </span></p>
<p style="top:101.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">recently released classification criteria were used to infer TBI se-</span></p>
<p style="top:114.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">verity in Table 3 (Ma et al., 2019; Siebold et al., 2018). One study </span></p>
<p style="top:127.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">intentionally compared outcomes after moderate and severe TBI </span></p>
<p style="top:140.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Davis et al., 2008), otherwise investigations focused on evaluat</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:153.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing a NUT following a specific severity of TBI. Two studies evalu-</span></p>
<p style="top:166.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ated a NUT following repetitive TBI (Wang et al., 2018; Zhang </span></p>
<p style="top:179.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018). In both studies animals suffered three TBIs by either </span></p>
<p style="top:192.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">FPI or Marmarou weight drop to produce repetitive mild and severe </span></p>
<p style="top:205.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBIs, respectively.</span></p>
<p style="top:242.8pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.2.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Animal characteristics</span></b></p>
<p style="top:270.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Most studies investigated NUTs in rat models of TBI (29 used </span></p>
<p style="top:283.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Sprague Dawley rats; six used Wistar rats), the remaining studies </span></p>
<p style="top:296.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">used mice (six used C57BL/six mice, two used ICR mice; Table 3) as </span></p>
<p style="top:309.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">an animal model of TBI. No interventions were evaluated for util-</span></p>
<p style="top:322.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ity across multiple species using comparable methodologies. Fasting </span></p>
<p style="top:335.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was studied in both mice and rats following TBI, however, TBI in-</span></p>
<p style="top:348.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">duction and severity modeling was considerably different between </span></p>
<p style="top:361.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies preventing results comparison. TBI was modeled in only </span></p>
<p style="top:374.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">male rats/mice except for one study (Zhu et al., 2017) that included </span></p>
<p style="top:387.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">male and female Sprague Dawley rats to evaluate docosahexaenoic </span></p>
<p style="top:400.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">acid (DHA) supplementation after FPI.</span></p>
<p style="top:437.8pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.2.4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Animal maturity</span></b></p>
<p style="top:465.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Age and maturity of rodents varied across included studies </span></p>
<p style="top:478.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Table 3). Animal age was commonly indicated based on the </span></p>
<p style="top:491.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">number of days post-natal (PND) at which animals were subject </span></p>
<p style="top:504.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to TBI or sham injury. Insights into the interaction of age and </span></p>
<p style="top:517.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI are gained by conducting experiments with animals at dif-</span></p>
<p style="top:530.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">fering stages of maturity. Adulthood in rats and mice is consid-</span></p>
<p style="top:543.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ered to begin after PND-56 and PND-42, respectively (Jackson </span></p>
<p style="top:556.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2017). Included studies used PND-7 to 17 and PND-35 </span></p>
<p style="top:569.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to 55 to define immature/juvenile and adolescent rats, respec-</span></p>
<p style="top:582.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tively. Juvenile and immature rats were used in three studies, </span></p>
<p style="top:595.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pre-adolescent/adolescent rats in eight studies, and adult rats </span></p>
<p style="top:608.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in 18 studies. All mice studies used late adolescent and adult </span></p>
<p style="top:621.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mice. Animal weight was the only measure of maturity reported </span></p>
<p style="top:634.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in 12 studies. Due to a variety of unreported environmental fac-</span></p>
<p style="top:647.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tors that could affect weight, animal age could not be inferred </span></p>
<p style="top:660.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in these studies. Four studies compared how a KD attenuated </span></p>
<p style="top:673.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NP impairments post-TBI between multiple age groups (primarily </span></p>
<p style="top:686.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pre-adolescent rats vs. adult rats), and identified a trend for the </span></p>
<p style="top:699.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">benefits of KD post-TBI being age specific and limited to pre-ad</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:712.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">olescent rats (Deng-Bryant et al., 2011; Greco et al., 2016; Prins </span></p>
<p style="top:725.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2005; Prins &amp; Hovda, 2009).</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">578&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:725.8pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">Included studies RoB evaluated using the SYRCLE tool</span></p>
<p style="top:632.1pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">1) Was the </span></b></p>
<p style="top:632.1pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">allocation </span></b></p>
<p style="top:632.1pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">sequence </span></b></p>
<p style="top:632.1pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adequately </span></b></p>
<p style="top:632.1pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">generated </span></b></p>
<p style="top:632.1pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">and applied?</span></b></p>
<p style="top:575.6pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">2) Were </span></b></p>
<p style="top:575.6pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the groups </span></b></p>
<p style="top:575.6pt;left:85.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">similar at </span></b></p>
<p style="top:575.6pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">baseline or </span></b></p>
<p style="top:575.6pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">were they </span></b></p>
<p style="top:575.6pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adjusted for </span></b></p>
<p style="top:575.6pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">confounders </span></b></p>
<p style="top:575.6pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">in the </span></b></p>
<p style="top:575.6pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">analysis?</span></b></p>
<p style="top:519.1pt;left:85.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">3) Was the </span></b></p>
<p style="top:519.1pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">allocation to </span></b></p>
<p style="top:519.1pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the different </span></b></p>
<p style="top:519.1pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">groups </span></b></p>
<p style="top:519.1pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adequately </span></b></p>
<p style="top:519.1pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">concealed </span></b></p>
<p style="top:519.1pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">during?</span></b></p>
<p style="top:462.8pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">4) Were </span></b></p>
<p style="top:462.8pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the animals </span></b></p>
<p style="top:462.8pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">randomly </span></b></p>
<p style="top:462.8pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">housed </span></b></p>
<p style="top:462.8pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">during the </span></b></p>
<p style="top:462.8pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">experiment?</span></b></p>
<p style="top:406.3pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">5) Were the </span></b></p>
<p style="top:406.3pt;left:85.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">caregivers and/or </span></b></p>
<p style="top:406.3pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">investigators blinded </span></b></p>
<p style="top:406.3pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">from knowledge </span></b></p>
<p style="top:406.3pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">which intervention </span></b></p>
<p style="top:406.3pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">each animal </span></b></p>
<p style="top:406.3pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">received during the </span></b></p>
<p style="top:406.3pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">experiment?</span></b></p>
<p style="top:319.3pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">6) Were </span></b></p>
<p style="top:319.3pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the animals </span></b></p>
<p style="top:319.3pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">selected at </span></b></p>
<p style="top:319.3pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">random for </span></b></p>
<p style="top:319.3pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:319.3pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">assessment?</span></b></p>
<p style="top:262.8pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">7) Was the </span></b></p>
<p style="top:262.8pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:262.8pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">assessor </span></b></p>
<p style="top:262.8pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">blinded?</span></b></p>
<p style="top:206.4pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">8) Were </span></b></p>
<p style="top:206.4pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">incomplete </span></b></p>
<p style="top:206.4pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:206.4pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">data </span></b></p>
<p style="top:206.4pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adequately </span></b></p>
<p style="top:206.4pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">addressed?</span></b></p>
<p style="top:150.0pt;left:85.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">9) Are </span></b></p>
<p style="top:150.0pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">reports of </span></b></p>
<p style="top:150.0pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the study </span></b></p>
<p style="top:150.0pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">free of </span></b></p>
<p style="top:150.0pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">selective </span></b></p>
<p style="top:150.0pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:150.0pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">reporting?</span></b></p>
<p style="top:93.7pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">10) Was </span></b></p>
<p style="top:93.7pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the study </span></b></p>
<p style="top:93.7pt;left:85.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">apparently </span></b></p>
<p style="top:93.7pt;left:95.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">free of other </span></b></p>
<p style="top:93.7pt;left:106.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">problems </span></b></p>
<p style="top:93.7pt;left:116.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">that could </span></b></p>
<p style="top:93.7pt;left:127.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">result in a </span></b></p>
<p style="top:93.7pt;left:137.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">high risk of </span></b></p>
<p style="top:93.7pt;left:148.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">bias?</span></b></p>
<p style="top:721.2pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins et al. (2005)</span></p>
<p style="top:632.1pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:93.7pt;left:164.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Davis et al. (2008)</span></p>
<p style="top:632.0pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:262.8pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:150.0pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:93.7pt;left:178.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Wang, Jin, </span></p>
<p style="top:717.2pt;left:202.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2009)</span></p>
<p style="top:632.0pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:192.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Wang, Qiao, </span></p>
<p style="top:717.2pt;left:227.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2009)</span></p>
<p style="top:632.0pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins and Hovda (2009)</span></p>
<p style="top:632.0pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Toklu et al. (2009)</span></p>
<p style="top:632.0pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.2pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:255.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bailes and Mills (2010)</span></p>
<p style="top:632.1pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.1pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:406.3pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:262.8pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:269.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cole et al. (2010)</span></p>
<p style="top:632.1pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:150.0pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:283.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schwartzkroin </span></p>
<p style="top:717.2pt;left:308.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2010)</span></p>
<p style="top:632.1pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:150.0pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sharma et al. (2010)</span></p>
<p style="top:632.0pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:262.8pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:322.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Deng-Bryant </span></p>
<p style="top:717.2pt;left:346.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2011)</span></p>
<p style="top:632.0pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:336.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mills et al. (2011)</span></p>
<p style="top:632.0pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:262.8pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shin and Dixon (2011)</span></p>
<p style="top:632.0pt;left:373.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:575.6pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.1pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:373.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:206.4pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu et al. (2011)</span></p>
<p style="top:632.1pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.1pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:262.8pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:388.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Saraiva et al. (2012)</span></p>
<p style="top:632.1pt;left:401.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:575.6pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.1pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:401.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:206.4pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:402.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Itoh et al. (2013)</span></p>
<p style="top:632.1pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:262.8pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lim et al. (2013)</span></p>
<p style="top:632.0pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:319.3pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:430.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kumar et al. (2014)</span></p>
<p style="top:632.0pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.8pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:406.3pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.3pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:150.0pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu et al. (2014)</span></p>
<p style="top:632.0pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:575.6pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.2pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:206.4pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:150.0pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhao et al. (2014)</span></p>
<p style="top:632.0pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.2pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:262.8pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:149.9pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ozbal et al. (2015)</span></p>
<p style="top:632.0pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.2pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:149.9pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:486.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wei et al. (2015)</span></p>
<p style="top:632.0pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:319.2pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:262.8pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:149.9pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.7pt;left:501.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:721.2pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cheng et al. (2016)</span></p>
<p style="top:632.0pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:575.6pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:519.0pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:462.7pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:406.3pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:319.2pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:262.8pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:206.4pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:149.9pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:93.6pt;left:515.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:84.6pt;left:542.6pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;579</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:634.1pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">1) Was the </span></b></p>
<p style="top:634.1pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">allocation </span></b></p>
<p style="top:634.1pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">sequence </span></b></p>
<p style="top:634.1pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adequately </span></b></p>
<p style="top:634.1pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">generated </span></b></p>
<p style="top:634.1pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">and applied?</span></b></p>
<p style="top:577.7pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">2) Were </span></b></p>
<p style="top:577.7pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the groups </span></b></p>
<p style="top:577.7pt;left:84.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">similar at </span></b></p>
<p style="top:577.7pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">baseline or </span></b></p>
<p style="top:577.7pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">were they </span></b></p>
<p style="top:577.7pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adjusted for </span></b></p>
<p style="top:577.7pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">confounders </span></b></p>
<p style="top:577.7pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">in the </span></b></p>
<p style="top:577.7pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">analysis?</span></b></p>
<p style="top:521.1pt;left:84.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">3) Was the </span></b></p>
<p style="top:521.1pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">allocation to </span></b></p>
<p style="top:521.1pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the different </span></b></p>
<p style="top:521.1pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">groups </span></b></p>
<p style="top:521.1pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adequately </span></b></p>
<p style="top:521.1pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">concealed </span></b></p>
<p style="top:521.1pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">during?</span></b></p>
<p style="top:464.8pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">4) Were </span></b></p>
<p style="top:464.8pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the animals </span></b></p>
<p style="top:464.8pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">randomly </span></b></p>
<p style="top:464.8pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">housed </span></b></p>
<p style="top:464.8pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">during the </span></b></p>
<p style="top:464.8pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">experiment?</span></b></p>
<p style="top:408.4pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">5) Were the </span></b></p>
<p style="top:408.4pt;left:84.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">caregivers and/or </span></b></p>
<p style="top:408.4pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">investigators blinded </span></b></p>
<p style="top:408.4pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">from knowledge </span></b></p>
<p style="top:408.4pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">which intervention </span></b></p>
<p style="top:408.4pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">each animal </span></b></p>
<p style="top:408.4pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">received during the </span></b></p>
<p style="top:408.4pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">experiment?</span></b></p>
<p style="top:321.3pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">6) Were </span></b></p>
<p style="top:321.3pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the animals </span></b></p>
<p style="top:321.3pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">selected at </span></b></p>
<p style="top:321.3pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">random for </span></b></p>
<p style="top:321.3pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:321.3pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">assessment?</span></b></p>
<p style="top:264.9pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">7) Was the </span></b></p>
<p style="top:264.9pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:264.9pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">assessor </span></b></p>
<p style="top:264.9pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">blinded?</span></b></p>
<p style="top:208.4pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">8) Were </span></b></p>
<p style="top:208.4pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">incomplete </span></b></p>
<p style="top:208.4pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:208.4pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">data </span></b></p>
<p style="top:208.4pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">adequately </span></b></p>
<p style="top:208.4pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">addressed?</span></b></p>
<p style="top:152.0pt;left:84.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">9) Are </span></b></p>
<p style="top:152.0pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">reports of </span></b></p>
<p style="top:152.0pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the study </span></b></p>
<p style="top:152.0pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">free of </span></b></p>
<p style="top:152.0pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">selective </span></b></p>
<p style="top:152.0pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">outcome </span></b></p>
<p style="top:152.0pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">reporting?</span></b></p>
<p style="top:95.7pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">10) Was </span></b></p>
<p style="top:95.7pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">the study </span></b></p>
<p style="top:95.7pt;left:84.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">apparently </span></b></p>
<p style="top:95.7pt;left:94.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">free of other </span></b></p>
<p style="top:95.7pt;left:105.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">problems </span></b></p>
<p style="top:95.7pt;left:115.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">that could </span></b></p>
<p style="top:95.7pt;left:126.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">result in a </span></b></p>
<p style="top:95.7pt;left:136.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">high risk of </span></b></p>
<p style="top:95.7pt;left:147.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">bias?</span></b></p>
<p style="top:723.2pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Greco et al. (2016)</span></p>
<p style="top:634.1pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.1pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.4pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.3pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.9pt;left:162.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:208.4pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:152.0pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:163.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schober et al. (2016)</span></p>
<p style="top:634.1pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.7pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.1pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:408.4pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.3pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:264.9pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.4pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:152.0pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Su et al. (2016)</span></p>
<p style="top:634.1pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.6pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.1pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.4pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.3pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:264.9pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:152.0pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:191.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Cui, et al. (2016)</span></p>
<p style="top:634.1pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.1pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.3pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:152.0pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:205.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Li, et al. (2016)</span></p>
<p style="top:634.1pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:321.3pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.4pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:152.0pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:219.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xing et al. (2016)</span></p>
<p style="top:634.1pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.3pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:264.8pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:152.0pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:233.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ji et al. (2017)</span></p>
<p style="top:634.0pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.6pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.8pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:408.3pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.3pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.4pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:152.0pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:247.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jiang et al. (2017)</span></p>
<p style="top:634.0pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.6pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:152.0pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liu et al. (2017)</span></p>
<p style="top:634.0pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:464.7pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.4pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:152.0pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:275.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xu et al. (2017)</span></p>
<p style="top:634.0pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:289.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhu et al. (2017)</span></p>
<p style="top:634.0pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.7pt;left:303.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elliott et al. (2018)</span></p>
<p style="top:634.0pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.4pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:151.9pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:317.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.2pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#xd6;zevren et al. (2018)</span></p>
<p style="top:634.0pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.6pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.4pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:151.9pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:331.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang et al. (2018)</span></p>
<p style="top:634.0pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.3pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:345.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xie et al. (2018)</span></p>
<p style="top:634.0pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.6pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.3pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:264.8pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.3pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:359.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhang et al. (2018)</span></p>
<p style="top:634.0pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.5pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:408.3pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.3pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:373.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gerbatin et al. (2019)</span></p>
<p style="top:634.0pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.5pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.2pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.8pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.3pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:387.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Krishna et al. (2019)</span></p>
<p style="top:634.0pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.5pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:521.0pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.2pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.7pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.3pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:151.9pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:401.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rubovitch et al. (2019)</span></p>
<p style="top:634.0pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:577.5pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:520.9pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.2pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:264.7pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:208.3pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:151.9pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:415.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:723.1pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Thau-Zuchman </span></p>
<p style="top:719.1pt;left:440.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019)</span></p>
<p style="top:634.0pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:577.5pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:520.9pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:464.7pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:408.2pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:321.2pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:264.7pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:208.3pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:151.9pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:95.6pt;left:430.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">UC</span></p>
<p style="top:666.7pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yes</span></p>
<p style="top:633.9pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">29</span></p>
<p style="top:577.5pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">43</span></p>
<p style="top:520.9pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1</span></p>
<p style="top:464.7pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:408.2pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3</span></p>
<p style="top:321.2pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6</span></p>
<p style="top:264.7pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">18</span></p>
<p style="top:208.3pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12</span></p>
<p style="top:151.9pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">43</span></p>
<p style="top:95.6pt;left:454.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:666.7pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No</span></p>
<p style="top:633.9pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:577.5pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:520.9pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:464.6pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5</span></p>
<p style="top:408.2pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:321.1pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7</span></p>
<p style="top:264.7pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2</span></p>
<p style="top:208.3pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7</span></p>
<p style="top:151.9pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:95.6pt;left:468.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:666.7pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Unclear</span></p>
<p style="top:633.9pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">14</span></p>
<p style="top:577.5pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:520.9pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">42</span></p>
<p style="top:464.6pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">38</span></p>
<p style="top:408.2pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">40</span></p>
<p style="top:321.1pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">30</span></p>
<p style="top:264.7pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">23</span></p>
<p style="top:208.3pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24</span></p>
<p style="top:151.9pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0</span></p>
<p style="top:95.6pt;left:482.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">43</span></p>
<p style="top:730.0pt;left:497.9pt;line-height:5.2pt"><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">Information acquired by contacting corresponding author. </span></p>
<p style="top:728.2pt;left:511.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Abbreviation: UC, unclear in published article.</span></p>
<p style="top:727.8pt;left:43.3pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">580&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:82.1pt;left:540.9pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">Study design and intervention details</span></p>
<p style="top:720.8pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Author (year) </span></b></p>
<p style="top:720.8pt;left:74.7pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">country</span></i></b></p>
<p style="top:646.6pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal study type </span></b></p>
<p style="top:646.6pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(# of study groups)</span></b></p>
<p style="top:566.5pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method of TBI delivery, TBI </span></b></p>
<p style="top:566.5pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">severity, mortality rate</span></b></p>
<p style="top:457.7pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal details </span></b></p>
<p style="top:457.7pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(</span></b><b><i><span style="font-family:Lato,serif;font-size:7.5pt">N</span></i></b><b><span style="font-family:Lato,serif;font-size:7.5pt">)</span></b></p>
<p style="top:396.7pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:329.9pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controls</span></b></p>
<p style="top:232.8pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Initiation of intervention </span></b></p>
<p style="top:232.8pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(duration of intervention)</span></b></p>
<p style="top:128.9pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Dosage</span></b></p>
<p style="top:720.8pt;left:90.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Anti-oxidants</span></i></p>
<p style="top:720.8pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Toklu et al. (2009) </span></p>
<p style="top:716.8pt;left:115.4pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Turkey</span></i></p>
<p style="top:646.6pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:115.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIAI, Mild, UC</span></p>
<p style="top:457.7pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">300&#x2013;350 g; </span></p>
<p style="top:453.7pt;left:115.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wistar rats </span></p>
<p style="top:453.7pt;left:125.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(64)</span></p>
<p style="top:396.7pt;left:104.7pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-Lipoic acid via </span></p>
<p style="top:392.7pt;left:115.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:104.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle; </span></p>
<p style="top:325.9pt;left:115.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid; </span></p>
<p style="top:325.9pt;left:125.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle</span></p>
<p style="top:232.8pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:115.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 dose 24 hr </span></p>
<p style="top:228.8pt;left:125.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">later (48 hr)</span></p>
<p style="top:128.9pt;left:103.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ji et al. (2017) </span></p>
<p style="top:716.8pt;left:150.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:139.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M.A. Flierl weight drop </span></p>
<p style="top:562.5pt;left:150.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">model, Mod, 8%</span></p>
<p style="top:457.7pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">28&#x2013;32 g; ICR </span></p>
<p style="top:453.7pt;left:150.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (UC)</span></p>
<p style="top:396.7pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Astaxanthin </span></p>
<p style="top:392.7pt;left:150.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diluted in olive </span></p>
<p style="top:392.7pt;left:161.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oil (1 ml/kg) via </span></p>
<p style="top:392.7pt;left:171.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:139.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> olive oil; </span></p>
<p style="top:325.9pt;left:150.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> olive oil</span></p>
<p style="top:232.8pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:150.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 dose per </span></p>
<p style="top:228.8pt;left:161.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 hr until sacrifice </span></p>
<p style="top:228.8pt;left:171.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(7 days)</span></p>
<p style="top:128.9pt;left:138.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">75 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:185.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jiang et al. (2017) </span></p>
<p style="top:716.8pt;left:196.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:185.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 7)</span></p>
<p style="top:566.5pt;left:184.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:185.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; </span></p>
<p style="top:453.7pt;left:196.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200&#x2013;240 g; </span></p>
<p style="top:453.7pt;left:206.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (UC)</span></p>
<p style="top:396.7pt;left:185.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Catechin supp </span></p>
<p style="top:392.7pt;left:196.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage at 5 </span></p>
<p style="top:392.7pt;left:206.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dosages</span></p>
<p style="top:329.9pt;left:185.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle</span></p>
<p style="top:232.8pt;left:185.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">One dose per day until </span></p>
<p style="top:228.8pt;left:196.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice (24 hr or 28 days)</span></p>
<p style="top:128.9pt;left:185.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dose 1:1 mg/kg; dose </span></p>
<p style="top:124.9pt;left:196.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2:5 mg/kg; dose </span></p>
<p style="top:124.9pt;left:206.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3:10 mg/kg; dose </span></p>
<p style="top:124.9pt;left:217.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4:20 mg/kg; dose </span></p>
<p style="top:124.9pt;left:227.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4:30 mg/kg</span></p>
<p style="top:720.8pt;left:241.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Krishna </span></p>
<p style="top:716.8pt;left:252.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:241.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mod, NR</span></p>
<p style="top:457.7pt;left:241.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:252.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (UC)</span></p>
<p style="top:396.7pt;left:241.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5% Blueberry-</span></p>
<p style="top:392.7pt;left:252.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched diet</span></p>
<p style="top:329.9pt;left:241.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:251.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:241.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:252.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(14 days)</span></p>
<p style="top:128.9pt;left:241.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:266.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Itoh et al. (2013) </span></p>
<p style="top:716.8pt;left:276.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Japan</span></i></p>
<p style="top:646.6pt;left:266.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:275.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:566.5pt;left:264.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:266.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-42; </span></p>
<p style="top:453.7pt;left:276.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">120&#x2013;140 g; </span></p>
<p style="top:453.7pt;left:287.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wistar rats </span></p>
<p style="top:453.7pt;left:297.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(123)</span></p>
<p style="top:396.7pt;left:266.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">EGCG dissolved </span></p>
<p style="top:392.7pt;left:276.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in drinking </span></p>
<p style="top:392.7pt;left:287.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">water</span></p>
<p style="top:329.9pt;left:265.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> regular drinking </span></p>
<p style="top:325.9pt;left:276.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">water; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> regular </span></p>
<p style="top:325.9pt;left:287.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">drinking water</span></p>
<p style="top:232.8pt;left:266.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:276.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(24 hr, 72 hr, 7 days)</span></p>
<p style="top:128.9pt;left:266.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0.1% EGCG drinking </span></p>
<p style="top:124.9pt;left:276.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">water; drank </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:311.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cheng et al. (2016) </span></p>
<p style="top:716.8pt;left:322.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:311.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:321.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 6)</span></p>
<p style="top:566.5pt;left:310.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 7%</span></p>
<p style="top:457.7pt;left:311.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-56 to </span></p>
<p style="top:453.7pt;left:322.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-84; </span></p>
<p style="top:453.7pt;left:332.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20&#x2013;26 g; 151 </span></p>
<p style="top:453.7pt;left:343.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">wild type, </span></p>
<p style="top:453.7pt;left:353.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">31 Nrf2 </span></p>
<p style="top:453.7pt;left:364.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">knockout; </span></p>
<p style="top:453.7pt;left:374.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C57BL/6 </span></p>
<p style="top:453.7pt;left:385.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (182)</span></p>
<p style="top:396.7pt;left:311.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(-)-Epicatechin </span></p>
<p style="top:392.7pt;left:322.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supp via </span></p>
<p style="top:392.7pt;left:332.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage in low, </span></p>
<p style="top:392.7pt;left:343.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate, high </span></p>
<p style="top:392.7pt;left:353.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dose</span></p>
<p style="top:329.9pt;left:311.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle; </span></p>
<p style="top:325.9pt;left:321.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle</span></p>
<p style="top:232.8pt;left:311.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 3 hr post-injury </span></p>
<p style="top:228.8pt;left:322.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 1 additional per 24 hr </span></p>
<p style="top:228.8pt;left:332.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for 3 or 7 days (72 hr </span></p>
<p style="top:228.8pt;left:343.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dosage differences or </span></p>
<p style="top:228.8pt;left:353.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7 days moderate dose </span></p>
<p style="top:228.8pt;left:364.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">only)</span></p>
<p style="top:128.9pt;left:311.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low (-)-epicatechin: </span></p>
<p style="top:124.9pt;left:321.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day; </span></p>
<p style="top:124.9pt;left:332.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate </span></p>
<p style="top:124.9pt;left:343.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(-)-epicatechin: </span></p>
<p style="top:124.9pt;left:352.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">15 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day; </span></p>
<p style="top:124.9pt;left:364.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">high (-)-epicatechin: </span></p>
<p style="top:124.9pt;left:373.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">45 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ozbal et al. (2015) </span></p>
<p style="top:716.8pt;left:409.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Turkey</span></i></p>
<p style="top:646.6pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:409.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Weight drop, NR, NR</span></p>
<p style="top:457.7pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Juvenile; PND-</span></p>
<p style="top:453.7pt;left:409.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7; 20&#x2013;30 g; </span></p>
<p style="top:453.7pt;left:420.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wistar rats </span></p>
<p style="top:453.7pt;left:430.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(42)</span></p>
<p style="top:396.7pt;left:398.9pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-Lipoic acid via </span></p>
<p style="top:392.7pt;left:409.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:398.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:409.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:409.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 additional </span></p>
<p style="top:228.8pt;left:420.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dose 24 hr later (48 hr)</span></p>
<p style="top:128.9pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:444.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wei et al. (2015) </span></p>
<p style="top:716.8pt;left:455.2pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:444.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:454.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 5)</span></p>
<p style="top:566.5pt;left:444.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feeney weight drop, NR, NR</span></p>
<p style="top:457.7pt;left:444.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">250&#x2013;280 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:455.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (150)</span></p>
<p style="top:396.7pt;left:444.4pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-Lipoic acid </span></p>
<p style="top:392.7pt;left:455.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in low and </span></p>
<p style="top:392.7pt;left:465.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">high dose via </span></p>
<p style="top:392.7pt;left:476.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:444.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle; </span></p>
<p style="top:325.9pt;left:454.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid; </span></p>
<p style="top:325.9pt;left:465.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle;</span></p>
<p style="top:232.8pt;left:444.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:455.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 dose 24 hr </span></p>
<p style="top:228.8pt;left:465.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">later (48 hr)</span></p>
<p style="top:128.9pt;left:444.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid: 20 mg/</span></p>
<p style="top:124.9pt;left:454.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">kg; high </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid </span></p>
<p style="top:124.9pt;left:465.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100 mg/kg</span></p>
<p style="top:720.8pt;left:490.2pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Branched chain amino acids</span></i></p>
<p style="top:720.8pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lim et al. (2013) </span></p>
<p style="top:716.8pt;left:514.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:514.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:503.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mild, 0%</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:457.7pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 to </span></p>
<p style="top:453.7pt;left:514.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-49; </span></p>
<p style="top:453.7pt;left:525.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20&#x2013;25 g; </span></p>
<p style="top:453.7pt;left:535.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C57BL/J6 </span></p>
<p style="top:453.7pt;left:546.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (19)</span></p>
<p style="top:396.7pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tap water </span></p>
<p style="top:392.7pt;left:514.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">containing </span></p>
<p style="top:392.7pt;left:525.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">valine, leucine, </span></p>
<p style="top:392.7pt;left:535.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and isoleucine</span></p>
<p style="top:329.9pt;left:504.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> tap water; </span></p>
<p style="top:325.9pt;left:514.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> tap water</span></p>
<p style="top:232.8pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:514.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(4 weeks)</span></p>
<p style="top:128.9pt;left:504.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100 mM of each BCAA </span></p>
<p style="top:124.9pt;left:514.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dissolved in tap water; </span></p>
<p style="top:124.9pt;left:525.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Drank </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;581</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:83.6pt;left:535.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:720.8pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Author (year) </span></b></p>
<p style="top:720.8pt;left:73.5pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">country</span></i></b></p>
<p style="top:646.6pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal study type </span></b></p>
<p style="top:646.6pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(# of study groups)</span></b></p>
<p style="top:566.5pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method of TBI delivery, TBI </span></b></p>
<p style="top:566.5pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">severity, mortality rate</span></b></p>
<p style="top:457.7pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal details </span></b></p>
<p style="top:457.7pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(</span></b><b><i><span style="font-family:Lato,serif;font-size:7.5pt">N</span></i></b><b><span style="font-family:Lato,serif;font-size:7.5pt">)</span></b></p>
<p style="top:396.7pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:329.9pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controls</span></b></p>
<p style="top:232.8pt;left:63.0pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Initiation of intervention </span></b></p>
<p style="top:232.8pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(duration of intervention)</span></b></p>
<p style="top:128.9pt;left:73.5pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Dosage</span></b></p>
<p style="top:720.8pt;left:89.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elliott et al. (2018) </span></p>
<p style="top:716.8pt;left:100.2pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:89.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:99.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:88.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mild, 0%</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:457.7pt;left:89.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 to </span></p>
<p style="top:453.7pt;left:100.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-49; </span></p>
<p style="top:453.7pt;left:110.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20&#x2013;25 g; </span></p>
<p style="top:453.7pt;left:121.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C57BL/J6 </span></p>
<p style="top:453.7pt;left:131.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (24)</span></p>
<p style="top:396.7pt;left:89.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tap water </span></p>
<p style="top:392.7pt;left:100.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">containing </span></p>
<p style="top:392.7pt;left:110.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">valine, leucine, </span></p>
<p style="top:392.7pt;left:121.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and isoleucine</span></p>
<p style="top:329.9pt;left:89.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> tap water; </span></p>
<p style="top:325.9pt;left:99.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> tap water</span></p>
<p style="top:232.8pt;left:89.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Initiated 48 hr post-injury </span></p>
<p style="top:228.8pt;left:100.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(5 days)</span></p>
<p style="top:128.9pt;left:89.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100 mM of each BCAA </span></p>
<p style="top:124.9pt;left:100.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dissolved in tap water; </span></p>
<p style="top:124.9pt;left:110.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Drank </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:124.9pt;left:121.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(approx 3&#x2013;5 ml/day)</span></p>
<p style="top:720.8pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cole et al. (2010) </span></p>
<p style="top:716.8pt;left:156.2pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.7pt;left:156.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lateral FPI, Mild to Mod, 0%</span></p>
<p style="top:457.7pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 to </span></p>
<p style="top:453.7pt;left:156.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-49; </span></p>
<p style="top:453.7pt;left:166.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20&#x2013;25 g; </span></p>
<p style="top:453.7pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C57BL/6 </span></p>
<p style="top:453.7pt;left:187.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (UC)</span></p>
<p style="top:396.7pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tap water </span></p>
<p style="top:392.7pt;left:156.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">containing </span></p>
<p style="top:392.7pt;left:166.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">valine, leucine, </span></p>
<p style="top:392.7pt;left:177.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and isoleucine; </span></p>
<p style="top:392.7pt;left:187.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">or tap water </span></p>
<p style="top:392.7pt;left:198.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">containing </span></p>
<p style="top:392.7pt;left:208.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">phenylalanine</span></p>
<p style="top:329.9pt;left:145.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> tap water; </span></p>
<p style="top:325.9pt;left:156.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> tap water</span></p>
<p style="top:232.9pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Initiated 48 hr post-injury </span></p>
<p style="top:228.9pt;left:156.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(5 days)</span></p>
<p style="top:128.9pt;left:145.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100 mM of each BCAA </span></p>
<p style="top:124.9pt;left:156.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dissolved in tap water; </span></p>
<p style="top:124.9pt;left:166.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Drank </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:222.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Creatine</span></i></p>
<p style="top:720.8pt;left:236.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Saraiva </span></p>
<p style="top:716.8pt;left:247.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2012) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brazil</span></i></p>
<p style="top:646.7pt;left:236.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 2)</span></p>
<p style="top:566.5pt;left:235.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 18.07%</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:457.7pt;left:236.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; </span></p>
<p style="top:453.7pt;left:247.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">250&#x2013;300 g; </span></p>
<p style="top:453.7pt;left:257.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wistar rats </span></p>
<p style="top:453.7pt;left:268.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">24 to 40)</span></p>
<p style="top:396.7pt;left:236.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Creatine supp </span></p>
<p style="top:392.7pt;left:247.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:329.9pt;left:236.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle; </span></p>
<p style="top:325.9pt;left:247.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> creatine supp; </span></p>
<p style="top:325.9pt;left:257.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle</span></p>
<p style="top:232.8pt;left:236.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:247.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 dose per </span></p>
<p style="top:228.8pt;left:257.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 hr until sacrifice (72 hr)</span></p>
<p style="top:128.9pt;left:235.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">300 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:282.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gerbatin </span></p>
<p style="top:716.8pt;left:292.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brazil</span></i></p>
<p style="top:646.6pt;left:282.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:292.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:282.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mod, 18.07%</span></p>
<p style="top:457.7pt;left:282.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-90; </span></p>
<p style="top:453.7pt;left:292.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wistar rats </span></p>
<p style="top:453.7pt;left:303.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(166)</span></p>
<p style="top:396.7pt;left:282.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Creatine supp </span></p>
<p style="top:392.7pt;left:292.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:329.9pt;left:282.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:292.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> creatine supp; </span></p>
<p style="top:325.9pt;left:303.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:282.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Initiated 7 days post-injury </span></p>
<p style="top:228.8pt;left:292.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 1 dose per 24 hr until </span></p>
<p style="top:228.8pt;left:303.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice (4 weeks)</span></p>
<p style="top:128.9pt;left:281.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">300 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:317.4pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Fasting and caloric restriction</span></i></p>
<p style="top:720.8pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liu et al. (2017) </span></p>
<p style="top:716.8pt;left:341.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:341.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Weight drop, Mild, NR</span></p>
<p style="top:457.7pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-84; </span></p>
<p style="top:453.7pt;left:341.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C57BL/6 </span></p>
<p style="top:453.7pt;left:352.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (45)</span></p>
<p style="top:396.7pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caloric </span></p>
<p style="top:392.7pt;left:341.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction</span></p>
<p style="top:329.9pt;left:331.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> normal caloric </span></p>
<p style="top:325.9pt;left:341.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">intake; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> high </span></p>
<p style="top:325.9pt;left:352.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">energy intake</span></p>
<p style="top:232.8pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feeding initiated 6&#x2013;10 hr </span></p>
<p style="top:228.8pt;left:341.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">post-injury (24 hr, 48 hr, </span></p>
<p style="top:228.8pt;left:352.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">35 days, or 37 days)</span></p>
<p style="top:128.9pt;left:331.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">High energy: normal </span></p>
<p style="top:124.9pt;left:341.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">caloric intake </span><span style="font-family:STIX,serif;font-size:7.5pt">&#xd7;</span><span style="font-family:Lato,serif;font-size:7.5pt"> 1.3; </span></p>
<p style="top:124.9pt;left:352.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">caloric restriction: 0.7 </span></p>
<p style="top:124.9pt;left:362.7pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#xd7;</span><span style="font-family:Lato,serif;font-size:7.5pt"> normal caloric intake; </span></p>
<p style="top:124.9pt;left:373.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> according </span></p>
<p style="top:124.9pt;left:383.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">to energy ratio;</span></p>
<p style="top:720.8pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rubovitch </span></p>
<p style="top:716.8pt;left:408.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Israel</span></i></p>
<p style="top:646.6pt;left:397.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 7)</span></p>
<p style="top:566.5pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Weight drop, Mild, NR</span></p>
<p style="top:457.7pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-42 to </span></p>
<p style="top:453.7pt;left:408.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-49; ICR </span></p>
<p style="top:453.7pt;left:419.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (177)</span></p>
<p style="top:396.7pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Intermittent </span></p>
<p style="top:392.7pt;left:408.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fasting </span></p>
<p style="top:392.7pt;left:419.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">or caloric </span></p>
<p style="top:392.7pt;left:429.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction</span></p>
<p style="top:329.9pt;left:397.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std caloric </span></p>
<p style="top:325.9pt;left:408.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">intake; sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> fasting; </span></p>
<p style="top:325.9pt;left:418.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> caloric </span></p>
<p style="top:325.9pt;left:429.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:440.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">caloric intake</span></p>
<p style="top:232.8pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:408.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(30 days)</span></p>
<p style="top:128.9pt;left:398.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Intermittent fasting: </span></p>
<p style="top:124.9pt;left:408.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">alternating 24 hr </span></p>
<p style="top:124.9pt;left:419.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">periods with/without </span></p>
<p style="top:124.9pt;left:429.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">access to food; Caloric </span></p>
<p style="top:124.9pt;left:440.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad </span></i></p>
<p style="top:124.9pt;left:450.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">libitum</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> according to </span></p>
<p style="top:124.9pt;left:461.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">energy ratio: 10% </span></p>
<p style="top:124.9pt;left:471.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction week 1, 20% </span></p>
<p style="top:124.9pt;left:482.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction week 2, </span></p>
<p style="top:124.9pt;left:492.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">30% restriction week </span></p>
<p style="top:124.9pt;left:503.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3, 40% restriction until </span></p>
<p style="top:124.9pt;left:513.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice</span></p>
<p style="top:725.4pt;left:43.3pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">582&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:720.8pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Author (year) </span></b></p>
<p style="top:720.8pt;left:74.8pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">country</span></i></b></p>
<p style="top:646.6pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal study type </span></b></p>
<p style="top:646.6pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(# of study groups)</span></b></p>
<p style="top:566.5pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method of TBI delivery, TBI </span></b></p>
<p style="top:566.5pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">severity, mortality rate</span></b></p>
<p style="top:457.7pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal details </span></b></p>
<p style="top:457.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(</span></b><b><i><span style="font-family:Lato,serif;font-size:7.5pt">N</span></i></b><b><span style="font-family:Lato,serif;font-size:7.5pt">)</span></b></p>
<p style="top:396.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:329.9pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controls</span></b></p>
<p style="top:232.8pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Initiation of intervention </span></b></p>
<p style="top:232.8pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(duration of intervention)</span></b></p>
<p style="top:128.9pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Dosage</span></b></p>
<p style="top:720.8pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Davis et al. (2008) </span></p>
<p style="top:716.8pt;left:101.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:89.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 5)</span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:566.5pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod and severe, NR</span></p>
<p style="top:457.7pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats </span></p>
<p style="top:453.7pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(30)</span></p>
<p style="top:396.7pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fasting</span></p>
<p style="top:329.9pt;left:90.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> regular </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:325.9pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">feeding</span></p>
<p style="top:232.8pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(24 hr or 48 hr)</span></p>
<p style="top:128.9pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No caloric intake for </span></p>
<p style="top:124.9pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">designated time period</span></p>
<p style="top:720.8pt;left:115.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Ketogenic diet (KD)</span></i></p>
<p style="top:720.8pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhang et al. (2018) </span></p>
<p style="top:716.8pt;left:140.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:139.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:129.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI </span><span style="font-family:STIX,serif;font-size:7.5pt">&#xd7;</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3, Mild, NR</span></p>
<p style="top:457.7pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-60; </span></p>
<p style="top:453.7pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">100&#x2013;140 g; </span></p>
<p style="top:453.7pt;left:150.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (72)</span></p>
<p style="top:396.7pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:129.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:139.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(7 days)</span></p>
<p style="top:128.9pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins et al. (2005) </span></p>
<p style="top:716.8pt;left:175.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:164.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 20)</span></p>
<p style="top:566.5pt;left:163.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-17 </span></p>
<p style="top:453.7pt;left:174.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 27), </span></p>
<p style="top:453.7pt;left:185.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 </span></p>
<p style="top:453.7pt;left:195.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 29), </span></p>
<p style="top:453.7pt;left:206.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-45 </span></p>
<p style="top:453.7pt;left:216.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 27), </span></p>
<p style="top:453.7pt;left:227.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-65 </span></p>
<p style="top:453.7pt;left:237.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 26); </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:248.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (109)</span></p>
<p style="top:396.7pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:164.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:174.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:175.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(1 hr, 6 hr, 24 hr, 7 days)</span></p>
<p style="top:128.9pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: 8.4% protein, 78.8% </span></p>
<p style="top:124.9pt;left:175.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fat, 0.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:185.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5% fiber, 3.8% ash; </span></p>
<p style="top:124.9pt;left:196.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Standard diet: 18.6% </span></p>
<p style="top:124.9pt;left:206.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">protein, 6.2% fat, 59.8% </span></p>
<p style="top:124.9pt;left:217.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">carbohydrate, 4.5% </span></p>
<p style="top:124.9pt;left:227.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fiber; 6.02% ash; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad </span></i></p>
<p style="top:124.9pt;left:238.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">libitum</span></i></p>
<p style="top:720.8pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins and Hovda </span></p>
<p style="top:716.8pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2009) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:272.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 7)</span></p>
<p style="top:566.5pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-adolescent </span></p>
<p style="top:453.7pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(PND-35); </span></p>
<p style="top:453.7pt;left:283.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult (PND-</span></p>
<p style="top:453.7pt;left:294.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">70); </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats </span></p>
<p style="top:453.7pt;left:304.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(90)</span></p>
<p style="top:396.7pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:262.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:272.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> KD; </span></p>
<p style="top:325.9pt;left:283.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:293.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:304.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet; PND-70 </span></p>
<p style="top:325.9pt;left:314.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> KD</span></p>
<p style="top:232.8pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(7 days)</span></p>
<p style="top:128.9pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: 8.4% protein, 78.8% </span></p>
<p style="top:124.9pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fat, 0.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:283.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5% fiber; Standard diet: </span></p>
<p style="top:124.9pt;left:294.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">18.6% protein, 6.2% fat, </span></p>
<p style="top:124.9pt;left:304.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">59.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:315.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4.5% fiber; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad </span></i></p>
<p style="top:124.9pt;left:325.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">libitum</span></i></p>
<p style="top:720.8pt;left:339.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Deng-Bryant </span></p>
<p style="top:716.8pt;left:350.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2011) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:339.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 8)</span></p>
<p style="top:566.5pt;left:338.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:339.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-adolescent </span></p>
<p style="top:453.7pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(PND-35); </span></p>
<p style="top:453.7pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult (PND-</span></p>
<p style="top:453.7pt;left:371.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">70); </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats </span></p>
<p style="top:453.7pt;left:381.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(UC)</span></p>
<p style="top:396.7pt;left:339.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:339.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:349.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> KD; </span></p>
<p style="top:325.9pt;left:360.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:370.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:381.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet; PND-70 </span></p>
<p style="top:325.9pt;left:391.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> KD; PND-70 </span></p>
<p style="top:325.9pt;left:402.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:339.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(6 hr or 24 hr)</span></p>
<p style="top:128.9pt;left:339.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: 8.4% protein, 78.8% </span></p>
<p style="top:124.9pt;left:350.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fat, 0.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:360.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5% fiber; Standard diet: </span></p>
<p style="top:124.9pt;left:371.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">18.6% protein, 6.2% fat, </span></p>
<p style="top:124.9pt;left:381.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">59.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:392.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4.5% fiber; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad </span></i></p>
<p style="top:124.9pt;left:402.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">libitum</span></i></p>
<p style="top:720.8pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schwartzkroin </span></p>
<p style="top:716.8pt;left:427.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2010) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:426.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lateral FPI, Mod, NR</span></p>
<p style="top:457.7pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND 56; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:427.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (55)</span></p>
<p style="top:396.7pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:416.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:426.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:427.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(3 weeks)</span></p>
<p style="top:128.9pt;left:416.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: 8% protein, 79% fat </span></p>
<p style="top:124.9pt;left:426.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><span style="font-family:STIX,serif;font-size:7.5pt">&gt;</span><span style="font-family:Lato,serif;font-size:7.5pt">29% saturated fats), </span></p>
<p style="top:124.9pt;left:437.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0.76% carbohydrates, </span></p>
<p style="top:124.9pt;left:448.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12% water/fiber/ash; </span></p>
<p style="top:124.9pt;left:458.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:472.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Greco et al. (2016) </span></p>
<p style="top:716.8pt;left:483.2pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.7pt;left:472.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.7pt;left:483.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 6)</span></p>
<p style="top:566.5pt;left:471.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 0%</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:457.7pt;left:472.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 </span></p>
<p style="top:453.7pt;left:483.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 36), </span></p>
<p style="top:453.7pt;left:493.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70 </span></p>
<p style="top:453.7pt;left:504.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 18); </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:514.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (54)</span></p>
<p style="top:396.7pt;left:472.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:472.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:483.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-35 TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:493.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70 sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:504.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet; PND-70 TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:514.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet</span></p>
<p style="top:232.8pt;left:472.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:483.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(6 hr or 24 hr)</span></p>
<p style="top:128.9pt;left:472.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: 8.4% protein, 78.8% </span></p>
<p style="top:124.9pt;left:483.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fat, 0.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:493.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5% fiber; Standard diet: </span></p>
<p style="top:124.9pt;left:504.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">18.6% protein, 6.2% fat, </span></p>
<p style="top:124.9pt;left:514.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">59.8% carbohydrate, </span></p>
<p style="top:124.9pt;left:525.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4.5% fiber; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad </span></i></p>
<p style="top:124.9pt;left:535.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">libitum</span></i></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:80.4pt;left:558.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;583</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:720.8pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Author (year) </span></b></p>
<p style="top:720.8pt;left:73.1pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">country</span></i></b></p>
<p style="top:646.6pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal study type </span></b></p>
<p style="top:646.6pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(# of study groups)</span></b></p>
<p style="top:566.5pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method of TBI delivery, TBI </span></b></p>
<p style="top:566.5pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">severity, mortality rate</span></b></p>
<p style="top:457.7pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal details </span></b></p>
<p style="top:457.7pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(</span></b><b><i><span style="font-family:Lato,serif;font-size:7.5pt">N</span></i></b><b><span style="font-family:Lato,serif;font-size:7.5pt">)</span></b></p>
<p style="top:396.7pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:329.9pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controls</span></b></p>
<p style="top:232.8pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Initiation of intervention </span></b></p>
<p style="top:232.8pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(duration of intervention)</span></b></p>
<p style="top:128.9pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Dosage</span></b></p>
<p style="top:720.8pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Wang, Jin, </span></p>
<p style="top:716.8pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2009) </span></p>
<p style="top:716.8pt;left:110.3pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:99.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feeney weight drop, UC, NR</span></p>
<p style="top:457.7pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">130&#x2013;140 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (80)</span></p>
<p style="top:396.7pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:89.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:99.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> KD; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet</span></p>
<p style="top:232.8pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(72 hr)</span></p>
<p style="top:128.9pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: protein 17.4%, fat </span></p>
<p style="top:124.9pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">69.8%, carbohydrate </span></p>
<p style="top:124.9pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0%; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Wang, Qiao, </span></p>
<p style="top:716.8pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2009) </span></p>
<p style="top:716.8pt;left:145.3pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.7pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.7pt;left:134.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 5)</span></p>
<p style="top:566.5pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feeney weight drop, UC, NR</span></p>
<p style="top:457.7pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND 35; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (25)</span></p>
<p style="top:396.7pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:329.9pt;left:124.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:134.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> KD; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:145.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet</span></p>
<p style="top:232.9pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.9pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(72 hr)</span></p>
<p style="top:128.9pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD: protein 17.4%, fat </span></p>
<p style="top:124.9pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">69.8%, carbohydrate </span></p>
<p style="top:124.9pt;left:145.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0%; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:159.3pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Multi-supplement</span></i></p>
<p style="top:720.8pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu et al. (2014) </span></p>
<p style="top:716.8pt;left:183.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.7pt;left:173.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 5)</span></p>
<p style="top:566.5pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mod, NR</span></p>
<p style="top:457.7pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200&#x2013;240 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:183.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (UC)</span></p>
<p style="top:399.7pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Curcumin-enriched </span></p>
<p style="top:395.7pt;left:183.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet, DHA-</span></p>
<p style="top:395.7pt;left:194.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched diet, or </span></p>
<p style="top:395.7pt;left:204.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">curcumin </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> DHA-</span></p>
<p style="top:395.7pt;left:215.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched diet</span></p>
<p style="top:329.9pt;left:173.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:183.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.9pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.9pt;left:183.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(14 days)</span></p>
<p style="top:128.9pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Curcumin: 500 ppm </span></p>
<p style="top:125.0pt;left:183.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched chow; DHA: </span></p>
<p style="top:125.0pt;left:194.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.2% DHA enriched </span></p>
<p style="top:125.0pt;left:204.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">chow; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:229.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Thau-Zuchman </span></p>
<p style="top:716.8pt;left:239.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">UK</span></i></p>
<p style="top:646.7pt;left:229.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.7pt;left:239.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:228.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 0%</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:457.7pt;left:229.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70 to </span></p>
<p style="top:453.7pt;left:239.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-84; </span></p>
<p style="top:453.7pt;left:250.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">22&#x2013;27 g; </span></p>
<p style="top:453.7pt;left:260.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C57BL/J6 </span></p>
<p style="top:453.7pt;left:271.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mice (30)</span></p>
<p style="top:396.7pt;left:229.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fortasyn </span></p>
<p style="top:392.7pt;left:239.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Connect multi-</span></p>
<p style="top:392.7pt;left:250.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplement </span></p>
<p style="top:392.7pt;left:260.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched diet</span></p>
<p style="top:329.9pt;left:229.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:239.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:229.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:239.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(10 weeks)</span></p>
<p style="top:128.9pt;left:229.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:285.4pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Polyunsaturated fatty acids</span></i></p>
<p style="top:720.8pt;left:299.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu et al. (2011) </span></p>
<p style="top:716.8pt;left:310.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:299.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:299.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mild, NR</span></p>
<p style="top:457.7pt;left:299.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200&#x2013;240 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:310.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (36)</span></p>
<p style="top:396.7pt;left:299.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA-enriched </span></p>
<p style="top:392.7pt;left:310.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet</span></p>
<p style="top:329.9pt;left:299.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:309.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:299.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:310.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(12 days)</span></p>
<p style="top:128.9pt;left:299.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.2% DHA enriched </span></p>
<p style="top:124.9pt;left:310.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">chow; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:324.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Su et al. (2016) </span></p>
<p style="top:716.8pt;left:334.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:322.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:566.5pt;left:324.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feeney weight drop, Mod, </span></p>
<p style="top:562.5pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3.7%</span></p>
<p style="top:457.7pt;left:324.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">250&#x2013;300 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:333.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (101</span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;)</span></p>
<p style="top:396.7pt;left:324.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Moderate (1:5) </span></p>
<p style="top:392.7pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">or high (1:1) </span></p>
<p style="top:392.7pt;left:344.8pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-3/</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-6 ratio </span></p>
<p style="top:392.7pt;left:355.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PUFA oil via </span></p>
<p style="top:392.7pt;left:366.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:323.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> &#x201c;western&#x201d; diet </span></p>
<p style="top:325.9pt;left:334.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(low </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-3/</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-6 PUFA </span></p>
<p style="top:325.9pt;left:344.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ratio; 1:30); TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:325.9pt;left:355.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x201c;western&#x201d; diet</span></p>
<p style="top:232.8pt;left:324.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 1 dose per 24 hr until </span></p>
<p style="top:228.8pt;left:345.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice (72 hr, 5 days, </span></p>
<p style="top:228.8pt;left:355.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7 days, or 19 days)</span></p>
<p style="top:128.9pt;left:324.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">All animals fed same fat-</span></p>
<p style="top:124.9pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">free chow and 5.5 ml/</span></p>
<p style="top:124.9pt;left:345.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">kg PUFA oil mixture: </span></p>
<p style="top:124.9pt;left:355.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low ratio &#x2212; 4% fish </span></p>
<p style="top:124.9pt;left:365.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oil </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> 96% linoleic acid; </span></p>
<p style="top:124.9pt;left:376.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate ratio: 21% </span></p>
<p style="top:124.9pt;left:386.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fish oil </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> 79% linoleic </span></p>
<p style="top:124.9pt;left:397.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acid; or High ratio: 58% </span></p>
<p style="top:124.9pt;left:407.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fish oil </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> 42% linoleic </span></p>
<p style="top:124.9pt;left:418.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acid</span></p>
<p style="top:720.8pt;left:432.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shin and Dixon </span></p>
<p style="top:716.8pt;left:443.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2011) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:432.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:431.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 0%</span></p>
<p style="top:457.7pt;left:431.4pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">PND-60</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;; </span></p>
<p style="top:453.7pt;left:443.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">275&#x2013;300 g; </span></p>
<p style="top:453.7pt;left:453.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats </span></p>
<p style="top:453.7pt;left:462.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">20to 24</span><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;)</span></p>
<p style="top:396.7pt;left:432.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fish oil supp via </span></p>
<p style="top:392.7pt;left:443.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:432.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> olive oil; sham</span></p>
<p style="top:232.8pt;left:432.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:443.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 1 dose per 24 hr until </span></p>
<p style="top:228.8pt;left:453.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice (7 days)</span></p>
<p style="top:128.9pt;left:432.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.5 ml/day containing </span></p>
<p style="top:124.9pt;left:443.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">360 mg EPA &amp; 240 mg </span></p>
<p style="top:124.9pt;left:453.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA</span></p>
<p style="top:720.8pt;left:478.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schober </span></p>
<p style="top:716.8pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2016) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:477.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:476.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, </span></p>
<p style="top:562.5pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.5%&#x2013;3.0% across groups</span></p>
<p style="top:457.7pt;left:478.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immature; </span></p>
<p style="top:453.7pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND17; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:499.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (400)</span></p>
<p style="top:396.7pt;left:478.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA-enriched </span></p>
<p style="top:392.7pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet</span></p>
<p style="top:329.9pt;left:477.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:488.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:478.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(24 hr, 48 hr, 72 hr, or </span></p>
<p style="top:228.8pt;left:499.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">50 days)</span></p>
<p style="top:128.9pt;left:478.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0.1% DHA enriched </span></p>
<p style="top:124.9pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">chow; fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:725.4pt;left:43.3pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:82.1pt;left:523.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">584&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:720.8pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Author (year) </span></b></p>
<p style="top:720.8pt;left:74.8pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">country</span></i></b></p>
<p style="top:646.6pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal study type </span></b></p>
<p style="top:646.6pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(# of study groups)</span></b></p>
<p style="top:566.5pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method of TBI delivery, TBI </span></b></p>
<p style="top:566.5pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">severity, mortality rate</span></b></p>
<p style="top:457.7pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal details </span></b></p>
<p style="top:457.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(</span></b><b><i><span style="font-family:Lato,serif;font-size:7.5pt">N</span></i></b><b><span style="font-family:Lato,serif;font-size:7.5pt">)</span></b></p>
<p style="top:396.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:329.9pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controls</span></b></p>
<p style="top:232.8pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Initiation of intervention </span></b></p>
<p style="top:232.8pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(duration of intervention)</span></b></p>
<p style="top:128.9pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Dosage</span></b></p>
<p style="top:720.8pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bailes and Mills </span></p>
<p style="top:716.8pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2010) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:90.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:89.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIAI, Severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 0%</span></p>
<p style="top:457.7pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; </span></p>
<p style="top:453.7pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">350&#x2013;400 g; </span></p>
<p style="top:453.7pt;left:112.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (40)</span></p>
<p style="top:396.7pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low or high </span></p>
<p style="top:392.7pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA-enriched </span></p>
<p style="top:392.7pt;left:112.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet</span></p>
<p style="top:329.9pt;left:90.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:101.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(30 days)</span></p>
<p style="top:128.9pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low DHA: </span></p>
<p style="top:124.9pt;left:100.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day; high </span></p>
<p style="top:124.9pt;left:110.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA: 40 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day; </span></p>
<p style="top:124.9pt;left:122.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mills et al. (2011) </span></p>
<p style="top:716.8pt;left:147.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:136.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIAI, Severe, 0%</span></p>
<p style="top:457.7pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; </span></p>
<p style="top:453.7pt;left:147.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">350&#x2013;400 g; </span></p>
<p style="top:453.7pt;left:157.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (40)</span></p>
<p style="top:396.7pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low or high </span></p>
<p style="top:392.7pt;left:147.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fish oil </span></p>
<p style="top:392.7pt;left:157.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(EPA </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> DHA) </span></p>
<p style="top:392.7pt;left:168.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supp via </span></p>
<p style="top:392.7pt;left:178.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:136.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:146.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Initiated 24 hr post-injury </span></p>
<p style="top:228.8pt;left:147.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 1 dose per 24 hr until </span></p>
<p style="top:228.8pt;left:157.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice (30 days)</span></p>
<p style="top:128.9pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low fish oil: </span></p>
<p style="top:124.9pt;left:145.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">10 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day; high </span></p>
<p style="top:124.9pt;left:156.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fish oil: 40 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhu et al. (2017) </span></p>
<p style="top:716.8pt;left:203.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:202.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, UC, NR</span></p>
<p style="top:457.7pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-49; </span></p>
<p style="top:453.7pt;left:203.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">300&#x2013;500 g; </span></p>
<p style="top:453.7pt;left:213.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats; 40 </span></p>
<p style="top:453.7pt;left:224.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">male, 40 </span></p>
<p style="top:453.7pt;left:234.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">female (80)</span></p>
<p style="top:396.7pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low or high </span></p>
<p style="top:392.7pt;left:203.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA supp via </span></p>
<p style="top:392.7pt;left:213.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:192.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:202.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet</span></p>
<p style="top:232.8pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:203.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 dose per </span></p>
<p style="top:228.8pt;left:213.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 hr until sacrifice </span></p>
<p style="top:228.8pt;left:224.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(15 days)</span></p>
<p style="top:128.9pt;left:192.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low DHA: </span></p>
<p style="top:124.9pt;left:201.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">370 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day; high </span></p>
<p style="top:124.9pt;left:212.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA: 740 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:248.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Traditional eastern medicine</span></i></p>
<p style="top:720.8pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#xd6;zevren </span></p>
<p style="top:716.8pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2018) </span></p>
<p style="top:716.8pt;left:283.6pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Turkey</span></i></p>
<p style="top:646.6pt;left:262.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pre-clinical (</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIAI, Mild, 0%</span></p>
<p style="top:457.7pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">280&#x2013;330 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (36)</span></p>
<p style="top:396.7pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ganoderma </span></p>
<p style="top:392.7pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lucidum supp </span></p>
<p style="top:392.7pt;left:283.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:329.9pt;left:262.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle; </span></p>
<p style="top:325.9pt;left:272.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle</span></p>
<p style="top:232.8pt;left:262.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 30 min post-</span></p>
<p style="top:228.8pt;left:273.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury (7 days)</span></p>
<p style="top:128.9pt;left:261.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20 ml</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sharma </span></p>
<p style="top:716.8pt;left:308.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2010) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">USA</span></i></p>
<p style="top:646.6pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:307.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FPI, Mod, NR</span></p>
<p style="top:457.7pt;left:297.4pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">PND-60; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:308.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (24)</span></p>
<p style="top:396.7pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Curcumin-</span></p>
<p style="top:392.7pt;left:308.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched diet</span></p>
<p style="top:329.9pt;left:297.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std diet; </span></p>
<p style="top:325.9pt;left:307.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> curcumin-</span></p>
<p style="top:325.9pt;left:318.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">enriched diet; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> Std </span></p>
<p style="top:325.9pt;left:329.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet;</span></p>
<p style="top:232.8pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury </span></p>
<p style="top:228.8pt;left:308.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(14 days)</span></p>
<p style="top:128.9pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chow enriched with </span></p>
<p style="top:124.9pt;left:308.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">500 ppm of curcumin; </span></p>
<p style="top:124.9pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fed </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ad libitum</span></i></p>
<p style="top:720.8pt;left:343.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Cui, </span></p>
<p style="top:716.8pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2016) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:343.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:353.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 4)</span></p>
<p style="top:566.5pt;left:342.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, </span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">10%</span></p>
<p style="top:457.7pt;left:343.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-56 to </span></p>
<p style="top:453.7pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-70; </span></p>
<p style="top:453.7pt;left:364.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200&#x2013;250 g; </span></p>
<p style="top:453.7pt;left:374.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (96)</span></p>
<p style="top:396.7pt;left:343.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">HYSA supp </span></p>
<p style="top:392.7pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage in </span></p>
<p style="top:392.7pt;left:364.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">low and high </span></p>
<p style="top:392.7pt;left:374.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dosage</span></p>
<p style="top:329.9pt;left:342.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline </span></p>
<p style="top:325.9pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vehicle</span></p>
<p style="top:232.8pt;left:342.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dose </span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">20 min post-injury </span></p>
<p style="top:228.8pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(Single dose post-injury)</span></p>
<p style="top:128.9pt;left:343.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low HSYA: 10 mg/kg; </span></p>
<p style="top:124.9pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">high HSYA: 30 mg/</span></p>
<p style="top:124.9pt;left:364.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">HSYA</span></p>
<p style="top:720.8pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Li, </span></p>
<p style="top:716.8pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2016) </span><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:399.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:387.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, 10%</span></p>
<p style="top:457.7pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; </span></p>
<p style="top:453.7pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">220&#x2013;280 g; </span></p>
<p style="top:453.7pt;left:409.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (88)</span></p>
<p style="top:396.7pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">RZD supp via </span></p>
<p style="top:392.7pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:388.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle</span></p>
<p style="top:232.8pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 4 hr post-injury </span></p>
<p style="top:228.8pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then one dose per 24 hr </span></p>
<p style="top:228.8pt;left:409.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">until sacrifice (14 or </span></p>
<p style="top:228.8pt;left:420.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 days)</span></p>
<p style="top:128.9pt;left:387.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">20 mg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xing et al. (2016) </span></p>
<p style="top:716.8pt;left:444.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:444.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 6)</span></p>
<p style="top:566.5pt;left:433.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200&#x2013;250 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (182)</span></p>
<p style="top:396.7pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">XFZY supp </span></p>
<p style="top:392.7pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage in </span></p>
<p style="top:392.7pt;left:455.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">low and high </span></p>
<p style="top:392.7pt;left:465.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dosage</span></p>
<p style="top:329.9pt;left:434.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle; </span></p>
<p style="top:325.9pt;left:444.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle; </span></p>
<p style="top:325.9pt;left:455.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> low XFZY dose; </span></p>
<p style="top:325.9pt;left:465.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> high XFZY dose</span></p>
<p style="top:232.8pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose immediately </span></p>
<p style="top:228.8pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">post-injury then 1 dose </span></p>
<p style="top:228.8pt;left:455.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">per 24 hr until sacrifice </span></p>
<p style="top:228.8pt;left:465.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(24 hr, 72 hr, 7 days, </span></p>
<p style="top:228.8pt;left:476.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">14 days, 21 days)</span></p>
<p style="top:128.9pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low XFZY: 9 g/kg; high </span></p>
<p style="top:124.9pt;left:444.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">XFZY: 18 g/kg</span></p>
<p style="top:720.8pt;left:490.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xu et al. (2017) </span></p>
<p style="top:716.8pt;left:500.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:490.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:500.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 6)</span></p>
<p style="top:566.5pt;left:489.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:490.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200&#x2013;300 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:500.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (108)</span></p>
<p style="top:396.7pt;left:490.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rhubarb (low, </span></p>
<p style="top:392.7pt;left:500.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate, high) </span></p>
<p style="top:392.7pt;left:511.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">or rhein (single </span></p>
<p style="top:392.7pt;left:521.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dose) supp via </span></p>
<p style="top:392.7pt;left:532.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:329.9pt;left:490.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham; TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> vehicle</span></p>
<p style="top:232.8pt;left:490.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immediately post-injury (8, </span></p>
<p style="top:228.8pt;left:500.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12, 24 hr)</span></p>
<p style="top:128.9pt;left:490.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low rhubarb: 3 g/kg; </span></p>
<p style="top:124.9pt;left:500.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate rhubarb: 6 g/</span></p>
<p style="top:124.9pt;left:511.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">kg; high rhubarb: 9 g/</span></p>
<p style="top:124.9pt;left:521.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">kg; Rhein: 12 mg/kg</span></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:80.4pt;left:552.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;585</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:720.8pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Author (year) </span></b></p>
<p style="top:720.8pt;left:73.1pt;line-height:7.5pt"><b><i><span style="font-family:Lato,serif;font-size:7.5pt">country</span></i></b></p>
<p style="top:646.6pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal study type </span></b></p>
<p style="top:646.6pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(# of study groups)</span></b></p>
<p style="top:566.5pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Method of TBI delivery, TBI </span></b></p>
<p style="top:566.5pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">severity, mortality rate</span></b></p>
<p style="top:457.7pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Animal details </span></b></p>
<p style="top:457.7pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(</span></b><b><i><span style="font-family:Lato,serif;font-size:7.5pt">N</span></i></b><b><span style="font-family:Lato,serif;font-size:7.5pt">)</span></b></p>
<p style="top:396.7pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention</span></b></p>
<p style="top:329.9pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Controls</span></b></p>
<p style="top:232.8pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Initiation of intervention </span></b></p>
<p style="top:232.8pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">(duration of intervention)</span></b></p>
<p style="top:128.9pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Dosage</span></b></p>
<p style="top:720.8pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xie et al. (2018) </span></p>
<p style="top:716.8pt;left:99.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.6pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:99.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:88.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CCI, Mod to severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-42 to </span></p>
<p style="top:453.7pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-56; </span></p>
<p style="top:453.7pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">220&#x2013;250 g; </span></p>
<p style="top:453.7pt;left:120.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (15)</span></p>
<p style="top:396.7pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AR-RAS herbal </span></p>
<p style="top:392.7pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">formula supp </span></p>
<p style="top:392.7pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:329.9pt;left:89.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle; </span></p>
<p style="top:325.9pt;left:99.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle</span></p>
<p style="top:232.8pt;left:89.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose </span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt">45 min post-</span></p>
<p style="top:228.8pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury then 1 dose per </span></p>
<p style="top:228.8pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 hr until sacrifice </span></p>
<p style="top:228.8pt;left:120.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(14 days)</span></p>
<p style="top:128.9pt;left:88.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3.24 g</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">kg</span><span style="font-family:Lato,serif;font-size:5.2pt">&#x2212;1</span><span style="font-family:Lato,serif;font-size:7.5pt">day</span></p>
<p style="top:720.8pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kumar et al. (2014) </span></p>
<p style="top:716.8pt;left:145.3pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">India</span></i></p>
<p style="top:646.6pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:144.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 5)</span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;</span></p>
<p style="top:566.5pt;left:133.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIAI, Severe</span><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;, NR</span></p>
<p style="top:457.7pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Adult; 250&#x2013;</span></p>
<p style="top:453.7pt;left:145.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">300 g; Wistar </span></p>
<p style="top:453.7pt;left:154.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (50</span><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">&#x200a;)</span></p>
<p style="top:396.7pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Panax ginseng </span></p>
<p style="top:392.7pt;left:145.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">suspended in </span></p>
<p style="top:392.7pt;left:155.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CMC via oral </span></p>
<p style="top:392.7pt;left:166.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">route</span></p>
<p style="top:329.9pt;left:134.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> CMC vehicle; </span></p>
<p style="top:325.9pt;left:145.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> CMC vehicle</span></p>
<p style="top:232.8pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Initiated 14 days post-</span></p>
<p style="top:228.8pt;left:145.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury (14 days)</span></p>
<p style="top:128.9pt;left:134.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Panax ginseng: </span></p>
<p style="top:124.9pt;left:145.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">0.5 ml/100 g of </span></p>
<p style="top:124.9pt;left:155.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bodyweight/day; </span></p>
<p style="top:124.9pt;left:166.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">suspended in CMC </span></p>
<p style="top:124.9pt;left:176.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via oral route</span></p>
<p style="top:720.8pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang et al. (2018) </span></p>
<p style="top:716.8pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">China</span></p>
<p style="top:646.6pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.6pt;left:201.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 3)</span></p>
<p style="top:566.5pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIAI x 3, Severe, NR</span></p>
<p style="top:457.7pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND70 to </span></p>
<p style="top:453.7pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PND-77; </span></p>
<p style="top:453.7pt;left:211.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">260&#x2013;300 g; </span></p>
<p style="top:453.7pt;left:222.3pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> rats (30)</span></p>
<p style="top:396.7pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Berberine supp </span></p>
<p style="top:392.7pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:329.9pt;left:190.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle; </span></p>
<p style="top:325.9pt;left:201.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> saline vehicle</span></p>
<p style="top:232.8pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 24 hr post-injury </span></p>
<p style="top:228.8pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 1 dose per 24 hr until </span></p>
<p style="top:228.8pt;left:211.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sacrifice (4 weeks)</span></p>
<p style="top:128.9pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">200 mg/kg of </span></p>
<p style="top:124.9pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bodyweight/day</span></p>
<p style="top:720.8pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhao et al. (2014) </span></p>
<p style="top:716.8pt;left:246.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">China</span></i></p>
<p style="top:646.7pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Random pre-clinical </span></p>
<p style="top:642.7pt;left:246.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(</span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span><span style="font-family:STIX,serif;font-size:7.5pt">=</span><span style="font-family:Lato,serif;font-size:7.5pt"> 5)</span></p>
<p style="top:566.5pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feeney weight drop, UC, NR</span></p>
<p style="top:457.7pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">250&#x2013;280 g; </span><i><span style="font-family:Lato,serif;font-size:7.5pt">SD</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> </span></p>
<p style="top:453.7pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats (50)</span></p>
<p style="top:396.7pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MSD supp via </span></p>
<p style="top:392.7pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage in low, </span></p>
<p style="top:392.7pt;left:257.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate, and </span></p>
<p style="top:392.7pt;left:267.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">high dosage</span></p>
<p style="top:329.9pt;left:236.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sham </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> distilled water; </span></p>
<p style="top:325.9pt;left:246.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> distilled water</span></p>
<p style="top:232.9pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">First dose 6 hr post-injury </span></p>
<p style="top:228.9pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">then 2 doses per 24 hr </span></p>
<p style="top:228.9pt;left:257.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">until sacrifice (24 hr, 72 hr, </span></p>
<p style="top:228.9pt;left:267.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5 days, 14 days)</span></p>
<p style="top:128.9pt;left:236.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low MSD: 0.5 ml/200 g; </span></p>
<p style="top:125.0pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate MSD: </span></p>
<p style="top:125.0pt;left:257.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1.0 ml/200 g; high </span></p>
<p style="top:125.0pt;left:267.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MSD: 2.0 ml/200 g</span></p>
<p style="top:727.6pt;left:283.2pt;line-height:5.2pt"><span style="font-family:Lato,serif;font-size:5.2pt">a</span><span style="font-family:Lato,serif;font-size:7.5pt">Inferred based on available information and criteria summarized by (Ma et al., 2019; Siebold et al., 2018). </span></p>
<p style="top:727.6pt;left:295.2pt;line-height:5.2pt"><span style="font-family:Lato,serif;font-size:5.2pt">b</span><span style="font-family:Lato,serif;font-size:7.5pt">Additional groups and were present in study but were excluded due to being outside scope of review. </span></p>
<p style="top:727.6pt;left:307.2pt;line-height:5.2pt"><span style="font-family:Lato,serif;font-size:5.2pt">c</span><span style="font-family:Lato,serif;font-size:7.5pt">Information acquired by contacting corresponding author. </span></p>
<p style="top:725.8pt;left:320.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Abbreviations: Mod, moderate TBI; NR, not reported in published article and not obtained by contacting author; supp, supplementation; Std, standard; UC, unclear in published article and not obtained by </span></p>
<p style="top:725.8pt;left:330.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">contacting author.</span></p>
<p style="top:725.4pt;left:43.3pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">586&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">Summary of biomarkers assessed and neurophysiological outcomes</span></p>
<p style="top:642.4pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:513.1pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:373.7pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:185.6pt;left:64.2pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:185.6pt;left:74.7pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:720.8pt;left:90.9pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Anti-oxidants</span></i></p>
<p style="top:720.8pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Toklu et al. (2009)</span></p>
<p style="top:642.4pt;left:104.7pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid (ALA) delivered via </span></p>
<p style="top:638.4pt;left:115.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.1pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Evans blue extravasation, brain water </span></p>
<p style="top:509.1pt;left:115.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">content</span></p>
<p style="top:373.8pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.4pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.6pt;left:104.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ALA &#x2193; oxidative stress, &#x2193; BBB </span></p>
<p style="top:181.6pt;left:115.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">disruption, and &#x2193; immune response </span></p>
<p style="top:181.6pt;left:125.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">versus control @ 48 hr post-injury</span></p>
<p style="top:513.1pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Luminol and lucigenin </span></p>
<p style="top:509.1pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">chemiluminescence, TBARS, GSH, </span></p>
<p style="top:509.1pt;left:150.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MPO</span></p>
<p style="top:373.8pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:164.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Na-K-ATPase activity</span></p>
<p style="top:373.8pt;left:164.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:164.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:178.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TNF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">, IL-1</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span></p>
<p style="top:373.8pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:192.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Itoh et al. (2013)</span></p>
<p style="top:642.4pt;left:192.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">EGCG dissolved in drinking water</span></p>
<p style="top:513.1pt;left:192.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">8-OHdG, 4-HNE positive cells; and </span></p>
<p style="top:509.1pt;left:203.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MDA levels</span></p>
<p style="top:373.8pt;left:192.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:192.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:192.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">EGCG &#x2193; oxidative stress and &#x2193; apoptosis </span></p>
<p style="top:181.7pt;left:203.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">versus control @ pid 1 and 3; EGCG &#x2193; </span></p>
<p style="top:181.7pt;left:213.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">glial activation versus control @ pid 7</span></p>
<p style="top:513.1pt;left:217.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NeuN, ssDNA, Bcl-2 positive cells</span></p>
<p style="top:373.8pt;left:217.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:227.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:217.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:513.1pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GFAP positive cells</span></p>
<p style="top:373.8pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glial activation</span></p>
<p style="top:273.5pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:255.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ozbal et al. (2015)</span></p>
<p style="top:642.4pt;left:255.4pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-Lipoic acid (ALA) delivered via </span></p>
<p style="top:638.4pt;left:266.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage in low and high dose</span></p>
<p style="top:513.1pt;left:255.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Neuron density; caspase-3, and </span></p>
<p style="top:509.1pt;left:266.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TUNEL positive cells</span></p>
<p style="top:373.8pt;left:255.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:266.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:255.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:255.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ALA &#x2193; morphological changes and </span></p>
<p style="top:181.7pt;left:266.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">apoptosis versus control in the cortex </span></p>
<p style="top:181.7pt;left:276.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and hippocampus; ALA &#x2193; oxidative </span></p>
<p style="top:181.7pt;left:287.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stress versus control @ 48 hr post-</span></p>
<p style="top:181.7pt;left:297.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury; benefit limited to cortex; greater </span></p>
<p style="top:181.7pt;left:308.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">benefits associated with higher dosage</span></p>
<p style="top:513.1pt;left:280.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GPx, SOD, and MDA levels</span></p>
<p style="top:373.8pt;left:280.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:280.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.9pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wei et al. (2015)</span></p>
<p style="top:642.5pt;left:322.0pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid (ALA) delivered via </span></p>
<p style="top:638.5pt;left:332.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.1pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caspase-3, Cytochrome C, Bax </span></p>
<p style="top:509.1pt;left:332.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">expression; Nissl body staining, </span></p>
<p style="top:509.1pt;left:343.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TUNEL positive cells</span></p>
<p style="top:373.8pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:332.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ALA &#x2193; morphological changes and </span></p>
<p style="top:181.7pt;left:332.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">apoptosis, &#x2193; oxidative stress, and </span></p>
<p style="top:181.7pt;left:343.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; edema versus control @ 48 hr </span></p>
<p style="top:181.7pt;left:353.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">post-injury</span></p>
<p style="top:513.1pt;left:357.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MDA and GPx activity</span></p>
<p style="top:373.8pt;left:357.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:357.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.2pt;left:371.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain water content</span></p>
<p style="top:373.8pt;left:371.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:371.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.9pt;left:385.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cheng et al. (2016)</span></p>
<p style="top:642.5pt;left:385.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(-)-Epicatechin supplementation </span></p>
<p style="top:638.5pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage in low, </span></p>
<p style="top:638.5pt;left:406.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate, high dose</span></p>
<p style="top:513.2pt;left:385.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fluoro-jade, Nissl body and propidium </span></p>
<p style="top:509.2pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">iodide staining; TUNEL positive cells</span></p>
<p style="top:373.8pt;left:385.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:385.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:385.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(-)-Epicatechin &#x2193; morphological changes </span></p>
<p style="top:181.7pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis, &#x2193; oxidative stress, and &#x2193; </span></p>
<p style="top:181.7pt;left:406.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">edema @ pid 3; &#x2193; myelin damage versus </span></p>
<p style="top:181.7pt;left:416.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ pid 28; greater benefits </span></p>
<p style="top:181.7pt;left:427.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">associated with higher dosage within </span></p>
<p style="top:181.7pt;left:437.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acute phase; dosing not compared for </span></p>
<p style="top:181.7pt;left:448.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">all outcomes</span></p>
<p style="top:513.2pt;left:409.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain water content</span></p>
<p style="top:373.9pt;left:409.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:409.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.2pt;left:424.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MPO, HO-1, oxidized hydroethidine, </span></p>
<p style="top:509.2pt;left:434.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Perls staining</span></p>
<p style="top:373.9pt;left:424.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:424.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.2pt;left:448.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MBP, Luxol fast blue staining; MMP-2 </span></p>
<p style="top:509.2pt;left:459.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and MMP-9 activity</span></p>
<p style="top:373.9pt;left:448.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.9pt;left:459.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:273.6pt;left:448.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.9pt;left:473.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ji et al. (2017)</span></p>
<p style="top:642.5pt;left:473.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Astaxanthin diluted in olive oil </span></p>
<p style="top:638.5pt;left:483.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage</span></p>
<p style="top:513.2pt;left:471.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lesion volume, cell density (mm</span><span style="font-family:Lato,serif;font-size:5.2pt">3</span><span style="font-family:Lato,serif;font-size:7.5pt">)</span></p>
<p style="top:373.7pt;left:473.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.7pt;left:483.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.4pt;left:473.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:473.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Astaxanthin &#x2193; lesion volume, &#x2191; cell </span></p>
<p style="top:181.6pt;left:483.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">density and &#x2191; markers of plasticity, </span></p>
<p style="top:181.6pt;left:494.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and neurogenesis </span></p>
<p style="top:181.6pt;left:504.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">astaxanthin versus control @ pid 7</span></p>
<p style="top:513.1pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Synapsin, GAP43, SYP, BDNF</span></p>
<p style="top:373.7pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:508.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:518.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.4pt;left:497.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:82.1pt;left:542.6pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;587</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:82.1pt;left:524.4pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:642.4pt;left:104.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:513.1pt;left:104.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:373.7pt;left:104.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:185.6pt;left:93.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:185.6pt;left:104.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:720.8pt;left:120.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jiang et al. (2017)</span></p>
<p style="top:642.4pt;left:120.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Catechin supplementation </span></p>
<p style="top:638.4pt;left:130.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage</span></p>
<p style="top:513.1pt;left:120.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain infarction volume</span></p>
<p style="top:373.8pt;left:120.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:130.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.4pt;left:120.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:120.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Catechin &#x2193; infarction volume, &#x2193; BBB </span></p>
<p style="top:181.6pt;left:130.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">disruption, &#x2193; immune response versus </span></p>
<p style="top:181.6pt;left:141.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ 24 hr post-injury; greater </span></p>
<p style="top:181.6pt;left:151.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">benefit associated with higher dosages</span></p>
<p style="top:513.1pt;left:144.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain water content, Evans blue </span></p>
<p style="top:509.1pt;left:155.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">extravasation, occludin, ZO-1</span></p>
<p style="top:373.8pt;left:144.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:144.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:169.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">IL-1</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">, iNOS, IL-6, arginase</span></p>
<p style="top:373.8pt;left:169.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:169.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:183.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Krishna et al. (2019)</span></p>
<p style="top:642.4pt;left:183.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5% Blueberry-enriched diet</span></p>
<p style="top:513.1pt;left:183.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BDNF, CREB, and CaMKII</span></p>
<p style="top:373.8pt;left:183.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:193.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:204.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:183.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.6pt;left:183.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Blueberry-enriched diet &#x2193; oxidative </span></p>
<p style="top:181.6pt;left:193.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stress versus control; blueberry &#x2191; </span></p>
<p style="top:181.6pt;left:204.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">markers of plasticity versus control @ </span></p>
<p style="top:181.6pt;left:214.7pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt"> pid 22; these &#x2191; were associated with </span></p>
<p style="top:181.6pt;left:225.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">improved behavioral outcomes</span></p>
<p style="top:513.1pt;left:218.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4-HNE</span></p>
<p style="top:373.8pt;left:218.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:218.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:239.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Branched chain amino acids</span></i></p>
<p style="top:720.8pt;left:253.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cole et al. (2010)</span></p>
<p style="top:642.4pt;left:253.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tap water containing valine, </span></p>
<p style="top:638.4pt;left:264.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">leucine, and isoleucine; or tap </span></p>
<p style="top:638.4pt;left:274.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">water containing phenylalanine</span></p>
<p style="top:513.1pt;left:253.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BCAA concentrations, net synaptic </span></p>
<p style="top:509.1pt;left:264.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">efficacy, Glutamate, GABA, BCATc, </span></p>
<p style="top:509.1pt;left:274.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BCATm, BCKD, GAD, GDH, AAT1, </span></p>
<p style="top:509.1pt;left:285.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AAT2</span></p>
<p style="top:373.7pt;left:253.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:264.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:274.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.4pt;left:253.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.6pt;left:253.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">LIV BCAAs &#x2191; net synaptic efficacy </span></p>
<p style="top:181.6pt;left:264.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">versus control @ pid 7; TBI &#x2193; </span></p>
<p style="top:181.6pt;left:274.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BCAA transanimation and enzymes </span></p>
<p style="top:181.6pt;left:285.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">responsible for glutamate metabolism</span></p>
<p style="top:720.8pt;left:299.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lim et al. (2013)</span></p>
<p style="top:642.4pt;left:299.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tap water containing valine, </span></p>
<p style="top:638.4pt;left:309.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">leucine, and isoleucine</span></p>
<p style="top:513.1pt;left:299.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Orexin activated neurons</span></p>
<p style="top:373.8pt;left:299.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:309.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:320.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.4pt;left:299.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.6pt;left:299.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BCAAs &#x2191; orexin activated neurons </span></p>
<p style="top:181.6pt;left:309.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">versus control @ pid 28, restoring </span></p>
<p style="top:181.6pt;left:320.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">regulation of arousal and wakefulness</span></p>
<p style="top:720.8pt;left:334.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elliott et al. (2018)</span></p>
<p style="top:642.4pt;left:334.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tap water containing valine, </span></p>
<p style="top:638.4pt;left:344.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">leucine, and isoleucine</span></p>
<p style="top:513.1pt;left:334.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glutamate and GABA labeling</span></p>
<p style="top:373.8pt;left:334.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:344.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:355.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:334.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.6pt;left:334.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BCAA &#x2191; excitatory signaling in </span></p>
<p style="top:181.6pt;left:344.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">presynaptic terminals of hypothalamus </span></p>
<p style="top:181.6pt;left:355.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and &#x2193; excitatory signaling in </span></p>
<p style="top:181.6pt;left:365.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">presynaptic terminals of cortex versus </span></p>
<p style="top:181.6pt;left:376.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ pid 7; no difference in </span></p>
<p style="top:181.6pt;left:386.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">inhibitory signaling in hypothalamus or </span></p>
<p style="top:181.6pt;left:397.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cortex</span></p>
<p style="top:720.8pt;left:411.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Creatine</span></i></p>
<p style="top:720.8pt;left:425.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Saraiva et al. (2012)</span></p>
<p style="top:642.4pt;left:425.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Creatine supplementation </span></p>
<p style="top:638.4pt;left:435.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage</span></p>
<p style="top:513.1pt;left:425.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBARS levels, protein carbonylation</span></p>
<p style="top:373.8pt;left:425.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:425.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:425.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Creatine &#x2193; oxidative stress versus </span></p>
<p style="top:181.6pt;left:435.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ pid 4 and 8</span></p>
<p style="top:513.1pt;left:438.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Na</span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> -K</span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> ATPase activity</span></p>
<p style="top:373.8pt;left:439.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:439.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NC</span></p>
<p style="top:720.8pt;left:453.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gerbatin </span></p>
<p style="top:716.8pt;left:463.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019)</span></p>
<p style="top:642.4pt;left:453.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Creatine supplementation </span></p>
<p style="top:638.4pt;left:463.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage</span></p>
<p style="top:513.1pt;left:453.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell loss</span></p>
<p style="top:373.8pt;left:453.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:463.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:453.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:453.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; cell loss within hippocampus and &#x2191; </span></p>
<p style="top:181.7pt;left:463.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">inhibitory action creatine versus control </span></p>
<p style="top:181.7pt;left:474.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 35</span></p>
<p style="top:513.1pt;left:477.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GABAergic inhibitory neurons, GAD, </span></p>
<p style="top:509.1pt;left:488.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GAD67, and [3H]flunitrazepam </span></p>
<p style="top:509.1pt;left:498.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">binding</span></p>
<p style="top:373.8pt;left:477.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:488.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:498.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:477.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:725.4pt;left:73.9pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">588&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:642.4pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:513.1pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:373.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:185.6pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:185.6pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:720.8pt;left:91.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Fasting and caloric restriction</span></i></p>
<p style="top:720.8pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Davis et al. (2008)</span></p>
<p style="top:642.4pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fasting</span></p>
<p style="top:513.1pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tissue sparing</span></p>
<p style="top:373.8pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.4pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.6pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">24 hr fast &#x2191; tissue sparing and &#x2193; </span></p>
<p style="top:181.6pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oxidative stress versus control @ 24 hr </span></p>
<p style="top:181.6pt;left:126.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">post moderate TBI; no differences in </span></p>
<p style="top:181.6pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tissue sparing 24 hr fast post severe </span></p>
<p style="top:181.6pt;left:147.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TBI; nor 48 hr fast @ 48 hr post </span></p>
<p style="top:181.6pt;left:157.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate or severe TBI</span></p>
<p style="top:513.1pt;left:128.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ca</span><span style="font-family:Lato,serif;font-size:5.2pt">2</span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> load and mitochondrial complex </span></p>
<p style="top:509.1pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">function</span></p>
<p style="top:373.7pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.4pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:154.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ROS production, protein carbonyls, </span></p>
<p style="top:509.1pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and lipid peroxidation</span></p>
<p style="top:373.8pt;left:154.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.4pt;left:154.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liu et al. (2017)</span></p>
<p style="top:642.4pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caloric restriction</span></p>
<p style="top:513.1pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nissl bodies</span></p>
<p style="top:373.8pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:178.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caloric restriction &#x2191; autophagy, &#x2193; glial </span></p>
<p style="top:181.6pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">activation, &#x2191; cell density compared to </span></p>
<p style="top:181.6pt;left:199.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control and high energy group @ pid 36</span></p>
<p style="top:513.1pt;left:203.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GFAP positive cells</span></p>
<p style="top:373.8pt;left:203.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glial activation</span></p>
<p style="top:273.5pt;left:203.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:217.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mTOR, LC3B and Beclin-1 positive </span></p>
<p style="top:509.1pt;left:227.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cells</span></p>
<p style="top:373.8pt;left:217.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:217.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.8pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rubovitch </span></p>
<p style="top:716.8pt;left:252.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019)</span></p>
<p style="top:642.4pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Intermittent fasting or caloric </span></p>
<p style="top:638.4pt;left:252.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">restriction</span></p>
<p style="top:513.1pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SIRT1 expression</span></p>
<p style="top:373.8pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.7pt;left:241.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caloric restriction and intermittent </span></p>
<p style="top:181.7pt;left:252.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fasting &#x2191; energy metabolism versus </span></p>
<p style="top:181.7pt;left:262.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ pid 30 in cortex; only fasting </span></p>
<p style="top:181.7pt;left:273.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191; energy metabolism versus control in </span></p>
<p style="top:181.7pt;left:283.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">hippocampus @ pid 30</span></p>
<p style="top:720.8pt;left:297.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Ketogenic diet</span></i></p>
<p style="top:720.8pt;left:311.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins et al. (2005)</span></p>
<p style="top:642.4pt;left:311.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:513.1pt;left:311.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fluoro-jade staining, contusion </span></p>
<p style="top:509.1pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">volume, and neuronal preservation</span></p>
<p style="top:373.8pt;left:311.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:311.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.7pt;left:311.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD &#x2193; cellular degeneration versus </span></p>
<p style="top:181.7pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ 6 and 24 hr post-injury; and </span></p>
<p style="top:181.7pt;left:332.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; contusion volume versus control @ </span></p>
<p style="top:181.7pt;left:343.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pid 7, benefits were specific to the pre-</span></p>
<p style="top:181.7pt;left:353.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">adolescent and adolescent animals</span></p>
<p style="top:513.1pt;left:336.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma glucose, lactate, and </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">OHB </span></p>
<p style="top:509.1pt;left:346.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">levels</span></p>
<p style="top:373.8pt;left:336.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:336.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:720.8pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Wang, Jin, </span></p>
<p style="top:716.8pt;left:378.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2009)</span></p>
<p style="top:642.4pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:513.1pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TUNEL positive cells, caspase-3 </span></p>
<p style="top:509.1pt;left:378.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">positive cells, cytosolic cytochrome </span></p>
<p style="top:509.1pt;left:388.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">c release, and mitochondrial </span></p>
<p style="top:509.1pt;left:399.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cytochrome c release</span></p>
<p style="top:373.8pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:378.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD &#x2193; apoptosis, &#x2193; mitochondrial </span></p>
<p style="top:181.7pt;left:378.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dysfunction, and &#x2193; edema versus </span></p>
<p style="top:181.7pt;left:388.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ 72 hr post-injury</span></p>
<p style="top:513.1pt;left:413.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma glucose and </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">OHB levels</span></p>
<p style="top:373.8pt;left:413.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:413.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:427.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain water content</span></p>
<p style="top:373.8pt;left:427.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:427.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.9pt;left:441.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Wang, Qiao, </span></p>
<p style="top:716.9pt;left:452.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2009)</span></p>
<p style="top:642.5pt;left:441.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:513.1pt;left:441.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TUNEL positive cells, Bax mRNA, and </span></p>
<p style="top:509.1pt;left:452.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bcl-2 mRNA</span></p>
<p style="top:373.8pt;left:441.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:452.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:441.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:441.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD &#x2193; apoptosis and &#x2193; edema versus </span></p>
<p style="top:181.7pt;left:452.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ 72 hr post-injury</span></p>
<p style="top:513.1pt;left:465.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">OHB levels</span></p>
<p style="top:373.8pt;left:466.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:466.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:480.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain water content</span></p>
<p style="top:373.8pt;left:480.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:480.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.9pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins and Hovda </span></p>
<p style="top:716.9pt;left:504.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2009)</span></p>
<p style="top:642.5pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:513.2pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Contusion volume</span></p>
<p style="top:373.8pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:504.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.7pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD &#x2193; contusion volume and &#x2193; cerebral </span></p>
<p style="top:181.7pt;left:504.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">metabolic rates of glucose in ipsilateral </span></p>
<p style="top:181.7pt;left:515.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cortex, hippocampus, and thalamus </span></p>
<p style="top:181.7pt;left:525.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 1, 3, and 7, benefits limited to </span></p>
<p style="top:181.7pt;left:536.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">younger animals</span></p>
<p style="top:513.2pt;left:518.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cerebral metabolic rates for glucose; </span></p>
<p style="top:509.2pt;left:528.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plasma glucose, lactate, and </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">OHB </span></p>
<p style="top:509.2pt;left:539.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">levels</span></p>
<p style="top:373.8pt;left:518.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:518.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:80.4pt;left:566.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;589</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:641.5pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:512.2pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:372.9pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:184.8pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:184.8pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:719.9pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schwartzkroin </span></p>
<p style="top:715.9pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2010)</span></p>
<p style="top:641.5pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:512.2pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell counts; dorsal hippocampal </span></p>
<p style="top:508.2pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">volume</span></p>
<p style="top:372.9pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:368.9pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:272.6pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NC</span></p>
<p style="top:184.8pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">No difference cell loss KD versus control </span></p>
<p style="top:180.8pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 63; KD &#x2193; amount of astrogliosis </span></p>
<p style="top:180.8pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and microgliosis versus control @ pid 63</span></p>
<p style="top:512.2pt;left:113.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hippocampal astrogliosis and </span></p>
<p style="top:508.2pt;left:124.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">microgliosis</span></p>
<p style="top:372.9pt;left:113.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glial activation</span></p>
<p style="top:272.6pt;left:113.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.0pt;left:138.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Deng-Bryant </span></p>
<p style="top:716.0pt;left:148.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2011)</span></p>
<p style="top:641.5pt;left:138.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:512.2pt;left:138.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma glucose, lactate, </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">OHB </span></p>
<p style="top:508.2pt;left:148.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">levels; nuclear magnetic resonance </span></p>
<p style="top:508.2pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">spectroscopy to quantify </span></p>
<p style="top:508.2pt;left:169.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">metabolites within brain: ATP, </span></p>
<p style="top:508.2pt;left:180.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">creatine, phosphocreatine, GABA, </span></p>
<p style="top:508.2pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">glutamate, glutamine, choline, </span></p>
<p style="top:508.2pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">taurine, glycine, myo-inositol, </span></p>
<p style="top:508.2pt;left:211.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">aspartate, alanine, NAA, lactate, </span></p>
<p style="top:508.2pt;left:222.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">PEtn, PChol, GroPEtn, GroP-Chol, </span></p>
<p style="top:508.2pt;left:232.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and NAD</span></p>
<p style="top:372.9pt;left:138.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:272.6pt;left:138.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:184.8pt;left:138.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mixed results of KD on energy </span></p>
<p style="top:180.8pt;left:148.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">metabolites versus control; results </span></p>
<p style="top:180.8pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">were age and time post-injury specific; </span></p>
<p style="top:180.8pt;left:169.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">broadly, KD &#x2193; metabolic deficits in </span></p>
<p style="top:180.8pt;left:180.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">younger animals versus control</span></p>
<p style="top:720.0pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Greco et al. (2016)</span></p>
<p style="top:641.6pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:512.2pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3NT, 4-HNE, SOD1, SOD2, and </span></p>
<p style="top:508.2pt;left:257.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NQO1</span></p>
<p style="top:372.9pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:272.6pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:184.8pt;left:246.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD &#x2193; oxidative stress versus control. </span></p>
<p style="top:180.8pt;left:257.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Benefits varied between 6&#x2013;24 hr post-</span></p>
<p style="top:180.8pt;left:267.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury, and were limited to younger </span></p>
<p style="top:180.8pt;left:278.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">animals</span></p>
<p style="top:512.2pt;left:271.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mitochondrial complex function</span></p>
<p style="top:372.9pt;left:271.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:272.6pt;left:271.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:720.0pt;left:292.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhang et al. (2018)</span></p>
<p style="top:641.6pt;left:292.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">KD</span></p>
<p style="top:512.3pt;left:292.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">OHB levels; NAA:creatine </span></p>
<p style="top:508.2pt;left:302.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ratio and choline:creatine ratio</span></p>
<p style="top:372.9pt;left:292.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:272.6pt;left:292.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:184.8pt;left:292.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mixed results of KD on energy </span></p>
<p style="top:180.8pt;left:302.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">metabolism versus control @ pid 7; </span></p>
<p style="top:180.8pt;left:313.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">no difference in edema between all </span></p>
<p style="top:180.8pt;left:323.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">groups; &#x2191; autophagy KD versus control </span></p>
<p style="top:180.8pt;left:334.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 7</span></p>
<p style="top:512.3pt;left:317.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain edema</span></p>
<p style="top:372.9pt;left:317.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:272.6pt;left:317.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NC</span></p>
<p style="top:512.3pt;left:331.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Beclin-1 expression</span></p>
<p style="top:372.9pt;left:331.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:272.6pt;left:331.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.0pt;left:348.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Multi-supplement</span></i></p>
<p style="top:720.0pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu et al. (2014)</span></p>
<p style="top:641.6pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Curcumin-enriched diet, </span></p>
<p style="top:637.6pt;left:373.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA-enriched diet, or </span></p>
<p style="top:637.6pt;left:383.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">curcumin </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> DHA-enriched diet</span></p>
<p style="top:512.3pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BDNF and p-TrkB</span></p>
<p style="top:373.0pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.0pt;left:373.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.0pt;left:383.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:272.6pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:184.8pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA and curcumin (in isolation and </span></p>
<p style="top:180.8pt;left:373.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">combination) &#x2193; oxidative stress, &#x2191; cell </span></p>
<p style="top:180.8pt;left:383.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis, and &#x2191; markers </span></p>
<p style="top:180.8pt;left:394.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of plasticity versus control @ pid 14; </span></p>
<p style="top:180.8pt;left:404.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">combination of DHA and curcumin </span></p>
<p style="top:180.8pt;left:415.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">elicited greater benefits than either in </span></p>
<p style="top:180.8pt;left:425.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">isolation</span></p>
<p style="top:512.3pt;left:397.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4-HNE and 4-HHE</span></p>
<p style="top:373.0pt;left:397.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:272.7pt;left:397.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:512.3pt;left:411.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">FADS2, 17</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">-HSD4, DHA content, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">n</span></i><span style="font-family:Lato,serif;font-size:7.5pt">-3 </span></p>
<p style="top:508.3pt;left:422.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DPA content, and serum cholesterol</span></p>
<p style="top:373.0pt;left:411.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.0pt;left:422.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:272.7pt;left:411.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.0pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Thau-Zuchman </span></p>
<p style="top:716.0pt;left:450.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2019)</span></p>
<p style="top:641.6pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fortasyn Connect multi-</span></p>
<p style="top:637.6pt;left:450.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplement enriched diet</span></p>
<p style="top:512.3pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lesion size</span></p>
<p style="top:373.0pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.0pt;left:450.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:272.7pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:184.8pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Multi-supplement &#x2193; morphological </span></p>
<p style="top:180.8pt;left:450.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">changes and apoptosis, &#x2191; cell </span></p>
<p style="top:180.8pt;left:460.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis, &#x2193; glial </span></p>
<p style="top:180.8pt;left:471.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">activation, and &#x2191; markers of plasticity </span></p>
<p style="top:180.8pt;left:481.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and neurogenesis versus control @ pid </span></p>
<p style="top:180.8pt;left:492.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">70</span></p>
<p style="top:512.3pt;left:464.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Iba-1, TSPO, GFAP, APC positive cells, </span></p>
<p style="top:508.3pt;left:474.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and NogoA levels</span></p>
<p style="top:373.0pt;left:464.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glial activation</span></p>
<p style="top:272.7pt;left:464.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:512.3pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BrdU positive cells, DCX positive cells, </span></p>
<p style="top:508.3pt;left:498.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">synaptophysin, and </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">-APP levels</span></p>
<p style="top:373.0pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.0pt;left:499.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.0pt;left:509.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:272.7pt;left:488.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:512.3pt;left:523.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma AA, EPA and DHA levels; </span></p>
<p style="top:508.3pt;left:534.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MBP, phosphatidylcholine and </span></p>
<p style="top:508.3pt;left:544.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">phosphatidylethanolamine levels</span></p>
<p style="top:373.0pt;left:523.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.0pt;left:534.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:272.7pt;left:523.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:724.5pt;left:43.3pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:81.3pt;left:559.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">590&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:642.4pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:513.1pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:373.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:185.6pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:185.6pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:720.8pt;left:91.0pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Polyunsaturated fatty acids</span></i></p>
<p style="top:720.8pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bailes and Mills </span></p>
<p style="top:716.8pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2010)</span></p>
<p style="top:642.4pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low or high DHA-enriched diet</span></p>
<p style="top:513.1pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Caspase-3 positive axons</span></p>
<p style="top:373.7pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.4pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:105.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Both low and high dose of DHA </span></p>
<p style="top:181.6pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; apoptosis, &#x2191; cell membrane </span></p>
<p style="top:181.6pt;left:126.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis, and &#x2193; number of injured </span></p>
<p style="top:181.6pt;left:136.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">axons versus control @ pid 30; high </span></p>
<p style="top:181.6pt;left:147.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dose DHA had greater benefit on </span></p>
<p style="top:181.6pt;left:157.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis than low dose</span></p>
<p style="top:513.1pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Serum DHA and EPA levels; AA:EPA </span></p>
<p style="top:509.1pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ratio</span></p>
<p style="top:373.8pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.8pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:273.4pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:153.8pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">-APP-positive axons</span></p>
<p style="top:373.8pt;left:154.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:175.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.4pt;left:154.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.8pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shin and Dixon </span></p>
<p style="top:716.8pt;left:199.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2011)</span></p>
<p style="top:642.4pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fish oil supplementation delivered </span></p>
<p style="top:638.4pt;left:199.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:513.1pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dopamine release</span></p>
<p style="top:373.8pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:199.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:210.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.6pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fish oil &#x2191; dopamine release versus </span></p>
<p style="top:181.6pt;left:199.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ pid 7</span></p>
<p style="top:720.8pt;left:224.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mills et al. (2011)</span></p>
<p style="top:642.4pt;left:223.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low or high fish oil (EPA </span><span style="font-family:STIX,serif;font-size:7.5pt">+</span><span style="font-family:Lato,serif;font-size:7.5pt"> DHA) </span></p>
<p style="top:638.4pt;left:234.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.4pt;left:245.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.1pt;left:224.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Axons positive for active caspase-3 </span></p>
<p style="top:509.1pt;left:234.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and cytochrome c</span></p>
<p style="top:373.8pt;left:224.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:234.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:224.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.6pt;left:224.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mixed results for influence of fish oil on </span></p>
<p style="top:181.6pt;left:234.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">apoptosis versus control @ pid 30; fish </span></p>
<p style="top:181.6pt;left:245.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oil &#x2191; cell membrane homeostasis, and &#x2193; </span></p>
<p style="top:181.6pt;left:255.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">axonal damage versus control @ pid 30; </span></p>
<p style="top:181.6pt;left:266.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">no apparent differences between fish </span></p>
<p style="top:181.6pt;left:276.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oil dosages</span></p>
<p style="top:513.1pt;left:248.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AA:EPA ratio</span></p>
<p style="top:373.8pt;left:248.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.8pt;left:259.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:273.5pt;left:248.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:273.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">APP-positive axons; axons positive for </span></p>
<p style="top:509.1pt;left:283.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">active RMO-14</span></p>
<p style="top:373.8pt;left:273.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:283.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:294.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:273.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.8pt;left:308.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu et al. (2011)</span></p>
<p style="top:642.4pt;left:308.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA-enriched diet</span></p>
<p style="top:513.1pt;left:308.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4-HNE, SOD, and SIR2 levels</span></p>
<p style="top:373.8pt;left:308.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:308.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:308.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA &#x2193; oxidative stress and &#x2191; cell </span></p>
<p style="top:181.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis versus control </span></p>
<p style="top:181.7pt;left:329.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ </span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt"> pid 7&#x2013;12; DHA &#x2191; markers of </span></p>
<p style="top:181.7pt;left:339.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plasticity to sham levels @ </span><span style="font-family:STIX,serif;font-size:7.5pt">~</span><span style="font-family:Lato,serif;font-size:7.5pt"> pid 7&#x2013;12</span></p>
<p style="top:513.1pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain DHA content and iPLA2 levels</span></p>
<p style="top:373.8pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.8pt;left:332.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:273.5pt;left:322.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:346.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BDNF, CAMKII, Syn-1, CREB, and </span></p>
<p style="top:509.1pt;left:357.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">STX-3 levels</span></p>
<p style="top:373.8pt;left:346.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:357.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:367.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:346.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.8pt;left:381.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schober </span></p>
<p style="top:716.9pt;left:392.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2016)</span></p>
<p style="top:642.4pt;left:381.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA-enriched diet</span></p>
<p style="top:513.1pt;left:381.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TNF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">, IL-1B, CCL2, IL-6, IL-10, IL-2</span></p>
<p style="top:373.8pt;left:381.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:381.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.7pt;left:381.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA &#x2191; tissue sparing @ pid 3 and 50, </span></p>
<p style="top:181.7pt;left:392.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; edema @ pid 12, and &#x2193; oxidative </span></p>
<p style="top:181.7pt;left:402.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stress @ pid 1 within the cortex versus </span></p>
<p style="top:181.7pt;left:413.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control; mixed results for MRI measures </span></p>
<p style="top:181.7pt;left:423.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 12 and 28; mixed immune </span></p>
<p style="top:181.7pt;left:434.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">response DHA versus control @ pid 1 </span></p>
<p style="top:181.7pt;left:444.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and 2</span></p>
<p style="top:513.1pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NOx</span></p>
<p style="top:373.8pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:395.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.1pt;left:410.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tissue sparing and contusion volume</span></p>
<p style="top:373.8pt;left:410.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:420.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:410.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:513.2pt;left:434.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Edema</span></p>
<p style="top:373.8pt;left:434.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:434.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.2pt;left:448.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fractional anisotropy, radial </span></p>
<p style="top:509.2pt;left:459.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diffusivity, axial diffusivity, and tract </span></p>
<p style="top:509.2pt;left:469.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">volume measured by MRI</span></p>
<p style="top:373.8pt;left:448.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:459.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:469.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:448.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:720.9pt;left:483.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Su et al. (2016)</span></p>
<p style="top:642.5pt;left:483.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Moderate (1:5) or high (1:1) </span></p>
<p style="top:638.5pt;left:493.8pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-3/</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-6 ratio PUFA oil delivered </span></p>
<p style="top:638.5pt;left:504.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage</span></p>
<p style="top:513.2pt;left:483.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Evans blue extravasation, edema; </span></p>
<p style="top:509.2pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">occludin and MFSD2A levels</span></p>
<p style="top:373.9pt;left:483.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:483.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:185.7pt;left:483.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">High dose of </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-3 fatty acids &#x2193; oxidative </span></p>
<p style="top:181.7pt;left:494.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">stress and &#x2193; BBB disruption @ pid </span></p>
<p style="top:181.7pt;left:504.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">5 versus &#x201c;western diet&#x201d; control; No </span></p>
<p style="top:181.7pt;left:514.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">benefit moderate dose of </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-3 fatty </span></p>
<p style="top:181.7pt;left:525.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acids versus &#x201c;western diet&#x201d; control @ </span></p>
<p style="top:181.7pt;left:536.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pid 5</span></p>
<p style="top:513.2pt;left:508.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4-HNE</span></p>
<p style="top:373.9pt;left:508.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:508.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:80.4pt;left:558.3pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;591</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:642.4pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:513.1pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:373.7pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:185.6pt;left:62.6pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:185.6pt;left:73.1pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:720.8pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhu et al. (2017)</span></p>
<p style="top:642.4pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low or high DHA supplementation </span></p>
<p style="top:638.4pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage</span></p>
<p style="top:513.1pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gross morphology; Bcl-2, Bax, and </span></p>
<p style="top:509.1pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">caspase-3 expression</span></p>
<p style="top:373.8pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.4pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:89.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low and high dose of DHA &#x2193; </span></p>
<p style="top:181.6pt;left:99.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">morphological changes and apoptosis </span></p>
<p style="top:181.6pt;left:110.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 15 versus control; high dose &#x2193; </span></p>
<p style="top:181.6pt;left:120.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">markers of apoptosis closer to sham </span></p>
<p style="top:181.6pt;left:131.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">levels than low dose</span></p>
<p style="top:720.8pt;left:145.3pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Traditional eastern medicine</span></i></p>
<p style="top:720.8pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sharma et al. (2010)</span></p>
<p style="top:642.4pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Curcumin-enriched diet</span></p>
<p style="top:513.1pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">4-HNE levels</span></p>
<p style="top:373.7pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.4pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:159.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Curcumin &#x2193; oxidative stress, &#x2191; cell </span></p>
<p style="top:181.6pt;left:169.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis, and &#x2191; markers </span></p>
<p style="top:181.6pt;left:180.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of plasticity, neurotransmission, and </span></p>
<p style="top:181.6pt;left:190.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis versus control @ pid 15; </span></p>
<p style="top:181.6pt;left:201.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">these benefits were associated with </span></p>
<p style="top:181.6pt;left:211.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">improved behavioral outcomes</span></p>
<p style="top:513.1pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">iPLA2 and FATPs levels</span></p>
<p style="top:373.8pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.8pt;left:183.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:273.4pt;left:173.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:197.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">STX-3, GAP-43, and NR2B levels</span></p>
<p style="top:373.8pt;left:197.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:208.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:218.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:197.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.8pt;left:233.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kumar et al. (2014)</span></p>
<p style="top:642.4pt;left:233.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Panax ginseng suspended in CMC </span></p>
<p style="top:638.4pt;left:243.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via oral route in low, </span></p>
<p style="top:638.4pt;left:254.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate, and high dosage</span></p>
<p style="top:513.1pt;left:233.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MDA, GSH, nitrite, catalase, and SOD </span></p>
<p style="top:509.1pt;left:243.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">levels</span></p>
<p style="top:373.8pt;left:233.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:233.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.6pt;left:233.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Moderate and high dose of panax </span></p>
<p style="top:181.6pt;left:243.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ginseng &#x2193; oxidative stress, &#x2193; </span></p>
<p style="top:181.6pt;left:254.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">impaired neurotransmission, and &#x2193; </span></p>
<p style="top:181.6pt;left:264.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">immune response within cortex and </span></p>
<p style="top:181.6pt;left:275.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">hippocampus versus control @ pid </span></p>
<p style="top:181.6pt;left:285.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">28; no difference between low dose </span></p>
<p style="top:181.6pt;left:296.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of panax ginseng versus control for </span></p>
<p style="top:181.6pt;left:306.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">outcomes</span></p>
<p style="top:513.1pt;left:257.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Acetylcholinesterase levels</span></p>
<p style="top:373.8pt;left:257.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:268.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:278.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:257.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:292.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TNF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt"> and IL-6 levels</span></p>
<p style="top:373.8pt;left:292.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:292.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhao et al. (2014)</span></p>
<p style="top:642.4pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Modified Shengyu decoction </span></p>
<p style="top:638.4pt;left:331.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(MSD) supplementation delivered </span></p>
<p style="top:638.4pt;left:341.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">via gavage in low, moderate, and </span></p>
<p style="top:638.4pt;left:352.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">high dosage</span></p>
<p style="top:513.1pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Water content</span></p>
<p style="top:373.8pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Both moderate and high dose of MSD </span></p>
<p style="top:181.7pt;left:331.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; cell loss in cortex and hippocampus </span></p>
<p style="top:181.7pt;left:341.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 14; moderate dose MSD &#x2193; </span></p>
<p style="top:181.7pt;left:352.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">edema versus control @ pid 1, and </span></p>
<p style="top:181.7pt;left:362.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; glial activation @ pid 5 in cortex </span></p>
<p style="top:181.7pt;left:373.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and hippocampus; mixed results of </span></p>
<p style="top:181.7pt;left:383.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">moderate dose MSD on immune </span></p>
<p style="top:181.7pt;left:394.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">response versus control @ pid 3; no </span></p>
<p style="top:181.7pt;left:404.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doses led to a difference in contusion </span></p>
<p style="top:181.7pt;left:415.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">volume versus control @ pid 14</span></p>
<p style="top:513.1pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Contusion volume and neuronal loss</span></p>
<p style="top:373.8pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:345.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:334.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:513.1pt;left:358.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">IL-1</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">, IL-6, TNF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">, and IL-10 levels</span></p>
<p style="top:373.8pt;left:359.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:359.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:513.1pt;left:373.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GFAP and Iba-1 positive cells</span></p>
<p style="top:373.8pt;left:373.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glial activation</span></p>
<p style="top:273.5pt;left:373.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:720.8pt;left:429.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Cui, </span></p>
<p style="top:716.9pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2016)</span></p>
<p style="top:642.4pt;left:429.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hydroxysafflor yellow A (HYSA) </span></p>
<p style="top:638.4pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.4pt;left:450.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage in low and high dosage</span></p>
<p style="top:513.1pt;left:429.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MDA, SOD, catalase levels; and </span></p>
<p style="top:509.1pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GSH:GSSG ratio</span></p>
<p style="top:373.8pt;left:429.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:429.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:429.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Both low and high dose HSYA &#x2193; </span></p>
<p style="top:181.7pt;left:439.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">oxidative stress versus control @ 6, </span></p>
<p style="top:181.7pt;left:450.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">12, and 24 hr post-injury; high dose </span></p>
<p style="top:181.7pt;left:460.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">appeared to have greater benefit than </span></p>
<p style="top:181.7pt;left:471.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">low dose</span></p>
<p style="top:720.9pt;left:485.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Li, </span></p>
<p style="top:716.9pt;left:495.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2016)</span></p>
<p style="top:642.5pt;left:485.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rhizoma drynariae (RZD) </span></p>
<p style="top:638.5pt;left:495.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.5pt;left:506.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.1pt;left:485.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lesion volume</span></p>
<p style="top:373.8pt;left:485.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:495.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:485.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:485.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">RZD &#x2193; lesion volume @ pid 3 versus </span></p>
<p style="top:181.7pt;left:495.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control; and mixed results for immune </span></p>
<p style="top:181.7pt;left:506.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">response versus control</span></p>
<p style="top:513.1pt;left:509.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasma IL-6 and IL-10 levels</span></p>
<p style="top:373.8pt;left:509.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:509.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:725.4pt;left:43.3pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:82.1pt;left:539.2pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Continues)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">592&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:642.4pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Intervention specifics</span></b></p>
<p style="top:513.1pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Biomarkers measured</span></b></p>
<p style="top:373.7pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Neurophysiological outcome evaluated</span></b></p>
<p style="top:185.6pt;left:64.3pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">Brief summary of results and main </span></b></p>
<p style="top:185.6pt;left:74.8pt;line-height:7.5pt"><b><span style="font-family:Lato,serif;font-size:7.5pt">takeaways</span></b></p>
<p style="top:720.8pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xing et al. (2016)</span></p>
<p style="top:642.4pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xuefu Zhuyu decoction (XFZY) </span></p>
<p style="top:638.4pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.4pt;left:112.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage in low and high dosage</span></p>
<p style="top:513.1pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AKT</span></p>
<p style="top:373.8pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.4pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:185.6pt;left:91.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Low dose of XFZY &#x2193; phosphorylation </span></p>
<p style="top:181.6pt;left:101.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of markers within the PI3K/AKT/</span></p>
<p style="top:181.6pt;left:112.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mTOR signaling pathway, thereby </span></p>
<p style="top:181.6pt;left:122.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">collectively &#x2193; immune response and </span></p>
<p style="top:181.6pt;left:133.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neuroinflammation versus control @ pid </span></p>
<p style="top:181.6pt;left:143.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1, 3, 7, and 14; Low dose XFZY &#x2191; cell </span></p>
<p style="top:181.6pt;left:154.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis versus control </span></p>
<p style="top:181.6pt;left:164.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 1, 3, 7, and 14; mixed results for </span></p>
<p style="top:181.6pt;left:175.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the high dose of XFZY versus control, </span></p>
<p style="top:181.6pt;left:185.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">overall low dose associated with better </span></p>
<p style="top:181.6pt;left:196.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">outcomes versus control</span></p>
<p style="top:513.1pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mTOR</span></p>
<p style="top:373.8pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cellular energy imbalance</span></p>
<p style="top:273.5pt;left:115.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:513.1pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">p70S6K</span></p>
<p style="top:373.8pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:140.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:150.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:129.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:513.1pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AA levels</span></p>
<p style="top:373.8pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cell membrane </span></p>
<p style="top:369.8pt;left:175.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">homeostasis</span></p>
<p style="top:273.5pt;left:164.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MIX</span></p>
<p style="top:513.1pt;left:188.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">TNF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt"> and IL-1</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt"> levels</span></p>
<p style="top:373.8pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:189.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.8pt;left:210.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xu et al. (2017)</span></p>
<p style="top:642.4pt;left:210.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rhubarb (low, moderate, </span></p>
<p style="top:638.4pt;left:220.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">high) or rhein (single dose) </span></p>
<p style="top:638.4pt;left:231.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.4pt;left:241.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.1pt;left:210.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">SOD, catalase, MDA levels; </span></p>
<p style="top:509.1pt;left:220.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">GSH:GSSH ratio</span></p>
<p style="top:373.8pt;left:210.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:210.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:210.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rhubarb and rhein &#x2193; oxidative stress </span></p>
<p style="top:181.7pt;left:220.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">versus control @ 8, 16, 24 hr post-</span></p>
<p style="top:181.7pt;left:231.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury; greater benefits associated </span></p>
<p style="top:181.7pt;left:241.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">with higher dosages; similar benefit </span></p>
<p style="top:181.7pt;left:252.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">observed between high dose of rhubarb </span></p>
<p style="top:181.7pt;left:262.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and dose of rhein</span></p>
<p style="top:720.8pt;left:276.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#xd6;zevren </span></p>
<p style="top:716.8pt;left:287.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">et al. (2018)</span></p>
<p style="top:642.4pt;left:276.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ganoderma lucidum </span></p>
<p style="top:638.4pt;left:287.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.4pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.1pt;left:276.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MDA, GSH, and MPO levels</span></p>
<p style="top:373.8pt;left:276.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxidative stress</span></p>
<p style="top:273.5pt;left:276.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:276.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ganoderma lucidum &#x2193; oxidative stress, </span></p>
<p style="top:181.7pt;left:287.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193; BBB permeability, &#x2191; neurogenesis, </span></p>
<p style="top:181.7pt;left:297.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and &#x2191; immune response versus control </span></p>
<p style="top:181.7pt;left:308.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 7; no difference in apoptosis </span></p>
<p style="top:181.7pt;left:318.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ganoderma lucidum versus control @ </span></p>
<p style="top:181.7pt;left:329.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pid 7</span></p>
<p style="top:513.1pt;left:290.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Brain water content and BBB </span></p>
<p style="top:509.1pt;left:301.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">permeability</span></p>
<p style="top:373.8pt;left:290.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">BBB integrity</span></p>
<p style="top:273.5pt;left:290.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:315.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">CD68</span></p>
<p style="top:373.8pt;left:315.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:315.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.1pt;left:329.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bcl-2</span></p>
<p style="top:373.8pt;left:329.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:339.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:329.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NC</span></p>
<p style="top:513.1pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">VEGF</span></p>
<p style="top:373.8pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:364.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:374.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:353.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:720.9pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang et al. (2018)</span></p>
<p style="top:642.5pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Berberine supplementation </span></p>
<p style="top:638.5pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">delivered via gavage</span></p>
<p style="top:513.1pt;left:388.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bax, cytochrome c, NF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3ba;</span><span style="font-family:Lato,serif;font-size:7.5pt">B, and p38 </span></p>
<p style="top:509.1pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mAPK expression</span></p>
<p style="top:373.8pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Morphological changes </span></p>
<p style="top:369.8pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and apoptosis</span></p>
<p style="top:273.5pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:388.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Berberine &#x2193; apoptosis, &#x2193; immune </span></p>
<p style="top:181.7pt;left:399.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">response, and &#x2191; angiogenesis versus </span></p>
<p style="top:181.7pt;left:409.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">control @ pid 28</span></p>
<p style="top:513.2pt;left:413.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">VEGF expression</span></p>
<p style="top:373.8pt;left:413.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plasticity, </span></p>
<p style="top:369.8pt;left:423.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurotransmission, and </span></p>
<p style="top:369.8pt;left:434.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neurogenesis</span></p>
<p style="top:273.5pt;left:413.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2191;</span></p>
<p style="top:513.2pt;left:448.1pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">IL-1</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">, TNF-</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">, MCP-1, and ATF-2 </span></p>
<p style="top:509.2pt;left:458.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">expression</span></p>
<p style="top:373.8pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Immune response</span></p>
<p style="top:273.5pt;left:448.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:720.9pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xie et al. (2018)</span></p>
<p style="top:642.5pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Astragali Radix and Radix Angelica </span></p>
<p style="top:638.5pt;left:483.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sinensis (AR-RAS) herbal formula </span></p>
<p style="top:638.5pt;left:493.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">supplementation delivered via </span></p>
<p style="top:638.5pt;left:504.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">gavage</span></p>
<p style="top:513.2pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NogoA expression</span></p>
<p style="top:373.8pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Glial activation</span></p>
<p style="top:273.5pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#x2193;</span></p>
<p style="top:185.7pt;left:472.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">AR-RAS &#x2193; glial activation versus control </span></p>
<p style="top:181.7pt;left:483.4pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">@ pid 14</span></p>
<p style="top:725.9pt;left:520.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Abbreviations: MIX, mixed results for biomarkers; NC, no change of biomarkers; &#x2193;, reduction of biomarkers; &#x2191;, increase of biomarkers.</span></p>
<p style="top:725.4pt;left:45.0pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TA B LE 4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:8.0pt">(Continued)</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;593</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:47.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Nutritional interventions and </span></b></p>
<p style="top:60.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">neurophysiological outcomes</span></b></p>
<p style="top:86.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Nutritional interventions</span></b></p>
<p style="top:114.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Nutritional interventions were administered to animals by supplement-</span></p>
<p style="top:127.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing a standard diet with a specific nutrient or natural compound, by </span></p>
<p style="top:140.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">directly manipulating macro/micronutrient constituents of the animal&apos;s </span></p>
<p style="top:153.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">diet, or by controlling availability of food (Table 3). Supplementation </span></p>
<p style="top:166.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">allowed for controlled and precise nutrient dosage to animals, while </span></p>
<p style="top:179.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">manipulating diet/water permitted animals to feed/drink </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:192.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">when food/water was available. Nutritional interventions described by </span></p>
<p style="top:205.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">included studies fell within one of eight distinct themes which were:</span></p>
<p style="top:231.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">1. natural compounds with known anti-oxidant properties (Cheng </span></p>
<p style="top:244.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2016; Itoh et al., 2013; Ji et al., 2017; Jiang et al., 2017; Krishna </span></p>
<p style="top:257.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2019; Ozbal et al., 2015; Toklu et al., 2009; Wei et al., 2015);</span></p>
<p style="top:270.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2. branched chain amino acids (BCAA) (Cole et al., 2010; Elliott </span></p>
<p style="top:283.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Lim et al., 2013);</span></p>
<p style="top:296.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">3. creatine (Gerbatin et al., 2019; Saraiva et al., 2012);</span></p>
<p style="top:309.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">4. fasting and caloric restriction (Davis et al., 2008; Liu et al., 2017; </span></p>
<p style="top:322.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Rubovitch et al., 2019);</span></p>
<p style="top:335.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">5. KD (Deng-Bryant et al., 2011; Greco et al., 2016; Hu, Wang, Jin, </span></p>
<p style="top:348.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2009; Hu, Wang, Qiao, et al., 2009; Prins et al., 2005; Prins </span></p>
<p style="top:361.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Hovda, 2009; Schwartzkroin et al., 2010; Zhang et al., 2018);</span></p>
<p style="top:374.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">6. multi-supplements (Thau-Zuchman et al., 2019; Wu et al., 2014);</span></p>
<p style="top:387.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">7. </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3 polyunsaturated fatty acids (PUFAs) (Bailes &amp; Mills, 2010; </span></p>
<p style="top:400.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Mills et al., 2011; Schober et al., 2016; Shin &amp; Dixon, 2011; Su </span></p>
<p style="top:413.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2016; Wu et al., 2011; Zhu et al., 2017); or</span></p>
<p style="top:426.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">8. natural compounds used in traditional eastern medicine (Kumar </span></p>
<p style="top:439.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2014; &#xd6;zevren et al., 2018; Sharma et al., 2010; Wang </span></p>
<p style="top:452.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Wang, Fan, et al., 2016; Wang, Zhang, et al., 2016; Xie </span></p>
<p style="top:465.4pt;left:56.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Xing et al., 2016; Zhao et al., 2014).</span></p>
<p style="top:502.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Neurophysiological outcomes</span></b></p>
<p style="top:530.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Biomarkers of morphological changes and apoptosis (24 studies), </span></p>
<p style="top:543.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">plasticity, neurotransmission, and neurogenesis (18 studies), indica</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:556.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tors of oxidative stress (18 studies), cellular energy imbalance (12 </span></p>
<p style="top:569.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies), cytokines representative of immune response post-TBI (11 </span></p>
<p style="top:582.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies), BBB integrity (11 studies), cell membrane homeostasis (8 </span></p>
<p style="top:595.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies), and glial activation (6 studies) were NP outcomes evaluated </span></p>
<p style="top:608.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Tables 4 and S1). Additionally, 29/43 studies included neurocogni</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:621.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tive and/or behavioral outcome measures. Neurocognitive and be-</span></p>
<p style="top:634.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">havioral outcomes were outside the focus of this review and are only </span></p>
<p style="top:647.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">discussed in subsequent sections if relevant. An overview of results </span></p>
<p style="top:660.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for each study is available in Table S1.</span></p>
<p style="top:697.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Anti-oxidants</span></b></p>
<p style="top:725.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Eight studies administered compounds with known anti-oxi-</span></p>
<p style="top:738.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dant properties to animals by gavage (an orally inserted tube </span></p>
<p style="top:49.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to administer food/supplement directly to stomach) or by en-</span></p>
<p style="top:62.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">riching the animal&apos;s diet/drinking water with the compound. </span></p>
<p style="top:75.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Anti-oxidant compounds </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:8.0pt">-lipoic acid (ALA) (Ozbal et al., 2015; </span></p>
<p style="top:88.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Toklu et al., 2009; Wei et al., 2015), catechin (Jiang et al., 2017), </span></p>
<p style="top:101.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(-)-epicatechin(Cheng et al., 2016), and astaxanthin (Ji et al., 2017) </span></p>
<p style="top:114.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were delivered via oral gavage. In the remaining studies, animals </span></p>
<p style="top:127.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">received (&#x2013;)-epigallocatechin gallate (EGCG) dissolved in drink-</span></p>
<p style="top:140.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing water (Itoh et al., 2013), and a diet enriched with blueberries </span></p>
<p style="top:153.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Krishna et al., 2019). In each study the intervention was initiated </span></p>
<p style="top:166.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">within 3 hr of TBI. In 7/8 anti-oxidant studies, delivered compounds </span></p>
<p style="top:179.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were associated with decreased markers of oxidative stress versus </span></p>
<p style="top:192.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">control. Two studies reported reduced BBB disruption following </span></p>
<p style="top:205.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ALA delivery. Both ALA and astaxanthin demonstrated capacity </span></p>
<p style="top:218.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to attenuate morphological changes and apoptosis versus control </span></p>
<p style="top:231.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post-TBI. Phenols (catechin and EGCG) elicited an anti-apoptotic </span></p>
<p style="top:244.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">benefit. Increased markers of plasticity were reported following a </span></p>
<p style="top:257.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">blueberry-enriched diet and astaxanthin supplementation versus </span></p>
<p style="top:270.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">control. Specifically, two doses of ALA after weight drop TBI re-</span></p>
<p style="top:283.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">duced BBB disruption, apoptosis, and oxidative stress within the </span></p>
<p style="top:296.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">first 48 hr after injury, although longer term outcomes were not </span></p>
<p style="top:309.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">explored (Ozbal et al., 2015; Toklu et al., 2009; Wei et al., 2015). </span></p>
<p style="top:322.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Collectively, animals gavaged with phenols (catechin and EGCG) </span></p>
<p style="top:335.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">beginning the same day as moderate to severe TBI displayed less </span></p>
<p style="top:348.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">apoptotic damage and oxidative stress and increased BBB integ-</span></p>
<p style="top:361.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">rity compared to controls (Cheng et al., 2016; Itoh et al., 2013; </span></p>
<p style="top:374.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Jiang et al., 2017).</span></p>
<p style="top:411.8pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Branched chain amino acids</span></b></p>
<p style="top:439.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Three studies provided tap water mixed with BCAAs valine, leu-</span></p>
<p style="top:452.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cine, and isoleucine to be drank </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> by mice post-TBI (Cole </span></p>
<p style="top:465.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2010; Elliott et al., 2018; Lim et al., 2013). Two studies provided </span></p>
<p style="top:478.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BCAA infused water 48 hr post-injury while the third made BCAAs </span></p>
<p style="top:491.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">available immediately post-injury. Only biomarkers representative of </span></p>
<p style="top:504.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neurotransmission were measured post-TBI; where administration </span></p>
<p style="top:517.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of BCAAs (valine, leucine, and isoleucine dissolved in tap water and </span></p>
<p style="top:530.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">drank </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> beginning 48 hr after mild to moderate FPI and last</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:543.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing for 5 days) improved synaptic efficacy (Cole et al., 2010; Elliott </span></p>
<p style="top:556.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018). These BCAA associated benefits supported the res</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:569.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">toration of excitatory (glutamatergic) and inhibitory (GABAergic) </span></p>
<p style="top:582.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neuron balance post-TBI. Greater excitatory&#x2013;inhibitory balance was </span></p>
<p style="top:595.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">related to improved regulation of sleep and arousal/wakefulness </span></p>
<p style="top:608.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">versus control at 4 weeks post-FPI in two studies (Elliott et al., 2018; </span></p>
<p style="top:621.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Lim et al., 2013).</span></p>
<p style="top:658.8pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.5&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Creatine</span></b></p>
<p style="top:686.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Two studies interrogated the effect of creatine supplementa-</span></p>
<p style="top:699.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion, delivered by oral gavage, on NP outcomes post-TBI (Gerbatin </span></p>
<p style="top:712.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2019; Saraiva et al., 2012). Creatine reduced oxidative stress </span></p>
<p style="top:725.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and cellular energy imbalance (Saraiva et al., 2012) and there was </span></p>
<p style="top:738.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reduced cells lost within the hippocampus and increased inhibitory </span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">594&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neuron action versus control (Gerbatin et al., 2019). Increased in-</span></p>
<p style="top:62.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">hibitory action associated with creatine supplementation also had a </span></p>
<p style="top:75.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">protective effect against drug-induced seizures (to simulate epileptic </span></p>
<p style="top:88.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">seizures post-TBI) versus control in one study (Gerbatin et al., 2019).</span></p>
<p style="top:125.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.6&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Fasting and caloric restriction</span></b></p>
<p style="top:153.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Two studies investigated fasting and caloric restriction in isola-</span></p>
<p style="top:166.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion (Davis et al., 2008; Liu et al., 2017), while a third study evalu</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:179.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ated both interventions to determine if one was more efficacious </span></p>
<p style="top:192.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post-TBI (Rubovitch et al., 2019). Rats that were acutely fasted for </span></p>
<p style="top:205.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">24 hr after induction of moderate TBI demonstrated increased tis</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:218.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sue sparing along with reduced oxidative stress and cellular energy </span></p>
<p style="top:231.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">imbalance compared to controls (Davis et al., 2008). Tissue spar</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:244.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing was not observed at 48 hr following moderate TBI, nor at ei</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:257.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ther timepoint for severe TBI. Data were not available for oxidative </span></p>
<p style="top:270.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">stress and cellular energy imbalance outcomes following 48 hr of </span></p>
<p style="top:283.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">fasting. Adult mice assigned to caloric restriction demonstrated </span></p>
<p style="top:296.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reduced glial activation, preserved cell density, and increased au-</span></p>
<p style="top:309.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tophagic activity post-TBI compared to controls (Liu et al., 2017). </span></p>
<p style="top:322.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Mice assigned to a high energy diet (130% of normal caloric intake) </span></p>
<p style="top:335.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">did not demonstrate any of the same benefits as seen following </span></p>
<p style="top:348.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">caloric restriction (Liu et al., 2017). Both chronic intermittent fast-</span></p>
<p style="top:361.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing and caloric restriction (Table 3. shows specific parameters) im-</span></p>
<p style="top:374.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">proved neurometabolic outcomes in the cortex of mice with TBI </span></p>
<p style="top:387.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">30 days post-injury. Only intermittent fasting produced this neu</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:400.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">rometabolic benefit within the hippocampus for TBI versus control </span></p>
<p style="top:413.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Rubovitch et al., 2019).</span></p>
<p style="top:450.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.7&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Ketogenic diet</span></b></p>
<p style="top:478.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The KD represents the most researched NUT to attenuate sec</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:491.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ondary damage after TBI as it was reported for eight studies. In all </span></p>
<p style="top:504.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies, KD increased metabolism of </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:8.0pt">-hydroxybutyrate, reducing </span></p>
<p style="top:517.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neuronal and glial reliance upon glucose as a primary fuel source. </span></p>
<p style="top:530.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Four of eight KD studies compared effects of this diet post-TBI </span></p>
<p style="top:543.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">between pre-adolescent and adult rats (Deng-Bryant et al., 2011; </span></p>
<p style="top:556.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Greco et al., 2016; Prins et al., 2005; Prins &amp; Hovda, 2009). </span></p>
<p style="top:569.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Following moderate TBI, adolescent rats receiving a KD demon</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:582.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">strated a reduction in cellular energy imbalances and markers of ap-</span></p>
<p style="top:595.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">optosis (Deng-Bryant et al., 2011; Greco et al., 2016; Hu, Wang, Jin, </span></p>
<p style="top:608.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2009; Hu, Wang, Qiao, et al., 2009; Prins et al., 2005; Prins &amp; </span></p>
<p style="top:621.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Hovda, 2009). However, these NP benefits did not appear to extend </span></p>
<p style="top:634.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to adult animals. The remaining KD studies only measured post-TBI </span></p>
<p style="top:647.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes in adult rats and presented mixed results in regard to </span></p>
<p style="top:660.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">anti-apoptotic, preservation of BBB integrity, and mitochondrial </span></p>
<p style="top:673.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">energy metabolism (Hu, Wang, Jin, et al., 2009; Hu, Wang, Qiao, </span></p>
<p style="top:686.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2009; Schwartzkroin et al., 2010; Zhang et al., 2018). While </span></p>
<p style="top:699.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">KD was associated with reduced glial activation versus control, this </span></p>
<p style="top:712.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">finding was not replicated across multiple studies for pre-adoles-</span></p>
<p style="top:725.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cent or adult rats (Schwartzkroin et al., 2010).</span></p>
<p style="top:47.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.8&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Multi-supplement</span></b></p>
<p style="top:75.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Two studies (Thau-Zuchman et al., 2019; Wu et al., 2014) provided </span></p>
<p style="top:88.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">multi-supplements as the intervention. Mice that were provided with </span></p>
<p style="top:101.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">10 weeks of a multi-supplement enriched diet (Fortasyn</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> Connect&#x2014;</span></p>
<p style="top:114.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">containing DHA, eicosapentaenoic acid, uridine monophosphate, </span></p>
<p style="top:127.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">choline, folic acid, vitamins B12, B6, C, and E, and selenium) exhibited </span></p>
<p style="top:140.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reduced lesion size and glial activation compared to controls (Thau-</span></p>
<p style="top:153.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Zuchman et al., 2019). Mice on the multi-supplement diet had im-</span></p>
<p style="top:166.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">proved cell membrane homeostasis and increased markers of plasticity </span></p>
<p style="top:179.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and neurogenesis (Thau-Zuchman et al., 2019). While these positive </span></p>
<p style="top:192.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes associated with a Fortasyn</span><sup><span style="font-family:Lato,serif;font-size:5.6pt">&#xae;</span></sup><span style="font-family:Lato,serif;font-size:8.0pt"> Connect enriched diet were </span></p>
<p style="top:205.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">encouraging, it was unclear which constituents within the supple-</span></p>
<p style="top:218.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ment facilitated these outcomes. Both a curcumin-enriched diet and </span></p>
<p style="top:231.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a DHA-enriched diet reduced oxidative stress, supported cell mem-</span></p>
<p style="top:244.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">brane homeostasis, and increased markers of plasticity post-TBI in rats </span></p>
<p style="top:257.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">compared to control at 2 weeks post-injury (Wu et al., 2014). All these </span></p>
<p style="top:270.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">benefits were observed to a greater extent when curcumin and DHA </span></p>
<p style="top:283.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were combined within the same diet, suggesting an additive advantage </span></p>
<p style="top:296.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of combining these supplements (Wu et al., 2014).</span></p>
<p style="top:333.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.9&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;</span></b><span style="font-family:STIX,serif;font-size:10.0pt">&#x3c9;</span><b><span style="font-family:Lato,serif;font-size:10.0pt">-3 polyunsaturated fatty acids</span></b></p>
<p style="top:361.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Of seven studies investigating PUFAs, three studies provided rats with </span></p>
<p style="top:374.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">a DHA-enriched diet (Bailes &amp; Mills, 2010; Schober et al., 2016; Wu </span></p>
<p style="top:387.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2011) while the others delivered DHA (Zhu et al., 2017), fish oil </span></p>
<p style="top:400.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Mills et al., 2011; Shin &amp; Dixon, 2011), or a mixed </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3/</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-6 PUFA oil </span></p>
<p style="top:413.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Su et al., 2016) via gavage. Treatment with PUFAs was initiated im-</span></p>
<p style="top:426.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mediately post-injury in six studies, with the remaining study delay-</span></p>
<p style="top:439.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing initiation until 24 hr post-injury (Mills et al., 2011). Delivery of </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3 </span></p>
<p style="top:452.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">PUFAs demonstrated capacity to attenuate apoptosis and oxidative </span></p>
<p style="top:465.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">stress, while promoting cell membrane homeostasis and BBB integrity, </span></p>
<p style="top:478.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and upregulate markers of plasticity across the TBI spectrum (Bailes &amp; </span></p>
<p style="top:491.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Mills, 2010; Mills et al., 2011; Schober et al., 2016; Su et al., 2016; Wu </span></p>
<p style="top:504.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2011, 2014; Zhu et al., 2017). These </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3 PUFA associated NP </span></p>
<p style="top:517.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">benefits between 3 and 50 days post-TBI followed both an enriched </span></p>
<p style="top:530.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">diet fed </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> or delivery via gavage. Delivery of DHA reduced </span></p>
<p style="top:543.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post-TBI apoptosis in three (Bailes &amp; Mills, 2010; Schober et al., 2016; </span></p>
<p style="top:556.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Zhu et al., 2017) of four studies (Mills et al., 2011) evaluating this out-</span></p>
<p style="top:569.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">come. Furthermore, rats supplemented with 1:1 </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3/</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-6 ratio PUFA oil </span></p>
<p style="top:582.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">exhibited reduced oxidative stress compared to control (Su et al., 2016), </span></p>
<p style="top:595.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and following a DHA-enriched diet in two studies (Schober et al., 2016; </span></p>
<p style="top:608.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Wu et al., 2011). Similarly, 1:1 </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3/</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-6 ratio PUFA oil supplementation </span></p>
<p style="top:621.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">resulted in reduced BBB disruption (Su et al., 2016), and two studies </span></p>
<p style="top:634.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Bailes &amp; Mills, 2010; Wu et al., 2011) showed a DHA-enriched diet </span></p>
<p style="top:647.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">assisted cell membrane homeostasis. Two studies observed improved </span></p>
<p style="top:660.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neurotransmission due to a DHA-enriched diet or fish oil supplemen-</span></p>
<p style="top:673.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tation (Bailes &amp; Mills, 2010; Shin &amp; Dixon, 2011). DHA reduced the </span></p>
<p style="top:686.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">number of injured axons in two studies (Bailes &amp; Mills, 2010; Mills </span></p>
<p style="top:699.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2011), however, there were mixed results of a DHA-related ben-</span></p>
<p style="top:712.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">efit on neurotransmission measured by magnetic resonance imaging in </span></p>
<p style="top:725.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">one study (Schober et al., 2016). The potential influence of DHA/fish </span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;595</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,
/9j/7gAOQWRvYmUAZAAAAAAA/9sAQwAGBAQEBAQGBAQGCAYGBggKCAcHCAoMCgoK
CgoMDAwMDA4ODAwMDhAQFRMMExQUFBQZGhwcHBofHx8fHx8fHx8f/90ABAA9/8AA
CwgALwHhAQARAP/EANIAAAEDBQADAAAAAAAAAAAAAAcABAYBAwUICQIKCxAAAQMB
BAIFBQclYQAAAAAAAQIDBAUABgcREiEIExQxQRUiUWFxFjI1N3SBsgkKFxgZGiMk
JSYnKCkqMzQ2ODk6QkNERUZHSElKUldykZW0wtNTVFVWWFlaYmNkZWZnaGlqc3V2
d3h5eoKDhIWGh4iJipKTlJaXmJmaoaKjpKWmp6ipqrGztba3uLm6wcPExcbHyMnK
0dLU1dbX2Nna4eLj5OXm5+jp6vDx8vP09fb3+Pn6/9oACAEAAAA/ANqbKysrKytC
MbGNPC28ctDr7D8CA/MivR3nWHG3mW1FCgppaFauQdR4RYOQ74VmNcfC64NHqMyL
UL+OIeq9XU+69LQwFoS9tTjq1lC155AjUkDUNdpPjbRjhLdiPiRh6/Ipsyky46Z0
cyHno9QjvLDakSEOuLC15kdhDx2/rzyIZzn0VvZDXLLEiezTK9d/iy/AE2SllT+g
+ttSm0uhGrQTmkDROWsHXadXqu5AnYrXZcddmJRMhVR2Ww3MktsPKiiGhgqaQ6lH
Gh5W8NfDnqsCIFRhJuhf/b7w1Rm80C8kmn3VZZqsxcxSkOITHjtMbeouIKs0klJ1
Z68xYg4hUTEmTdm4NRpk5+Bf1SUCSEyHEsyXYsF+UuO6yhe51KWprIkpyzOWeVvJ
+/VFxiufRqiFS6VXoFepVNrNPZlSYjscyZjTMhtSW3GyptwBQSVaxrGpQNsjsibx
Xlot341NuMpaH6GhivVIoW5pJgw32222iRmTprJUdI60tKztkcZKzGvDgPOvpRZM
iOowI9Sp8iM+6w42p0t5cc0tBOpZSQcxyrSrCWKiPhxd14LeddmU6LKkOyHnX3HH
nmULcWVurWrWTnlnkOAWhV9byVG9eNVGwgjSn4NIYhKq1aVFdUw9KACtqjbYgpWl
vnpXokFQOWYyti8TX3cEL13TvNdJx5ii1ieKXWaMXnHIqw5kUvtoWpQbdA0jmnLM
gZ75zw0l67NP2Qd6qJe2pVBmhM0tiXGiifUQ0iU8I63FJDD2Yz0lnLeGeoWM+GLc
ZFxKS5Blyp0SQ2uTEfnKUuSY8l1bzKHFKW4olCHEozJJIHTWlFlZWVlZWVlZWVlZ
WVlZWVlZWVlZWVlZWVlZWVlZWVlZWVlZWVlZWVv/0CJe3ZOUG409VPvRda8cBRW4
lh16Myht9LaikraUp8BSeHVwEWm+GeKF18VaEuuXaW4naXC1KivgJfYXvpC0pUoZ
KGtJBIPNBAljiy22pYSVlIJ0U75yG8OXYK3h2U937ovtxb03TvLSXXklTSJcVlvT
SDkSkmRkoDhytNMNsU2MS2lzKfd+sUyDtIejzqgwhpiQCrRyaUlxekdWee9acWgW
OlRjw8Lq9BUdOZVojlOp8VAK3pMmSkoQ00hOalq155AagCd4WhUvBK8Eq4GH0qlP
Mwr33JajvsIkE7ndVxjj0VxSAogaSQAoZ8PJzGav5dm/GMNEi3Nq9HF2aY5JYfrE
p2WzKdW2ydPaYqWCrMqUBx7mhkBz055Cl/8ADm88W+91MR8PI8eW/duKumv0d97c
4fhKStKUtOqCkpUkOK59yjwZGR0uFe2sXhRfS8VMRTeJlPkxaZR0SW5D7jklTS3n
XXUhLSc9zoQhIJA1knXkBTAwFvXW7s3toN4YjNLnVOuPXjoVTakoe3LJURosr0Eh
YzGYKk5jh3wM5oGcXZ7lzpdcu+w5Ou7KddqjzM5gNzAqI9FDjAIBBO26ZCwnIgga
jnZpfvBWXLxMoWJVzSmO6ahEXeODp7WiUyw626Hx3yXElsZjhyBGsHN3Fw3Ve+rX
pr2Jt2WX5E8JapTe6W3trhNMlDcdKgUhDpWVrUTxuaxkTlaJUzDzFuJgdUsIplJj
vvO6bVOm7ua2tuOt5L2i6NHS0knSy0QQcwNWVp9dJjE2m0e6l1V0iPTo9Mbix6tU
DMakabEVnRKGWw2Dm4pKQScikE5a9Ya39w4vAcRaNi7ccMSKpTWFQ59LkuFlE2Ko
LGSHclJQ6A4ctIZHVmdWvwvHcq8uKt5Luy70U4UKg3cl8UFQ3JDciXNlJy2pJ2hS
2m2k5azpFSsyMhv2b0G6d+YOOtbxCl0htNIrEJqmo0ZjSnmgyWAH1IyAKTtROiCS
Mxy8itCgw6bEagQGUR47CQhplsBKEJG8ABqAtesEdkNj/VcJJ1Mod36dHlzpzCpT
j0vTLTbQWUJSlKFIKlEpOZzGQ4Dnqm+DeJHWVLjRr1ORBCkF1yNKYSSpsOtEZlBO
spIUCM97e15Z2m9lZWVlZWVlZWVlZWVgXiBsk69hrPES9FwZkZl9x5EKUZ7RbkIa
VlpJKGVgEgg6JOYBs2u1snrzXxhv1C6+GtUqcaMva3nY0pK0pXkFaGqPrVkQchr1
2tUnZj3QVVDSb20Gp0BxLm1PKXovBhWeR21GTTqcuEBJPKseqfUINWgsVOmPtyok
ptLrD7SgpDiFjNKkkaiCLOLKysrKysrKysrKysrKytjLyNXjeo0hu6ciJFqh0Nzv
Tm1usJ49OnpJbUhRzTmBkdRyOu2m94sbsbo+IvOMrd4Es7iq6IMlFOabZbWEvpSr
RWGw7okck55b9t27Kyt//9Ek7LCBFl4K1WQ+2lbkORDeYURmULMhtokHgzS4ocw2
1KuXe6+eBd+W520rYeQlvd1PcV2DlxXkpcSCU5jWlQU2sZ5HXyRbfq5d8aHfy7cO
9F33g9EmICssxptODn7TgBOitJ1EeU1ZGwb2aUFp/DOmTCnNyPWWUpVyEusSAodO
UixzosNunUeDT2QA3FjMsoA1DRbQlI+gtdnVCBS4q51TksxIzYzcffcS02kctSyE
jp7YCj4jYd3lqCKfRLw0uoTU5ltlmS047nkQdABWZ1b+XBaRPyo0VIXKebZSdQLi
gkHypFsdGvZdabUEUmFWIEic5paEVqS0t46IKlZISsq1AZnVZ3LqtLgaW7pkeNoj
NW2uoRkDwnSItZpV4aDXS8KHUolQ3OUh/cr7b21leeiFbWpWROics7OJ1Rp9MZMm
pSmYjSQSXH3EtpAG+c1EC2ORfO6LlGkXibrMFVKirW2/PEhsx0LQQFJLmloZgkDL
Ozqh3god5oCapd6fGqUNSikPxXUuo0k76c0kgEcIt41u8l37tRd23hqUSmMHPJyW
8hlJI1kArUMzyhbH0LES4d55G47vXhptQkeeMeU0tw8xAVpHphaQ2ZVeuUa78NVQ
rs+NToydRelOoZRnv5aSykZ8q2HomJeHt45iadQrx0ydKXzyOzKaU4ryVIVmd7gt
JbY6t3ku9dqNuu8NTiUxk55OS3kMg5b+WmoZnmWZXfv7cm9bqo92q7T6m8gEqajS
W3HABvnRSoqy5eVsRibh1hvfuHHcxAYZCIJUpiWt8xVtpVlpp2wKRxpyGYOrhtlL
hRLlU67UemYfqiLo0NS2GjDcDze2JUdszcClaS9IkqJJJNs888zGaXIkOJaabBUt
xZCUpSN8knIAWjMTFPDWdURSYd6KS9MUrQSyiYyVKVvaIyXkTyhaU2xNRvddWkyG
olTrEGLIfcS0yw7IbQ4txaghKUoKtIkkgAAWtXivxc26Sm0XnrcClre1tolSG2lK
HJCVKBI1b9sjS6tS63CbqVGlsTojwzbkR3Eutq5ikEizq2Hr98rp3VSld5azBpml
rSJUhtpShvagpQJ6a1bv3wurextbt2avCqiW+4m5H23Sjg44JUSOntlH5DEVlcmU
4hlptJU444oJQlI3yScgBzbRqFilhvUqiKRT7z0mRMUooSw3MZUpSgctFOS9Zz4B
aUWVtcdm0BzirvHhFVUPKsOWc7Cfoua16/bnmLFtCNmzRaXEvFd2uRm0NzahGkNS
ykAKcTHU1tS1Zb5G2FOZ4ABwWJ2w+l1CThCGphUpqNU5TUTS4Gsm1kDlaa19PnYs
3hvVdq6UMT7zVOLTI5OSXJTqWgo8hIUQVHXvDO2JuvithzfOWafdm8EKdKGZEdKy
h1QTvlKHAhSgOSAbSu0JrWNmFF35qqdVb0U9qShWg40hwvFChvhW1BYSeSDlaS0C
8dBvTT01a7lQj1KGpRQH4ziXEaSd9JKSclDPWDrs7mzoVNiuTqjIaixmU6Tr7y0t
toTyVKUQkDm2hkTHHCKdURSo166aqQpQSkF3RbUonIAOKAbJ5htOQQoAg5g6wRbF
1+9N27qxd23kqkSmMHnq5TyGgo8hOkQVHlC2Kuvinh5fSUYN2K/CnygCdzoc0XiE
75CFhKyByQLSdxxtlBcdUlCBvqUQAOnNo/JxGuFEqcaivXgp275byI7EREhtx5br
ighKAhClKzJUBrFrVUxOw/ot4Wbq1WvQo1WfKUoiOOgLCl5aKVHnqCcxohRBPBaT
2iN48XMM7pyVQrwXkgRZKDkuPtocdQfSyGtNaenFsvdq+F1r4xFTrrVSLVGUEBxU
ZxKygkZgLAOkk8ogW0QxE7uGq3sJh5kItu3ejFXDq5koQbzXghQZWrOOpem8kHeK
kNha0jlkC2Zu/eW7966emq3bqMapRFEp26M4lxIUN9J0SclDhB12yVv/0ijsp+iP
r/k8LzLYtE8YcDm8R8NqJea7kcc6Wm0mJopQADOYSygllW9mtOstn2rwjIHYA41T
sJbxKpdZLi7vT3QioRyDpRnee7oQnfCk5ZLT30ByQLH3ZbzYdSwbg1CA83JjSKrC
dYebUFoWhbT5SpKhmCCDqNjiHmo0ESH1htpprTcWo5BKUpzJPKAFtRI98pGySxh4
h1yorg3Gp23ShAD25kPx2CEoU6dJOk44pac+FKSQnLLOzLZK3GuPcKZQr2YXy2Kc
+46tl+PAlaSm3G0hTb7ei4paDvhRByzy4Scy3dtVPx7wGjVm+aXXKlTWZiTJjuuM
KEqMhaA9k2pCVFSdFRSQU5k6rAPYoFS8baUtZKlGNNJJ1nuXXybGjZc3Fu+i5sm/
7KH2qyJMSOt1Eh3a3Gjm3oqaKy3vZawAdVsVsHgOJF7elMLqD9o7svbnNXWfpFYg
1WqyBW5E0yYsyY5IYQU7UsbUlZ4xPYQjR3ssssrYC4mG2KeLGELFHu49Fg0GlzJL
oYfeWhVTlqUFE5JQUhLY0Up0yBpZnmFPCOjV/Y54RXmvVf5O1OuOpfi0oOpc0XAn
amkkoKkBbq1AK0c8kgE8gD3BqBVdkbidMreJsl2p06kMbpMHSUiMHHF6LLCUJOSW
xxyjlrVo8cTmc8psn8JqRhwKTiJh40qiaUrcspuGtbSW3lJUtl5rRObeegoKCchv
ZDfsVdjPi9OxOurJgXhcDlboim25DwABkMOA7U8QMhpcYpK8tWYz4crAm+OIFNv9
sgRTMTZbrVzqXVX4KYemtDCExyttC3AkgjTcSC4vfCTlmANRdv3gJQ1TLv4i4Kw4
7NSptQiSFR4T6ERZcZLiSpSSV7WlQG+UkBSc88zlYgY04pxMJrmO10oTIqEhe5qZ
FXnouPqBOkrIg6CACpWXKGYJFhThLhSzjZds4kYxy5lbkVR57ifFMhxiPGYbWpsq
QhpSAklSVZAagANWZNshdrYtOXHxbpV7rq1dbdAibY89HeUrdYXolIYCkJCVtK0h
mVZHIEEHftBNl7c1u7D1KrcGrVV8VuTMMmHLmOPx0KG1rG1JUeMT2EI0d7LLLLKx
Y2JHRMQels36NNhfifiXVsX8XIuEdEqi6XdhqaYk99lwNGTtGkqU4peYBQkIUltP
PSRmc8xktkbhXhVdm5cO8VwHIkGo02Qyw4zGlhxchpeY0yC4pRcSrJWkNeWefBlO
dj7eCfjNhRMu5e6fP3TSZaIxqESS5HlOM6KXGSp1BCioa0qz58AM8znbWN+DU6fj
OKHTZy5EuBeXccCXUFKe49mbtbS3d8q1pBUBv2PuMOxpU9dKsX8qF6alWrxU+K5N
kOzA2I7rbKdNxtttKQWkhIVoAKIG9laM7C++FXZvbUbkuPrcpkmC5NaYUSUtSGXG
0lSAee6SXDpZb+Q5FjNsicaV4T3dYjUXa3K/VtNMMODSQw0jLbJCk8ORICAdRPJA
ItGMP9j3d+/1zYV8MVpFQrlersdMwvuy3UbmafGm0htKVBIySQSCCAdQAAs9wm2O
NQwsxOmXjg1kv0Ew1tRmDmmQ4t0jjHwkBspRlmFDfOWoa7DzELEip41YwRcKaXVF
0y6TMxcaY6y4GTKTHClyXFrJAKewaktJOreJBJ1LZIYXYXXXulAvLh67EgVCnyWo
7rEaXprfaWDk5kXFq2xCkg6Q3wTnvCxW2LeIdZv9h44i8DypU+jSjCVKWc1vNaCF
tKWeFYCiknfOQJ1k2Mdtctm13RN3/X1V5juWh+xrxhuhhjh5V0XmTPJcqq3kqjRH
Hm9FTEdCUl3U0lRKTxqlDg5NsHVJNZ2W2Kgi02QxQ6dTovYqzLVpPJjJWNtcShAy
cdUpQJSCABkM9WdtqqfT7rYK4bqZjhTdJu/DcfdWci66pIK1qO8C4tR8qchqtrLh
jWqXjjibUr34x1OGik0pvTp9InSkMxUreWQ02hDikBaUJSSvVxxy0s88rR/ZBU65
9xcQaXePCOqRI+6Gd0FukyELTEksr0dJO1KUEJWCOM3swdWRysacVcW7w9a3Um+N
LWqHUrxIixH5DPGllTiHDIU2Rz3SLKkpO+ArVrFopsaKZgfem5j9AvRFp0q88l97
diKjo7odQpXYIx1rIVkE5Z7WdIKzJ4DYs4IYY1jCmTeqgLWHaBIqDcuiOlwKdKFt
5OJcSNYKdFCc++sibA3FHEl7GHF6JhsKsKVc2JP3LLcLyWGpAjlRkvOLUUpI4wpa
CjlvHfNn2yPuVgnDuNGq+H8qjRapTX2Wdz0+U045JYc4xWmhDilLWk5K0zryBzJt
KsA8Ub61XBG8DsaO5Xa5dgKZpyFErcfQtsKZSrvpZRx2oa1JAA12xOBdwKpjBOrN
+cbWZlW2l0RadDqAdZZSsgqeWhobWkJTmlKQkZA58IsF8S4UXCrGie3cKSqOzSpj
D8FTTpWWitDbimSrMkgFRQQonVqOeu29t5rq0e/t3xSK8l/cr+1vKTHfdjr0gNQ0
2lIURx28dR5Fuf1Cj1KhYvxId3G93VCBeAMU5EheW2vNSShnbFcgqAKjYuXg2JGK
dRvTGqUqtxKoqpPh6p1QrW27HWSFOK0VDSXyEaPIGYSLTXZMY3Ve6LkXDS48lbVW
kNNmfPSc3mW3BottIVwOr58pW+BllrOYlFK2K+GJuy1T7yw3qjWXmgqdWDJeEhcl
QBWtJ09AAHnoKTq38zna9gXgRJwdql4Jb1WFQYqRaahoSkoKWWitQU6Dxu2cdlxu
rIHk5DVPFBuQ9j3XWYj25313hUlp/R0trWX0hK8jqOR15W2AxA2KN2JF1arXWqvU
pd5Wo7s1yozXkuJkvNoK1haNEaKVaJAyPG5jfyysMdh5eqqU3EpV123lcT6xEfU7
HJOht0dG2IdA3grJKk58IPMtuzb/0yZsrHktYI1pJORdehIHLO6mlea2IVxXQ/cm
776TmHKVCUDzWGzbXDZU4FEKfxSuhG43LTrsNpO9yZiQPkXLybx42A7WJFZcw5cw
znkyaemexOgLUrXGUjbA42Mwc21bZpZasjr4TbfPFFMxeFF500/MyDQ5gQBv9y68
8uXlnbTTY1US4d5sQjdy/sJqaxPhuJgJeccbG60KQsJBbWjWUBYAPDq37bdxMAcG
4Wtm6dPV66pU99GqXbPzaHRruXKqVJoMJinwmoUoojxm0tNpKm1lRCUgDMnfNtLt
id0ddJ6SzfMddtidlz0TUvpfD+jLQrYPdBF7elMLqD9vHZxdBl0elE/qEe012IfR
Nx/XwmdSTazsw2JTuEG2R0ktsVWI5II3g2Q6gE8rTWkc2w12EM1hu8d6KepWTz8K
K8hPJSy64lfxrybFDZebR1huRtuWlxQh7V5PpKz+O6VhfsI4UrnQXnqvHCKzCYYW
deiXHHFLT04DavK2kWKGx6ouMRVidhPVIxcqmkt9hzTTGlOoUpC3EK0dJtwlJCgp
ORIz1HPME0e8mKGx/vgYKzIp0iMtK5dLeXpRZTRPCkEtqSoAhLidY4DnYo7MSqP1
6FcKvMJWinVGnvymUq75W+mM5krg0tFSfjbFvYp3mp1cwhp1KjOJMuiLeiy2cxpJ
K3XHW1Eb+ipK9R4SDyDYxW1j2cPQRdLpTN+i2LTPYn6fWEYu1c/3XO0cuTthytqh
hLFu1LxUpNOxEjpkU6XKdjTW31qbAfdS4hsrUhSCMnSnPXzdVt1oux8wYhq0mrqQ
VH012x0eUccWLS6711btXSirg3YpcSlsOr2xxuI0hpK15ZaStEDM5DLXbQuX3ce9
7DVX0pW3dxZ6K69/rx1HzGctqXsOOjdc9eeV9GMWubMpM4YrxzJ0toNIj7lz57o7
Y/p5cvSzzttJgpeen3swuu7UoDiV7TAYhyUA625EZtLTiCODWnMZ8BB4bS+obo3B
JETuOWXNp8n0To/G2544LRLpz8UKTSsQIyJFMmuuxXkPrW2lL7iFJZKihSCOwmiN
/h123Ui7H3BmGdJq6kFRHnrtjw8o4tYtL7v3Xu5dOGqn3ZpkWlxlrLi2orSWkqWQ
BpEJAzOQAzNsnbXLZtd0Td/19VeY7lrWxBpEC8GEd5qHVWg/DnVV9h9s6wUORIyV
b+eR16jwG2vc2PeXAbFcpaJ3dQJmmws5pRKjK56Tl3w62rI5b2ZG+LbVY13niYgb
Gyp3oussuxZrEV9aRrWhKJTO3NrA3lIKSFcwnesFNibSMPLz1+sXavpS4VRmPMtS
KZutGmSGtMPoSCciclJVlv5AngttVEwjwugq04t06MhXJ3CwrqSDZtf6n4eValQM
Lr0JbjR7xhyPS4zKNrAXFSl0FpSUlDakaijPIHeyO9bVLFHYr3zuDElXhob6K5R4
gU64tsFuWw0nWVrb1hQSN9SCeTkBYg7ErFW9F4HKnh7W5Tk4RYKpdMkvKK3WglSW
1MqWSSpHYRJTnvZEb2QAJwq5zsTFWlxcQ4rMinOTHYtQblg7WhxwLbStesZBLhBJ
O9vm28sfBnCaMpK2bo0fNO8TDaV1JJtevRVrq4RXJqt5YtMjxIcBG3KiwWm44edU
UttpyQkJzUpSRpEHIcy2vtwL34jbJy9E6kVetLu7dqntB+XCpB2l15LitFDJdObh
ByOkTxurnuvUIse7t0W6OKtSu5d+MmLAhNwkMtAlR1x2VKUpSiVKUoklRO+TboLB
7kY/rkjqItoBdbu46n+wxT5nm3Qa3P3H9dQpWO14JkxJLrU5iSzpbymg0ypnLlaI
Atvddi8dLvdd+BeSivJeh1BlLzSkkHLSGtCst5STmlQ4CCLZPTSFBGY0iCQnPXkM
szl04tz7xE7uGq3sJh5kItvfe7ulK1690r6JXbSLYodHZR+k83zGctvnb//UfbJi
+9cvhTZeG9AoL+jFnpMue8/HSlYj5lIaRtpVkSQc1ZEZb2vVLMDMVanIp13cO69d
6TFmRoqYSZ7b8Z2OpEVg6C1AO7aCUtgEAK18reNrjbbzamnUhaFgpWhQBSpJGRBB
1EG2juyEwIew9vM3VbsNhyhVZxa2GdNIVFdBClsZKUCUa80HkajvZnd9ttDsRLTq
QtC2wlSVDMEFORBHCLaYYu7GK9VyqtIvLcQiVRQ6ZDID6WZUEg6YTmtSNIJI4xST
pckZ6zmMOr0bKfERHEGl1pqNDaAbk1WQiGXWUateaUqeWvI6iBnySN+2zd1rmRLt
XQauiuXKqKNqdRJmSnFOPvuSCpTzilKKsipSyQODetpRW8OcTMCMQItSpAbW7FfW
ulTkuNKQ+0c0ZLbUsKTpJVorSQN85HhsTcVqPjrfnDEVa/DsOEl2VERBu/TQ2A+t
1YSHpDy3lpGWfGISojM5nLK2R2O2HmOOHCpAVSqS1TKw/EclmZK0n22mioLU0Ixc
SVaCzkFHLMDl2YbIumYnYsToFMpN0VxodDflhElyoQiqTthQgLCNuSUJyazAOZ16
8rSLY8SsRrgUeJcGv3Pc3M9PWsVNuoQyGkPlOkVtB1SlaJBPGnMjgsdLzXcpV7rv
z7tVtrbYNRZUw+kHJQCt5STryUkgKSeAgG2oycLsTtjfflq+1EZYrlGYK21OpebY
L8VzIKadQtQUhe8QUhQBAOvetI8Qazf/AGTbNPutc2hilUiI+JM6VPlsZ7cElCc0
tqUvQSFqy0QSSd4ZWOuEmGFKwnui1dunuGS+4syJ8xSdEvyFAAqA16KQEhKU8AHJ
JNgfQKpidsa63UqTWKUit3QqE12RDWzKaS61tilZKbC1BQJAGmhQAzGYVvktLw3H
vnsoL8QbzOU5F3LsQmERd0uvsvSnGg4txZCGlK7CEqISDklO/meE44nYP0HEW4TV
ys9xGnIb4kyQNLczjKNrQCMxpIKeNUORr3wLagv3NxowEvIJtPc3DIVmhEmLIZdY
ktg55KbcOak8OTiBlzbHfDi6mNOJ0ymXnxcrBjUKA83NhUuGplpUt5pWk0t0xcgE
JIzyUSTllkN+0a2RNOxQxZmQKXSboqiwqK/K0JDk+EpcgrKUBYTtydBOTeeRzOvg
ytLdja5iBcykxMPLzXWXHimRJeRVUToi0tpWkuaK2kOrWTpJIBTyRmNRNoXj7sYa
3Irs6++H6GpEactUmdTVuIZWy8s5uONKcKUKQokqKSQQTqzG9gMN75bKGrqbuVdi
oJcEdO17dOMNxUdsDRzLrgW4oJy1ZaR5FthqXS7w4R3KXJS3NvxeCoTA/UnFy24+
2POIyKkGQsIbaQEJSlKdfDlyNXHcL8ZHcQVX/N10B1dZNXMUToehpGRuja9LdGeX
BnlbZjE28t86thgYVHum69ULzQJcSRGXOioEDbEFsqUsuBLupZKQjka8rADBe5eL
OE99E3pfukqoMqivRXWUVCE2sJcKVaSSX1DMFA1Hgsf8csGGMZbtw3Yy006u09Jc
hOu8cgh0AuR3SjS40kDJQzyIzGYJz1ZpUXHLAuvuwKStVNkSSEuMJejSI7+R0UqK
FLWjPkEgKFtj8LbiYp3irUHELGerrW9ABXR6NFW2hlpTqNFT7wjZNqOiSAnNW/rP
BYa487GCuCuTr64fobkwpripMynKcQy5HdWdJxTRcKEKbJOeWYIzyAI3sPhvfLZR
V4oubdqpIWmOkNGTO3G4qO2Bo6RcWHHVgZcAUbbS4cXLlXIu+YNUqsmtVSY+qZUq
hJWpRdkuBKVaCVE6DYCAlKRwDPhtKba0Y63Ox2xgTCpUe6cWm06myHXmyanGedfU
oaCVk6TYSNHPjcuHWbOMBLpY44SNSKBULqxptKqM1t915NSjNuxioJbccABc2waK
QdHUdWo67THHzASJi3Ej1SlPtQLwwUFtl90HapDOZVtLpSCoZEkoUAcsyMjnqGGG
FzMZsKFTboXnu4zXbo10libFbnRgEbaNqW81pupVrSclJIBOQ3iLRbEDYw4hXAq7
l4bhSN206M5t8WS3IRGmxcjmArTU2CpPApB18gb1pdh/dvZM4lxWWbz3pkUi7a+M
fkNuRt2PNjIKQ2qOkuBRGrSWocnjt6xGxnwdrV4LmXcp2GryYdRui+27TNueUlza
22wgJS6rSO2ZpQoFWo5azaMO4q42VyhzMPJNyo6rzyI7kN2aKhGTGycQUKeLWmRp
ZEnRCss+DLVaRbHfAV3CaPLrVfkNya7UW0srSwSWYzAIVtaVEAqUpQBUcstQA4SY
PjtsWapX67Lvnh1tCnJyy9PpTqwzm8rWt1lauM448cpKiNeZB15CJ4eQ9lXOWbn0
KruwYkLJp52ZIiPJioGSQAo7e8QBqARnlwZWPqcEYruFtYuFVKtKqVRroMifWJa1
uuOThoFt0JUpWSElpACAeejfzOdtd8OsLMfcN8S+Jl2Ew4sxbKkvyHn2nYTsQqTm
taArbSnPIgBIWD09nGN+AOKD98I1c3Wm8r1dMdl6YVMRCmYQG9qDSlICWgEjQIzy
G/r1nYKgNY23UuaXqymDe+uLMdpinR1twGYrSG1Ba1SHE5vKJCdIaI172q2utOwB
x8p1+GL9t0GGuYxVBVQyZ0bay4HtuKO4uejnqttxc2q3sq9NcfvjQkUCYh3QTHbm
NzUuI0UnbAttKQnWSNE69Vhtj/sfGcV0M1+gvtQbwxGtpCncwzKZBJS24UglKkkn
RXkd/IjLIgAXXuzslMNq2bo3WW9AflrzEVMqG7HWo5AuBLri0JOrWcgbH65+H+JF
yosnEG8K134v1LaTFbiLmpixokVagpbba1pDe+kFWSQNWSRvkhOvYBY9V6/Eu/Lt
AhtSZVRNR2hM6MW0q2wOJRntuZAyAz4bbK3oqmJ0/DsJpt1GFXgqbT0WXTl1Fnao
iVpcQHttySl0c9ISMjryJ1G2uuF+CGO2GV9YN8Y124s8w0uoVGXUYzYWh5tTagFh
xWiRpZg5Gx6522OnkNI3l/i+crf/2Q==">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">oil dosing was considered in three studies (Bailes &amp; Mills, 2010; Mills </span></p>
<p style="top:62.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2011; Zhu et al., 2017); a low and high dose of DHA improved </span></p>
<p style="top:75.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">apoptosis (Bailes &amp; Mills, 2010; Zhu et al., 2017) and cell membrane </span></p>
<p style="top:88.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">homeostasis while reducing axonal damage (Bailes &amp; Mills, 2010; Mills </span></p>
<p style="top:101.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2011) compared to control, with the higher dose demonstrating </span></p>
<p style="top:114.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">greater benefit than the low dose in two studies (Bailes &amp; Mills, 2010; </span></p>
<p style="top:127.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Zhu et al., 2017). In an experiment where </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3/</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-6 ratios were com-</span></p>
<p style="top:140.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pared, rats that received a high ratio (1:1) demonstrated reduced BBB </span></p>
<p style="top:153.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">disruption post-TBI compared to &#x201c;western diet&#x201d; (1:30) controls. In con-</span></p>
<p style="top:166.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">trast, delivery of a moderate </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3/</span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-6 ratio (1:5) did not alter BBB dis-</span></p>
<p style="top:179.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ruption versus the same controls (Su et al., 2016).</span></p>
<p style="top:216.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">3.3.10&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Traditional eastern medicine</span></b></p>
<p style="top:244.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ten distinct traditional eastern compounds were examined for post-</span></p>
<p style="top:257.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI utility, including: curcumin (Sharma et al., 2010), panax ginseng </span></p>
<p style="top:270.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Kumar et al., 2014), modified Shengyu decoction (MSD; multi-herbal </span></p>
<p style="top:283.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">supplement) (Zhao et al., 2014), Hydroxysafflor Yellow A (HYSA; fla</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:296.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vonoid extracted from Safflower) (Wang, Zhang, et al., 2016), Xuefu </span></p>
<p style="top:309.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Zhuyu decoction (multi-herbal supplement) (Xing et al., 2016), gano</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:322.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">derma lucidum (mushroom polysaccharides) (&#xd6;zevren et al., 2018), </span></p>
<p style="top:335.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">berberine (compound within Barberry roots) (Wang et al., 2018), </span></p>
<p style="top:348.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Astragali Radix and Radix Angelica Sinensis (AR-RAS; multi-herbal </span></p>
<p style="top:361.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">supplement) (Xie et al., 2018), rhubarb and rhein (an active com</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:374.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pound within rhubarb) (Xu et al., 2017), and Rhizoma drynariae </span></p>
<p style="top:387.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(RZD; an active compound with roots of Drynaria Fortunei) (Wang, </span></p>
<p style="top:400.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Li, et al., 2016). Rats that fed </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> for 2 weeks on a curcumin-</span></p>
<p style="top:413.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">enriched diet, beginning immediately after moderate FPI, displayed </span></p>
<p style="top:426.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reduced oxidative stress while markers of cell membrane homeosta-</span></p>
<p style="top:439.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sis and neuroplasticity were amplified at 14 days post-injury (Sharma </span></p>
<p style="top:452.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2010; Wu et al., 2014). Overall, the traditional eastern inter</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:465.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ventions demonstrated capacity to influence the multiple aspects of </span></p>
<p style="top:478.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">secondary injury post-TBI in a beneficial manner compared to con-</span></p>
<p style="top:491.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">trol. Due to heterogeneity and lack of replication for 9/10 traditional </span></p>
<p style="top:504.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">eastern interventions, results were not summarized; however, for an </span></p>
<p style="top:517.4pt;left:44.7pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">overview of these benefits please see Tables 4 and S1.</span></p>
<p style="top:554.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;DISCUSSION</span></b></p>
<p style="top:580.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;State and limitations of the evidence</span></b></p>
<p style="top:608.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The purpose of this review was to consolidate available evidence </span></p>
<p style="top:621.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for post-TBI NUTs and their associated effects on NP outcomes in </span></p>
<p style="top:634.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">both animal and human studies. The aim was to identify NUTs that </span></p>
<p style="top:647.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">demonstrated the most plausible &#x201c;over-the-counter&#x201d; potential to </span></p>
<p style="top:660.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reduce NP dysfunction (at a cellular level) after TBI in a way that </span></p>
<p style="top:673.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may reduce downstream deficits experienced by clinical patients. </span></p>
<p style="top:686.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Our review revealed that no studies have evaluated NP outcomes </span></p>
<p style="top:699.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post-TBI in response to a NUT in humans. Several post-TBI NUTs </span></p>
<p style="top:712.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were investigated for efficacy on clinical outcomes only, since these </span></p>
<p style="top:725.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies did not provide insight into how the NUTs interacted with </span></p>
<p style="top:49.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pathophysiological mechanisms of TBI they are beyond the scope </span></p>
<p style="top:62.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of this review (Aquilani et al., 2005, 2008; Noguchi et al., 2017; </span></p>
<p style="top:75.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Sakellaris et al., 2006, 2008; Theadom et al., 2012, 2013, 2018; </span></p>
<p style="top:88.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Walter et al., 2017; Yang &amp; Xu, 2007). Therefore, knowledge of how </span></p>
<p style="top:101.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUTs may promote favorable NP outcomes after TBI relies entirely </span></p>
<p style="top:114.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">on pre-clinical evidence. Animal studies provide valuable insight into </span></p>
<p style="top:127.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the molecular underpinnings and safety of emerging interventions </span></p>
<p style="top:140.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Shultz et al., 2017). However, methodological inconsistencies be-</span></p>
<p style="top:153.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tween animal studies and clinical investigations often lead to failed </span></p>
<p style="top:166.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">translation (de Vries et al., 2014; Perel et al., 2007; Shultz et al., 2017). </span></p>
<p style="top:179.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">A main review finding was the number of methodological caveats </span></p>
<p style="top:192.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(and their relation to the biofidelity and validity of the evidence) </span></p>
<p style="top:205.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">that need to be considered before interpreting the translational </span></p>
<p style="top:218.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">potential and salient findings of interventions reviewed. Biofidelity </span></p>
<p style="top:231.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">refers to &#x201c;concordance between specific features of a given animal </span></p>
<p style="top:244.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">model and the human disease or condition being modeled&#x201d; and &#x201c;goes </span></p>
<p style="top:257.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">hand in hand with confirmation of experimental results across dif-</span></p>
<p style="top:270.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ferent animal models with clinical findings in humans (i.e., validity)&#x201d; </span></p>
<p style="top:283.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Wojnarowicz et al., 2017, p. 8). Aspects of study design including </span></p>
<p style="top:296.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">characteristics of animals used, method of TBI induction, interven-</span></p>
<p style="top:309.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion parameters, and measurement of outcomes in many of the in-</span></p>
<p style="top:322.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cluded studies threaten biofidelity.</span></p>
<p style="top:359.8pt;left:305.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.1.1&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Animal characteristics</span></b></p>
<p style="top:387.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Males have typically accounted for a higher proportion of recorded </span></p>
<p style="top:400.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBIs than females in clinical practice, however, females have typi-</span></p>
<p style="top:413.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cally experienced worse symptom burden and longer recovery time-</span></p>
<p style="top:426.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">lines than males (Gupte et al., 2019; Merritt et al., 2019; Solomito </span></p>
<p style="top:439.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018). Only one study within our review included both male </span></p>
<p style="top:452.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and female animals&#x2014;but no sex-related results were presented (Zhu </span></p>
<p style="top:465.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2017). This male bias has been extensively reported across </span></p>
<p style="top:478.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">multiple disciplines and is particularly prevalent within neurosci-</span></p>
<p style="top:491.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ence (Prendergast et al., 2014). Exclusion of female rodents was </span></p>
<p style="top:504.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">often justified by the assumption that female rodents demonstrate </span></p>
<p style="top:517.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">higher variability than males due to the estrous cycle (Prendergast </span></p>
<p style="top:530.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2014). However, a 2014 review consolidated data from 293 </span></p>
<p style="top:543.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">articles and concluded that females were not more variable than </span></p>
<p style="top:556.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">males across a range of physiological, morphological, and behavioral </span></p>
<p style="top:569.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">measures (Prendergast et al., 2014). There is a need to ensure in</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:582.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clusion of females in future pre-clinical and clinical investigations to </span></p>
<p style="top:595.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">understand if sex differences exist and to increase the likelihood of </span></p>
<p style="top:608.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">translation and generalizability.</span></p>
<p style="top:621.4pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Neurophysiological outcomes across multiple maturational </span></p>
<p style="top:634.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">stages in response to a post-TBI NUT were only evaluated in four </span></p>
<p style="top:647.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies, all of which administered a KD (Deng-Bryant et al., 2011; </span></p>
<p style="top:660.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Greco et al., 2016; Prins et al., 2005; Prins &amp; Hovda, 2009). The ben-</span></p>
<p style="top:673.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">eficial effect associated with KD was limited to younger animals. </span></p>
<p style="top:686.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Evidence suggests maturational differences in NP consequences </span></p>
<p style="top:699.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and recovery post-TBI (Shrey et al., 2011). Therefore, interactions </span></p>
<p style="top:712.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">would likely be shared between maturational stage and influence </span></p>
<p style="top:725.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of NUTs on NP outcomes after TBI. Expanded knowledge of such </span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">596&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">interactions would contribute to identification of nutritional candi-</span></p>
<p style="top:62.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dates likely to translate to clinical practice.</span></p>
<p style="top:75.4pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">All the interventions investigated within this review were ad-</span></p>
<p style="top:88.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ministered to rodents, and no investigations evaluated the benefit </span></p>
<p style="top:101.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of the intervention across multiple species. Concordance of results </span></p>
<p style="top:114.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">across more than one animal species has been shown to increase the </span></p>
<p style="top:127.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">likelihood of translation to humans in pharmaceutical toxicity stud-</span></p>
<p style="top:140.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ies (Olson et al., 2000). While financial and logistical challenges may </span></p>
<p style="top:153.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">make adopting a multi-species methodology difficult, such efforts </span></p>
<p style="top:166.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">would inform the design of future RCTs that would potentially pro-</span></p>
<p style="top:179.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vide information that may benefit TBI patients sooner.</span></p>
<p style="top:216.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.1.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;TBI induction</span></b></p>
<p style="top:244.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">In most real-world TBIs the head moves freely and results in a mild </span></p>
<p style="top:257.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">closed head injury (Hiskens et al., 2019; Wang, Cui, et al., 2016, for </span></p>
<p style="top:270.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">reviews). Most included studies performed craniotomy to deliver a </span></p>
<p style="top:283.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">traumatic force directly to exposed dura. Freedom of head move-</span></p>
<p style="top:296.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ment was prevented or unclear during TBI modeling in many studies. </span></p>
<p style="top:309.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">In a clinical setting, patients rarely require anesthetic following TBI, </span></p>
<p style="top:322.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">yet for ethical reasons, nearly all studies anesthetized animals while </span></p>
<p style="top:335.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI was modeled. Anesthetic has been reported to effect behavio-</span></p>
<p style="top:348.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ral and NP outcomes following TBI and may produce artifacts that </span></p>
<p style="top:361.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">complicate the interpretation of study findings (Shultz et al., 2017; </span></p>
<p style="top:374.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Wojnarowicz et al., 2017, for reviews). Therefore, differences in the </span></p>
<p style="top:387.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">type and level of anesthetics delivered between laboratories during </span></p>
<p style="top:400.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI induction require consideration when interpreting study out-</span></p>
<p style="top:413.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">comes. Since these factors are inconsistent with clinical mTBI (rep-</span></p>
<p style="top:426.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">resenting 95% of all TBIs) there is a need to adopt next-generation </span></p>
<p style="top:439.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI modeling techniques that more accurately replicate the injury </span></p>
<p style="top:452.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">conditions experienced by the bulk of clinical patients (Hiskens </span></p>
<p style="top:465.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2019; Shultz et al., 2017). Pre-clinical studies evaluating the </span></p>
<p style="top:478.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">effect of a NUT following blast-related TBIs, commonly seen during </span></p>
<p style="top:491.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">military service, are needed.</span></p>
<p style="top:504.4pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Most of the evidence consolidated within this review has been </span></p>
<p style="top:517.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gained from animal studies replicating conditions of moderate to se-</span></p>
<p style="top:530.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vere TBI. While these animal models aim to serve as surrogates for </span></p>
<p style="top:543.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical presentations of TBI, differences in criteria used to ascertain </span></p>
<p style="top:556.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI severity in animal studies (i.e., cortical deformation or velocity) </span></p>
<p style="top:569.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">versus clinical practice (Glasgow Coma Score and neuroimaging </span></p>
<p style="top:582.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">findings) must be taken into account when considering potential </span></p>
<p style="top:595.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">translation of study findings. Given the differing severity of patho-</span></p>
<p style="top:608.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">physiology across the TBI spectrum, it remains to be seen whether </span></p>
<p style="top:621.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">an intervention that shows promise within one severity of TBI sever-</span></p>
<p style="top:634.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ity is beneficial in more/less severe cases (Dixon, 2017).</span></p>
<p style="top:671.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.1.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Intervention parameters and outcome </span></b></p>
<p style="top:684.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">measurements</span></b></p>
<p style="top:712.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Animals were either fed </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> or gavaged to deliver the </span></p>
<p style="top:725.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUT in studies within this review. Animals fed </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> may be </span></p>
<p style="top:49.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">representative of humans prescribed a supplement or altered diet </span></p>
<p style="top:62.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">as an intervention following TBI; however, these methods of deliv-</span></p>
<p style="top:75.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ery may lead to high variability in the amount of nutrient/compound </span></p>
<p style="top:88.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ingested across subjects. Additionally, adherence may be an issue </span></p>
<p style="top:101.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in clinical populations if the prescribed diet is vastly different than </span></p>
<p style="top:114.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the patient&apos;s habitual diet. On the other hand, gavage allows for pre</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:127.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cise dosing but is invasive and involves bypassing the early stages </span></p>
<p style="top:140.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of digestion and absorption. Delivery of a supplement orally would </span></p>
<p style="top:153.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">be more representative of what would be viable for clinical patients </span></p>
<p style="top:166.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with mTBI, while gavage replicates tube feeding that may be neces-</span></p>
<p style="top:179.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sary in humans following moderate or severe TBI. Future research </span></p>
<p style="top:192.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">should investigate if differences in post-TBI outcomes exist if the </span></p>
<p style="top:205.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">same NUT is fed </span><i><span style="font-family:Lato,serif;font-size:8.0pt">ad libitum</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> or delivered via gavage.</span></p>
<p style="top:218.4pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Evidence from pharmaceutical studies show that discontinu-</span></p>
<p style="top:231.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ity between timing and mode of drug administration in animal and </span></p>
<p style="top:244.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clinical studies contribute to failed translation (Agoston, 2017; </span></p>
<p style="top:257.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Mohamadpour et al., 2019). These shortcomings may be due to our </span></p>
<p style="top:270.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">limited understanding of physiological and pathological temporal </span></p>
<p style="top:283.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">differences between humans and rodents (Agoston, 2017). For ex-</span></p>
<p style="top:296.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ample, the lifespan of a rat is highly accelerated to that of a human; </span></p>
<p style="top:309.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with one rat day equating to </span><span style="font-family:STIX,serif;font-size:8.0pt">~</span><span style="font-family:Lato,serif;font-size:8.0pt">27 human days, and </span><span style="font-family:STIX,serif;font-size:8.0pt">~</span><span style="font-family:Lato,serif;font-size:8.0pt">13.7 rat days </span></p>
<p style="top:322.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">being comparable to one human year (Agoston, 2017). Based on </span></p>
<p style="top:335.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">these figures initiating a NUT 24 hr post-injury in a rat may be rep</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:348.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">resentative of </span><span style="font-family:STIX,serif;font-size:8.0pt">~</span><span style="font-family:Lato,serif;font-size:8.0pt">21 days post-injury in humans. Measuring outcomes </span></p>
<p style="top:361.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">at 7 days post-TBI in rats could possibly be indicative of outcomes at </span></p>
<p style="top:374.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">6 months for humans. Research is needed to elucidate the possible </span></p>
<p style="top:387.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">temporal discordance between rodent and human TBI pathophysi-</span></p>
<p style="top:400.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ology to increase the likelihood of intervention translation from the </span></p>
<p style="top:413.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">laboratory to clinical practice. Future studies should consider deliv-</span></p>
<p style="top:426.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ering a NUT in separate groups of animals to compare NP outcomes </span></p>
<p style="top:439.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">under ideal conditions (i.e., immediately post-injury) and under de-</span></p>
<p style="top:452.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">layed conditions that are clinically representative.</span></p>
<p style="top:465.4pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">A distinct advantage of animal studies is the ability to collect in-</span></p>
<p style="top:478.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">vasive outcome measures that would be unethical and impractical </span></p>
<p style="top:491.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to acquire in humans. However, a strong case has been presented </span></p>
<p style="top:504.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">that &#x201c;pre-clinical researchers should also prioritize incorporating </span></p>
<p style="top:517.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">methods/outcomes that are applicable in both the experimen-</span></p>
<p style="top:530.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tal and clinical settings&#x201d; (Shultz et al., 2017, p. 404). Most studies </span></p>
<p style="top:543.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in this review involved biochemical assays on slices of brain tissue </span></p>
<p style="top:556.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post-sacrifice to quantify NP biomarkers. While this provided an ac-</span></p>
<p style="top:569.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">curate post-mortem measurement of outcomes within the brain, it </span></p>
<p style="top:582.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may not be representative of the amount of circulating biomarkers </span></p>
<p style="top:595.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">while the animal was still alive. Incorporation of blood biomarkers </span></p>
<p style="top:608.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and neuroimaging in animal studies would expand understanding </span></p>
<p style="top:621.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of the relationships shared between biomarkers measured pre- and </span></p>
<p style="top:634.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">post-sacrifice. Incorporation of biomarkers in animal studies would </span></p>
<p style="top:647.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">allow comparisons and cross-validation against the growing number </span></p>
<p style="top:660.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of biomarkers that can be measured in human clinical populations </span></p>
<p style="top:673.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Shultz et al., 2017).</span></p>
<p style="top:686.4pt;left:320.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Taken together, the examples in this section illustrate method-</span></p>
<p style="top:699.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ological factors that limit the biofidelity of the available evidence for </span></p>
<p style="top:712.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUTs to improve NP outcomes post-TBI. These factors need to be </span></p>
<p style="top:725.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">carefully considered when interpreting study results. Researchers </span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;597</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">must find ways to account for financial and logistical constraints in </span></p>
<p style="top:62.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">order to improve the biofidelity and validity of investigations in a </span></p>
<p style="top:75.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">manner that will benefit clinical patients with TBI.</span></p>
<p style="top:112.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.2&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Risk of bias</span></b></p>
<p style="top:140.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">There is difficulty with assessing RoB in systematic reviews of animal </span></p>
<p style="top:153.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies due to poor methodological reporting (de Vries et al., 2014; </span></p>
<p style="top:166.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Hooijmans et al., 2014; Perel et al., 2007). Studies within this review </span></p>
<p style="top:179.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were often missing (or did not clearly communicate) key methodo-</span></p>
<p style="top:192.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">logical details, including: blinding procedures, severity of TBI mod-</span></p>
<p style="top:205.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">eled, mortality rate following TBI, age of animals used, sample size, </span></p>
<p style="top:218.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">number of animals used for each outcome measure, and whether an-</span></p>
<p style="top:231.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">imals were randomized for outcome measure assessment (Kilkenny </span></p>
<p style="top:244.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2010; Landis et al., 2012). As a result, determination of RoB </span></p>
<p style="top:257.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">was limited without these key methodological details (Tables 2 and </span></p>
<p style="top:270.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">3). In some cases, authors of the original studies may have assumed </span></p>
<p style="top:283.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">that the reader had prior knowledge of commonly used method-</span></p>
<p style="top:296.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ologies in TBI animal studies, and thus these details were not ex-</span></p>
<p style="top:309.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">plicitly stated. For example, random selection of housing may not </span></p>
<p style="top:322.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">be possible in a TBI study because uninjured control animals may </span></p>
<p style="top:335.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">overpower the TBI animals in competition for food. To overcome this </span></p>
<p style="top:348.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">issue animals belonging to the same study groups may have been </span></p>
<p style="top:361.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">housed together. To enhance methodological transparency, it is rec-</span></p>
<p style="top:374.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ommended that future studies incorporate a figure/diagram that </span></p>
<p style="top:387.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">clearly depicts key aspects of study design as shown in some studies </span></p>
<p style="top:400.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Gerbatin et al., 2019; Itoh et al., 2013; Kumar et al., 2014; Saraiva </span></p>
<p style="top:413.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2012; Schwartzkroin et al., 2010; Thau-Zuchman et al., 2019; </span></p>
<p style="top:426.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Xing et al., 2016).</span></p>
<p style="top:439.4pt;left:57.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The quality of results reported was low in many studies where </span></p>
<p style="top:452.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">only simple figures with p values were published. Values or descrip-</span></p>
<p style="top:465.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tive statistics for outcomes were rarely provided in tabular format or </span></p>
<p style="top:478.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">within text, preventing meta-analysis to evaluate the size and mean-</span></p>
<p style="top:491.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ingfulness of effects attributed to the delivered NUT. However, all </span></p>
<p style="top:504.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies reported a positive benefit of the NUT administered on NP </span></p>
<p style="top:517.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes compared to control. The absence of negative findings </span></p>
<p style="top:530.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may be indicative of potential publication bias, possibly skewing the </span></p>
<p style="top:543.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUT associated benefits reported. Registration of animal studies </span></p>
<p style="top:556.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to prevent publication bias, innovation of TBI models to improve </span></p>
<p style="top:569.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">biofidelity, thorough and transparent reporting of methodologies </span></p>
<p style="top:582.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and results, and clinically relevant intervention timing and delivery </span></p>
<p style="top:595.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">are the focus of ongoing initiatives (Collins &amp; Tabak, 2014; Hiskens </span></p>
<p style="top:608.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2019; Hooijmans et al., 2012, 2014; Kilkenny et al., 2010; Landis </span></p>
<p style="top:621.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2012; Mohamadpour et al., 2019; Wojnarowicz et al., 2017).</span></p>
<p style="top:658.8pt;left:44.8pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.3&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Implications for clinical TBI patients</span></b></p>
<p style="top:686.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Unfortunately, due to limitations of the evidence, this review could </span></p>
<p style="top:699.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">not definitively recommend a single NUT as the primary &#x201c;over-the-</span></p>
<p style="top:712.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">counter&#x201d; candidate for clinical patients post-TBI. Further research </span></p>
<p style="top:725.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">should focus on anti-oxidant compounds (ALA, curcumin, phenols), </span></p>
<p style="top:49.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">BCAAs (combined leucine, isoleucine, valine), and </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3 PUFAs (spe-</span></p>
<p style="top:62.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cifically DHA) which appear to be the most promising supplementa-</span></p>
<p style="top:75.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion candidates that might facilitate improved clinical outcomes for </span></p>
<p style="top:88.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI patients in the future.</span></p>
<p style="top:101.4pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Following TBI, patients often endure an array of functional and </span></p>
<p style="top:114.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">neurobehavioral deficits which seemingly develop as consequences </span></p>
<p style="top:127.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of cellular damage and dysfunction triggered by the secondary injury </span></p>
<p style="top:140.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">phase of TBI (Giza &amp; Hovda, 2014; Kenzie et al., 2018). Functional </span></p>
<p style="top:153.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">consequences of TBI often include mood instability, impaired cog-</span></p>
<p style="top:166.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">nition and memory, confusion, intolerance to cognitive and physi-</span></p>
<p style="top:179.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cal loading, vestibulo-ocular deficiencies, and sleep disturbances </span></p>
<p style="top:192.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Akin et al., 2017; Ellis et al., 2016; Kenzie et al., 2018; Mathias &amp; </span></p>
<p style="top:205.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Alvaro, 2012; Polinder et al., 2018; Theadom et al., 2016). Cellular </span></p>
<p style="top:218.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">disruptions impair neurological networks and subsequently manifest </span></p>
<p style="top:231.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">in symptom complaints and deficits at the experiential and social </span></p>
<p style="top:244.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">levels (Kenzie et al., 2018). Approximately 50% of patients experi</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:257.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ence sleep-wake disturbances after TBI (Mathias &amp; Alvaro, 2012). </span></p>
<p style="top:270.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Excessive glutamate release post-TBI creates an imbalance in the </span></p>
<p style="top:283.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">glutamate/GABA pool and contributes to impaired neurotransmis-</span></p>
<p style="top:296.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sion which in turn dysregulates networks responsible for restorative </span></p>
<p style="top:309.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sleep (Kenzie et al., 2018). Without restorative sleep the patient </span></p>
<p style="top:322.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">may experience impaired executive function, mood instability, and </span></p>
<p style="top:335.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">high levels of stress that further compound sleep-wake disruption </span></p>
<p style="top:348.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Kenzie et al., 2018). In this regard, pre-clinical evidence suggests pa</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:361.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tients with post-TBI sleep-wake disorders may experience a positive </span></p>
<p style="top:374.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">benefit from BCAA supplementation via improved balance of glu-</span></p>
<p style="top:387.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tamate/GABA pools within orexin neurons (Cole et al., 2010; Elliott </span></p>
<p style="top:400.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2018; Lim et al., 2013).</span></p>
<p style="top:413.4pt;left:318.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ionic dysregulation and subsequent mitochondrial dysfunc-</span></p>
<p style="top:426.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion are hallmarks of TBI that contribute to oxidative stress (Giza </span></p>
<p style="top:439.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">&amp; Hovda, 2014; Shichiri, 2014). Excessive free radical produc</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:452.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion can trigger apoptosis and lipid peroxidation of cell mem-</span></p>
<p style="top:465.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">branes (Giza &amp; Hovda, 2014; Kannan &amp; Jain, 2000; Stoica &amp; </span></p>
<p style="top:478.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Faden, 2010). Moderate and severe TBI can elicit considerable </span></p>
<p style="top:491.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">amounts of neuronal death severely impairing neuroconnectivity </span></p>
<p style="top:504.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and transmission (Giza &amp; Hovda, 2014; Kenzie et al., 2018). Across </span></p>
<p style="top:517.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the TBI spectrum, mitochondrial dysfunction and impaired cell </span></p>
<p style="top:530.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">membrane homeostasis within neuronal, axonal, and glial cells </span></p>
<p style="top:543.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">can exacerbate neurotransmission impairment. Biomechanical </span></p>
<p style="top:556.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">forces deforming brain cells during TBI can damage axons and </span></p>
<p style="top:569.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">increase BBB permeability, both of which can be further ag-</span></p>
<p style="top:582.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">gravated by unregulated free radicals (Kuriakose et al., 2019; </span></p>
<p style="top:595.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Ljubisavljevic, 2016). Compromised tight junctions between en-</span></p>
<p style="top:608.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dothelial cells within the BBB results in cerebral edema further </span></p>
<p style="top:621.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">compromising neurotransmission (Kenzie et al., 2018; Luissint </span></p>
<p style="top:634.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2012). Globally impaired neurotransmission can affect TBI </span></p>
<p style="top:647.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">patients through diminished sensorimotor integration, executive </span></p>
<p style="top:660.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">function, and working memory while manifesting clinically as </span></p>
<p style="top:673.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">mood instability, cognitive fatigue, and inability to complete ac-</span></p>
<p style="top:686.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tivities of daily living (Kenzie et al., 2018). Introduction of anti-ox</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:699.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">idants such as ALA, curcumin, or phenols early after moderate </span></p>
<p style="top:712.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">or severe TBI may promote tissue sparing and combat oxida-</span></p>
<p style="top:725.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tive stress to blunt the overall cellular damage and downstream </span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">598&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:49.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">impairments experienced by the patient (Cheng et al., 2016; Itoh </span></p>
<p style="top:62.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">et al., 2013; Jiang et al., 2017; Ozbal et al., 2015; Toklu et al., 2009; </span></p>
<p style="top:75.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Wei et al., 2015). </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3 PUFAs have demonstrated the same an-</span></p>
<p style="top:88.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ti-apoptotic and anti-oxidant benefits as anti-oxidant compounds </span></p>
<p style="top:101.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">but with additional advantages (Lewis, 2016; Michael-Titus &amp; </span></p>
<p style="top:114.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Priestley, 2014). DHA is a major constituent of cell membranes </span></p>
<p style="top:127.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">within the central nervous system (Lo Van et al., 2016). At a cellu-</span></p>
<p style="top:140.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">lar level, delivery of DHA post-TBI may proactively combat oxida-</span></p>
<p style="top:153.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tive stress while providing the necessary building blocks to repair </span></p>
<p style="top:166.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">phospholipid bilayers damaged by lipid peroxidation. Pre-clinical </span></p>
<p style="top:179.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">evidence suggests that the administration of DHA after TBI up-</span></p>
<p style="top:192.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">regulates brain-derived neurotrophic factor (BDNF) expression. </span></p>
<p style="top:205.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Expression of BDNF plays a crucial role in the regulation of neu-</span></p>
<p style="top:218.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">roplasticity and neurogenesis so that injured cells/networks can </span></p>
<p style="top:231.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">repair and/or reorganize themselves (Binder &amp; Scharfman, 2004; </span></p>
<p style="top:244.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Hempstead, 2015). Upregulation of BDNF by DHA supplementa-</span></p>
<p style="top:257.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion (or other means) creates an internal environment that pro-</span></p>
<p style="top:270.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">motes recovery at the cellular and network level that may further </span></p>
<p style="top:283.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">alleviate functional deficits and symptom burden for patients. A </span></p>
<p style="top:296.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pre-clinical study demonstrated that combining curcumin with </span></p>
<p style="top:309.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">DHA led to an additive benefit that exceeded the benefits ob-</span></p>
<p style="top:322.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">served following administration of either compound in isolation </span></p>
<p style="top:335.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Wu et al., 2014). There is a need to better understand how con</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:348.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">stituents of multi-supplement interact with outcomes.</span></p>
<p style="top:361.4pt;left:59.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Outside of the neurotrauma literature, reviews of NUTs to im</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:374.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">prove outcomes following musculoskeletal injuries and soft-tis-</span></p>
<p style="top:387.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sue wounds have concluded that evidence supporting a single </span></p>
<p style="top:400.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">intervention in humans remains elusive (Quain &amp; Khardori, 2015; </span></p>
<p style="top:413.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Tipton, 2015; Wild et al., 2010). These reviews recommended a </span></p>
<p style="top:426.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">well-balanced diet of whole foods that are minimally processed </span></p>
<p style="top:439.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">and abstaining from alcohol consumption (Quain &amp; Khardori, 2015; </span></p>
<p style="top:452.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Tipton, 2015). Supplementation is likely only appropriate if the in-</span></p>
<p style="top:465.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">dividual&apos;s habitual diet is deficient in a given nutrient or compound </span></p>
<p style="top:478.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Quain &amp; Khardori, 2015; Tipton, 2015). Physiological responses to </span></p>
<p style="top:491.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">injury such as inflammation and apoptosis are important biological </span></p>
<p style="top:504.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">processes for recovery under normal conditions and complete elim-</span></p>
<p style="top:517.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ination of these mechanisms would be unfavorable (Tipton, 2015). </span></p>
<p style="top:530.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">These general recommendations appear appropriate for patients </span></p>
<p style="top:543.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">with TBI in the interim while the biofidelity and validity of NUTs for </span></p>
<p style="top:556.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">TBI continue to be elucidated.</span></p>
<p style="top:593.8pt;left:46.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">4.4&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;Future directions</span></b></p>
<p style="top:621.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Modification of lifestyle factors, such as diet and exercise, are con-</span></p>
<p style="top:634.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">sidered safe for investigation in human subjects given contraindi-</span></p>
<p style="top:647.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">cations are considered and accounted for. This presents a unique </span></p>
<p style="top:660.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">opportunity in the case of NUTs for TBI to potentially conduct </span></p>
<p style="top:673.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pre-clinical and clinical studies in parallel to accelerate the iden-</span></p>
<p style="top:686.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tification of strategies that might benefit clinical patients. Such </span></p>
<p style="top:699.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">study designs have begun to be adopted in other areas of trans-</span></p>
<p style="top:712.4pt;left:46.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">lational research and serve as an innovative approach to account </span></p>
<p style="top:49.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">for the innate ethical and logistical limitations of both clinical and </span></p>
<p style="top:62.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">pre-clinical study designs (Jordan et al., 2019). Although studies </span></p>
<p style="top:75.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">evaluating NUTs have been conducted in humans with TBI, none </span></p>
<p style="top:88.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">were included in this review due to a lack of NP outcome meas-</span></p>
<p style="top:101.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ures. Future clinical investigations of post-TBI NUTs should make </span></p>
<p style="top:114.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">efforts to include NP measures within their outcome batteries. </span></p>
<p style="top:127.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Due to the difficulties of running RCTs, it is imperative to include </span></p>
<p style="top:140.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NP measures alongside clinical/behavioral measures in order to </span></p>
<p style="top:153.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">maximize the data acquired during a given collection. Inclusion </span></p>
<p style="top:166.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of NP measures in human trials would improve our understand-</span></p>
<p style="top:179.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing of why interventions evaluated in RCTs fail or succeed, while </span></p>
<p style="top:192.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">providing cross-validation of biomarkers acquired in pre-clinical </span></p>
<p style="top:205.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">studies. Preliminary evidence suggests a positive effect of deliver-</span></p>
<p style="top:218.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ing exercise and DHA in combination after TBI on NP outcomes </span></p>
<p style="top:231.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">(Wu et al., 2013). Given exercise has become a pillar of TBI reha-</span></p>
<p style="top:244.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">bilitation, future investigation into the relationship of exercise and </span></p>
<p style="top:257.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUTs is warranted. Finally, pre-clinical studies investigating diets/</span></p>
<p style="top:270.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">supplements that may be detrimental for post-TBI NP outcomes </span></p>
<p style="top:283.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">would be highly informative.</span></p>
<p style="top:320.8pt;left:307.5pt;line-height:10.0pt"><b><span style="font-family:Lato,serif;font-size:10.0pt">5&#x2003;</span></b><span style="font-family:Lato,serif;font-size:10.0pt">|</span><b><span style="font-family:Lato,serif;font-size:10.0pt">&#x2003;CONCLUSIONS</span></b></p>
<p style="top:348.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Our objective was to identify NUTs introduced post-TBI demon</span><span style="font-family:Lato,serif;font-size:8.0pt">-</span></p>
<p style="top:361.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">strating potential to improve NP outcomes after TBI. Available </span></p>
<p style="top:374.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">evidence regarding the efficacy of NUTs delivered to attenuate NP </span></p>
<p style="top:387.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">outcomes secondary to TBI was from 43 pre-clinical animal studies </span></p>
<p style="top:400.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">utilizing 2,897 rodents. No studies evaluated the effect of a NUT </span></p>
<p style="top:413.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">on NP outcomes of TBI in humans. The overall reporting of meth-</span></p>
<p style="top:426.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ods and results of included pre-clinical studies was poor, limiting </span></p>
<p style="top:439.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the biofidelity of evidence. Decisive recommendations about which </span></p>
<p style="top:452.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">NUTs most effectively combat secondary injury following TBI in a </span></p>
<p style="top:465.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">manner that would benefit clinical patients could not be made. Initial </span></p>
<p style="top:478.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">evidence from animal studies provides a platform from which future </span></p>
<p style="top:491.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">investigations can be launched to determine which aspects of nutri-</span></p>
<p style="top:504.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">tion (particularly anti-oxidant compounds, BCAAs, and </span><span style="font-family:STIX,serif;font-size:8.0pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:8.0pt">-3 PUFAs) </span></p>
<p style="top:517.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">could be manipulated to promote better recovery outcomes across </span></p>
<p style="top:530.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the TBI spectrum for humans. With TBI complexity and heterogene-</span></p>
<p style="top:543.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ity of outcomes, innovative and collaborative efforts are needed for </span></p>
<p style="top:556.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">the identification of interventions to reduce the global health burden </span></p>
<p style="top:569.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">of this injury.</span></p>
<p style="top:595.4pt;left:307.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">CONFLICT OF INTEREST</span></b></p>
<p style="top:608.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">All authors declare no conflict of interest.</span></p>
<p style="top:634.4pt;left:307.5pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">AUTHOR CONTRIBUTIONS</span></b></p>
<p style="top:647.4pt;left:307.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Conceptualization</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, J.M, P.H., K.Q., A.T., R.B.; </span><i><span style="font-family:Lato,serif;font-size:8.0pt">Methodology</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, J.M, P.H., </span></p>
<p style="top:660.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">K.Q., A.T., R.B.; </span><i><span style="font-family:Lato,serif;font-size:8.0pt">Investigation</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, J.M.; </span><i><span style="font-family:Lato,serif;font-size:8.0pt">Formal Analysis</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, J.M., P.H.; </span><i><span style="font-family:Lato,serif;font-size:8.0pt">Writing -  </span></i></p>
<p style="top:673.4pt;left:307.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Original Draft</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, J.M.; </span><i><span style="font-family:Lato,serif;font-size:8.0pt">Writing - Review &amp; Editing</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, J.M, P.H., K.Q., A.T., </span></p>
<p style="top:686.4pt;left:307.5pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">R.B.; </span><i><span style="font-family:Lato,serif;font-size:8.0pt">Supervision</span></i><span style="font-family:Lato,serif;font-size:8.0pt">, P.H., K.Q., A.T.</span></p>
<p style="top:699.4pt;left:307.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Authors: McGeown (80%), Hume (5%), Quarrie (5%), Theadom (5%), </span></i></p>
<p style="top:712.4pt;left:307.5pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Borotkanics (5%)</span></i><span style="font-family:Lato,serif;font-size:8.0pt">.</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;599</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:47.8pt;left:44.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">PEER REVIEW</span></b></p>
<p style="top:75.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">The peer review history for this article is available at https://publo </span></p>
<p style="top:88.4pt;left:44.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">ns.com/publo n/10.1002/jnr.24746.</span></p>
<p style="top:114.4pt;left:44.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">ORCID</span></b></p>
<p style="top:127.4pt;left:44.8pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Joshua P. McGeown</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:127.4pt;left:126.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://orcid.org/0000-0003-0225-4488</span><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:140.4pt;left:44.8pt;line-height:8.0pt"><i><span style="font-family:Lato,serif;font-size:8.0pt">Patria A. Hume</span></i><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:140.4pt;left:110.0pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt"> </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://orcid.org/0000-0003-1847-8128</span><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:166.4pt;left:44.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">REFERENCES</span></b></p>
<p style="top:179.8pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Agoston, D. V. (2017). How to translate time? The temporal aspect of </span></p>
<p style="top:190.3pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">human and rodent biology. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">8</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 92. https://doi.</span></p>
<p style="top:200.8pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.3389/fneur.2017.00092</span></p>
<p style="top:211.3pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Akin, F. W., Murnane, O. D., Hall, C. D., &amp; Riska, K. M. (2017). Vestibular </span></p>
<p style="top:221.8pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">consequences of mild traumatic brain injury and blast exposure: A re-</span></p>
<p style="top:232.3pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">view. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Injury</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">31</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), 1188&#x2013;1194. https://doi.org/10.1080/02699 </span></p>
<p style="top:242.8pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">052.2017.1288928</span></p>
<p style="top:253.3pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Alsalaheen, B. A., Mucha, A., Morris, L. O., Whitney, S. L., Furman, J. M., </span></p>
<p style="top:263.8pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Camiolo-Reddy, C. E., Collins, M. W., Lovell, M. R., &amp; Sparto, P. J. </span></p>
<p style="top:274.3pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2010). Vestibular rehabilitation for dizziness and balance disorders </span></p>
<p style="top:284.8pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">after concussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurologic Physical Therapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">34</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 87&#x2013;93. </span></p>
<p style="top:295.3pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1097/NPT.0b013 e3181 dde568</span></p>
<p style="top:305.8pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Aquilani, R., Boselli, M., Boschi, F., Viglio, S., Iadarola, P., Dossena, M., </span></p>
<p style="top:316.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Pastoris, O., &amp; Verri, M. (2008). Branched-chain amino acids may </span></p>
<p style="top:326.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">improve recovery from a vegetative or minimally conscious state </span></p>
<p style="top:337.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in patients with traumatic brain injury: A pilot study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Archives of </span></i></p>
<p style="top:347.8pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Physical Medicine and Rehabilitation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">89</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), 1642&#x2013;1647. https://doi.</span></p>
<p style="top:358.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.apmr.2008.02.023</span></p>
<p style="top:368.8pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Aquilani, R., Iadarola, P., Contardi, A., Boselli, M., Verri, M., Pastoris, O., </span></p>
<p style="top:379.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Boschi, F., Arcidiaco, P., &amp; Viglio, S. (2005). Branched-chain amino </span></p>
<p style="top:389.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acids enhance the cognitive recovery of patients with severe trau-</span></p>
<p style="top:400.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Archives of Physical Medicine and Rehabilitation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:410.8pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">86</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), 1729&#x2013;1735. https://doi.org/10.1016/j.apmr.2005.03.022</span></p>
<p style="top:421.3pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Archer, T., Svensson, K., &amp; Alricsson, M. (2012). Physical exer</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:431.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cise ameliorates deficits induced by traumatic brain injury. </span></p>
<p style="top:442.3pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Acta Neurologica Scandinavica</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:442.3pt;left:178.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">125</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), </span></p>
<p style="top:442.3pt;left:209.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">293&#x2013;302. </span></p>
<p style="top:442.3pt;left:249.9pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.</span></p>
<p style="top:452.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1600-0404.2011.01638.x</span></p>
<p style="top:463.3pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ashbaugh, A., &amp; McGrew, C. (2016). The role of nutritional supplements </span></p>
<p style="top:473.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in sports concussion treatment. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Sports Medicine Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:484.3pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">15</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 16&#x2013;19. https://doi.org/10.1249/JSR.00000 00000 000219</span></p>
<p style="top:494.8pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bailes, J. E., &amp; Mills, J. D. (2010). Docosahexaenoic acid reduces traumatic </span></p>
<p style="top:505.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">axonal injury in a rodent head injury model. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:515.8pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">27</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), 1617&#x2013;1624. https://doi.org/10.1089/neu.2009.1239</span></p>
<p style="top:526.3pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Baker, J. G., Freitas, M. S., Leddy, J. J., Kozlowski, K. F., &amp; Willer, B. S. </span></p>
<p style="top:536.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2012). Return to full functioning after graded exercise assessment </span></p>
<p style="top:547.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and progressive exercise treatment of postconcussion syndrome. </span></p>
<p style="top:557.8pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Rehabilitation Research and Practice</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2012</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 705309. https://doi.</span></p>
<p style="top:568.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1155/2012/705309</span></p>
<p style="top:578.8pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Barker-Collo, S., Theadom, A., Jones, K., Feigin, V. L., &amp; Kahan, M. </span></p>
<p style="top:589.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2016). Accuracy of an international classification of diseases code </span></p>
<p style="top:599.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">surveillance system in the identification of traumatic brain injury. </span></p>
<p style="top:610.3pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroepidemiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">47</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 46&#x2013;52. https://doi.org/10.1159/00044 </span></p>
<p style="top:620.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">8403</span></p>
<p style="top:631.3pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bhatnagar, S., Iaccarino, M. A., &amp; Zafonte, R. (2016). Pharmacotherapy </span></p>
<p style="top:641.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in rehabilitation of post-acute traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:652.3pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">1640</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 164&#x2013;179. https://doi.org/10.1016/j.brain res.2016.01.021</span></p>
<p style="top:662.8pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Binder, D. K., &amp; Scharfman, H. E. (2004). Brain-derived neurotrophic fac</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:673.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tor. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Growth Factors</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 123&#x2013;131.</span></p>
<p style="top:683.8pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bothe, M. K., &amp; Stover, J. F. (2015). The branched chain amino acids </span></p>
<p style="top:694.3pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in the context of other amino acids in traumatic brain injury. In  </span></p>
<p style="top:704.8pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">R. Rajendram, V. Preedy, &amp; V. Patel (Eds.), </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Branched Chain Amino Acids </span></i></p>
<p style="top:48.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">in Clinical Nutrition, Nutrition and Health</span></i><span style="font-family:Lato,serif;font-size:7.5pt"> (pp. 111&#x2013;125). New York, NY: </span></p>
<p style="top:58.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Humana Press.</span></p>
<p style="top:69.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chakraborty, S., Skolnick, B., &amp; Narayan, R. K. (2016). Neuroprotection </span></p>
<p style="top:79.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">trials in traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Neurology and Neuroscience </span></i></p>
<p style="top:90.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 1&#x2013;8. https://doi.org/10.1007/s1191 0-016-0625-x</span></p>
<p style="top:100.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cheng, T., Wang, W., Li, Q., Han, X., Xing, J., Qi, C., Lan, X. I., Wan, J., </span></p>
<p style="top:111.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Potts, A., Guan, F., &amp; Wang, J. (2016). Cerebroprotection of flavanol </span></p>
<p style="top:121.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(-)-epicatechin after traumatic brain injury via Nrf2-dependent and </span></p>
<p style="top:132.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">-independent pathways. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Free Radical Biology and Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">92</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 15&#x2013;28. </span></p>
<p style="top:142.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/j.freer adbio med.2015.12.027</span></p>
<p style="top:153.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Cole, J. T., Mitala, C. M., Kundu, S., Verma, A., Elkind, J. A., Nissim, I., </span></p>
<p style="top:163.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Cohen, A. S. (2010). Dietary branched chain amino acids amelio-</span></p>
<p style="top:174.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rate injury-induced cognitive impairment. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Proceedings of the National </span></i></p>
<p style="top:184.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Academy of Sciences of the United States of America</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">107</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 366&#x2013;371. </span></p>
<p style="top:195.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1073/pnas.09102 80107</span></p>
<p style="top:205.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Collins, F. S., &amp; Tabak, L. A. (2014). Policy: NIH plans to enhance reproduc</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:216.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ibility. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Nature</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">505</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7485), 612&#x2013;613. https://doi.org/10.1038/505612a</span></p>
<p style="top:226.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Davies, D. J. (2018). Supplementary magnesium in traumatic brain injury: </span></p>
<p style="top:237.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Where do we go from here? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of the Royal Army Medical Corps</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:247.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">164</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(6), 397&#x2013;398. https://doi.org/10.1136/jramc -2018-000985</span></p>
<p style="top:258.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Davis, L. M., Pauly, J. R., Readnower, R. D., Rho, J. M., &amp; Sullivan, P. G. </span></p>
<p style="top:268.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2008). Fasting is neuroprotective following traumatic brain injury. </span></p>
<p style="top:279.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neuroscience Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">86</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(8), 1812&#x2013;1822. https://doi.</span></p>
<p style="top:289.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1002/jnr.21628</span></p>
<p style="top:300.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">de Vries, R. B. M., Wever, K. E., Avey, M. T., Stephens, M. L., Sena, E. S., &amp; </span></p>
<p style="top:310.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Leenaars, M. (2014). The usefulness of systematic reviews of animal </span></p>
<p style="top:321.2pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">experiments for the design of preclinical and clinical studies. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">ILAR </span></i></p>
<p style="top:331.7pt;left:318.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">55</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 427&#x2013;437. https://doi.org/10.1093/ilar/ilu043</span></p>
<p style="top:342.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Deng-Bryant, Y., Prins, M. L., Hovda, D. A., &amp; Harris, N. G. (2011). </span></p>
<p style="top:352.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ketogenic diet prevents alterations in brain metabolism in young but </span></p>
<p style="top:363.2pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">not adult rats after traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:373.7pt;left:318.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), 1813&#x2013;1825. https://doi.org/10.1089/neu.2011.1822</span></p>
<p style="top:384.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Dixon, K. J. (2017). Pathophysiology of traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Physical </span></i></p>
<p style="top:394.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medicine and Rehabilitation Clinics of North America</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 215&#x2013;225. </span></p>
<p style="top:405.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/j.pmr.2016.12.001</span></p>
<p style="top:415.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Elliott, J. E., De Luche, S. E., Churchill, M. J., Moore, C., Cohen, A. S., </span></p>
<p style="top:426.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Meshul, C. K., &amp; Lim, M. M. (2018). Dietary therapy restores gluta</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:436.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matergic input to orexin/hypocretin neurons after traumatic brain </span></p>
<p style="top:447.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury in mice. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Sleep</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">41</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), zsx212. https://doi.org/10.1093/sleep/ </span></p>
<p style="top:457.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">zsx212</span></p>
<p style="top:468.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ellis, M. J., Cordingley, D., Vis, S., Reimer, K., Leiter, J., &amp; Russell, K. </span></p>
<p style="top:478.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2015). Vestibulo-ocular dysfunction in pediatric sports-related con-</span></p>
<p style="top:489.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurosurgery Pediatrics</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 248&#x2013;255. https://</span></p>
<p style="top:499.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.3171/2015.1.PEDS1 4524</span></p>
<p style="top:510.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ellis, M. J., Leddy, J. J., &amp; Willer, B. (2015). Physiological, vestibulo-ocu-</span></p>
<p style="top:520.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lar and cervicogenic post-concussion disorders: An evidence-based </span></p>
<p style="top:531.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">classification system with directions for treatment. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Injury</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">29</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), </span></p>
<p style="top:541.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">238&#x2013;248. https://doi.org/10.3109/02699 052.2014.965207</span></p>
<p style="top:552.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ellis, M. J., Leddy, J., &amp; Willer, B. (2016). Multi-disciplinary management </span></p>
<p style="top:562.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of athletes with post-concussion syndrome: An evolving patho-</span></p>
<p style="top:573.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">physiological approach. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 136. https://doi.</span></p>
<p style="top:583.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.3389/fneur.2016.00136</span></p>
<p style="top:594.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Feigin, V. L., Theadom, A., Barker-Collo, S., Starkey, N. J., McPherson, K., </span></p>
<p style="top:604.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kahan, M., Dowell, A., Brown, P., Parag, V., Kydd, R., Jones, K., Jones, </span></p>
<p style="top:615.2pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A., &amp; Ameratunga, S. (2013). Incidence of traumatic brain injury in </span></p>
<p style="top:625.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">New Zealand: A population-based study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Lancet Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), </span></p>
<p style="top:636.2pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">53&#x2013;64. https://doi.org/10.1016/s1474 -4422(12)70262 -4</span></p>
<p style="top:646.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fernandes, J., Arida, R. M., &amp; Gomez-Pinilla, F. (2017). Physical exer-</span></p>
<p style="top:657.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cise as an epigenetic modulator of brain plasticity and cognition. </span></p>
<p style="top:667.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience and Biobehavioral Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">80</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 443&#x2013;456. https://doi.</span></p>
<p style="top:678.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.neubi orev.2017.06.012</span></p>
<p style="top:688.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gardner, A. J., &amp; Zafonte, R. (2016). Neuroepidemiology of traumatic </span></p>
<p style="top:699.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Handbook of Clinical Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">138</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 207&#x2013;223. https://</span></p>
<p style="top:709.7pt;left:318.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1016/B978-0-12-80297 3-2.00012 -4</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">600&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:48.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gerbatin, R. R., Silva, L. F. A., Hoffmann, M. S., Della-Pace, I. D., do </span></p>
<p style="top:58.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Nascimento, P. S., Kegler, A., de Zorzi, V. N., Cunha, J. M., Botelho, </span></p>
<p style="top:69.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P., Neto, J. B. T., Furian, A. F., Oliveira, M. S., Fighera, M. R., &amp; </span></p>
<p style="top:79.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Royes, L. F. F. (2019). Delayed creatine supplementation counter-</span></p>
<p style="top:90.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">acts reduction of GABAergic function and protects against seizures </span></p>
<p style="top:100.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">susceptibility after traumatic brain injury in rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Progress in Neuro-</span></i></p>
<p style="top:111.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Psychopharmacology and Biological Psychiatry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">92</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 328&#x2013;338. https://</span></p>
<p style="top:121.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1016/j.pnpbp.2019.02.004</span></p>
<p style="top:132.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Giza, C. C., &amp; Hovda, D. A. (2014). The new neurometabolic cascade </span></p>
<p style="top:142.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of concussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurosurgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">75</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl. 4), S24&#x2013;S33. https://doi.</span></p>
<p style="top:153.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1227/NEU.00000 00000 000505</span></p>
<p style="top:163.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gomez-Pinilla, F. (2011). The combined effects of exercise and foods in </span></p>
<p style="top:174.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">preventing neurological and cognitive disorders. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Preventive Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:184.7pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">52</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, S75&#x2013;S80. https://doi.org/10.1016/j.ypmed.2011.01.023</span></p>
<p style="top:195.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gomez-Pinilla, F., Vaynman, S., &amp; Ying, Z. (2008). Brain-derived neuro</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:205.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">trophic factor functions as a metabotrophin to mediate the effects </span></p>
<p style="top:216.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of exercise on cognition. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European Journal of Neuroscience</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(11), </span></p>
<p style="top:226.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">2278&#x2013;2287. https://doi.org/10.1111/j.1460-9568.2008.06524.x</span></p>
<p style="top:237.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Greco, T., Glenn, T. C., Hovda, D. A., &amp; Prins, M. L. (2016). Ketogenic diet </span></p>
<p style="top:247.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">decreases oxidative stress and improves mitochondrial respiratory </span></p>
<p style="top:258.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">complex activity. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Cerebral Blood Flow and Metabolism</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">36</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), </span></p>
<p style="top:268.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1603&#x2013;1613. https://doi.org/10.1177/02716 78X15 610584</span></p>
<p style="top:279.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Griesbach, G. S., Hovda, D. A., &amp; Gomez-Pinilla, F. (2009). Exercise-</span></p>
<p style="top:289.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">induced improvement in cognitive performance after traumatic brain </span></p>
<p style="top:300.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury in rats is dependent on BDNF activation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">1288</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:310.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">105&#x2013;115. https://doi.org/10.1016/j.brain res.2009.06.045</span></p>
<p style="top:321.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Griesbach, G. S., Hovda, D. A., Molteni, R., Wu, A., &amp; Gomez-Pinilla, F. </span></p>
<p style="top:331.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2004). Voluntary exercise following traumatic brain injury: Brain-</span></p>
<p style="top:342.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">derived neurotrophic factor upregulation and recovery of function. </span></p>
<p style="top:352.7pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">125</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 129&#x2013;139. https://doi.org/10.1016/j.neuro scien </span></p>
<p style="top:363.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ce.2004.01.030</span></p>
<p style="top:373.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gupte, R., Brooks, W., Vukas, R., Pierce, J., &amp; Harris, J. (2019). Sex differ-</span></p>
<p style="top:384.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ences in traumatic brain injury: What we know and what we should </span></p>
<p style="top:394.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">know. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">36</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(22), 3063&#x2013;3091. https://doi.</span></p>
<p style="top:405.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1089/neu.2018.6171</span></p>
<p style="top:415.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hempstead, B. L. (2015). Brain-derived neurotrophic factor: Three </span></p>
<p style="top:426.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ligands, many actions. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Transactions of the American Clinical and </span></i></p>
<p style="top:436.7pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Climatological Association</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">126</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 9&#x2013;19.</span></p>
<p style="top:447.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., </span></p>
<p style="top:457.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., &amp; Sterne, J. A. C. </span></p>
<p style="top:468.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2011). The Cochrane Collaboration&apos;s tool for assessing risk of bias </span></p>
<p style="top:478.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in randomised trials. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BMJ</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">343</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, d5928. https://doi.org/10.1136/</span></p>
<p style="top:489.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bmj.d5928</span></p>
<p style="top:499.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hiskens, M. I., Angoa-Perez, M., Schneiders, A. G., Vella, R. K., &amp; Fenning, </span></p>
<p style="top:510.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. S. (2019). Modeling sports-related mild traumatic brain injury </span></p>
<p style="top:520.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">in animals&#x2014;A systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neuroscience Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:531.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">97</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(10), 1194&#x2013;1222. https://doi.org/10.1002/jnr.24472</span></p>
<p style="top:541.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hooijmans, C. R., Rovers, M., de Vries, R. B., Leenaars, M., &amp; Ritskes-</span></p>
<p style="top:552.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hoitinga, M. (2012). An initiative to facilitate well-informed de-</span></p>
<p style="top:562.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cision-making in laboratory animal research: Report of the First </span></p>
<p style="top:573.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">International Symposium on Systematic Reviews in Laboratory </span></p>
<p style="top:583.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Animal Science. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Laboratory Animals</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">46</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 356&#x2013;357. https://doi.</span></p>
<p style="top:594.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1258/la.2012.012052</span></p>
<p style="top:604.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-</span></p>
<p style="top:615.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hoitinga, M., &amp; Langendam, M. W. (2014). SYRCLE&apos;s risk of bias </span></p>
<p style="top:625.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tool for animal studies. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BMC Medical Research Methodology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 43. </span></p>
<p style="top:636.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1186/1471-2288-14-43</span></p>
<p style="top:646.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Z. G., Wang, H. D., Jin, W., &amp; Yin, H. X. (2009). Ketogenic diet re</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:657.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">duces cytochrome c release and cellular apoptosis following trau-</span></p>
<p style="top:667.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matic brain injury in juvenile rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Annals of Clinical and Laboratory </span></i></p>
<p style="top:678.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Science</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">39</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 76&#x2013;83.</span></p>
<p style="top:688.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Hu, Z.-G., Wang, H.-D., Qiao, L., Yan, W., Tan, Q.-F., &amp; Yin, H.-X. (2009). </span></p>
<p style="top:699.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">The protective effect of the ketogenic diet on traumatic brain inju-</span></p>
<p style="top:709.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ry-induced cell death in juvenile rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Injury</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">23</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), 459&#x2013;465. </span></p>
<p style="top:720.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1080/02699 05090 2788469</span></p>
<p style="top:48.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Itoh, T., Tabuchi, M., Mizuguchi, N., Imano, M., Tsubaki, M., Nishida, </span></p>
<p style="top:58.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S., Hashimoto, S., Matsuo, K., Nakayama, T., Ito, A., Munakata, </span></p>
<p style="top:69.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">H., &amp; Satou, T. (2013). Neuroprotective effect of (-)-epigallocate-</span></p>
<p style="top:79.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">chin-3-gallate in rats when administered pre- or post-traumatic brain </span></p>
<p style="top:90.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neural Transmission</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">120</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), 767&#x2013;783. https://doi.</span></p>
<p style="top:100.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1007/s0070 2-012-0918-4</span></p>
<p style="top:111.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jackson, S. J., Andrews, N., Ball, D., Bellantuono, I., Gray, J., Hachoumi, </span></p>
<p style="top:121.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">L., Holmes, A., Latcham, J., Petrie, A., Potter, P., Rice, A., Ritchie, A., </span></p>
<p style="top:132.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Stewart, M., Strepka, C., Yeoman, M., &amp; Chapman, K. (2017). Does </span></p>
<p style="top:142.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">age matter? The impact of rodent age on study outcomes. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Laboratory </span></i></p>
<p style="top:153.2pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Animals</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:153.2pt;left:356.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">51</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), </span></p>
<p style="top:153.2pt;left:383.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">160&#x2013;169. </span></p>
<p style="top:153.2pt;left:423.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1177/00236 77216 </span></p>
<p style="top:163.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">653984</span></p>
<p style="top:174.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">James, S. L., Theadom, A., Ellenbogen, R. G., Bannick, M. S., Montjoy-</span></p>
<p style="top:184.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Venning, W., Lucchesi, L. R., &amp; Murray, C. J. L. (2019). Global, regional, </span></p>
<p style="top:195.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and national burden of traumatic brain injury and spinal cord injury, </span></p>
<p style="top:205.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1990&#x2013;2016: A systematic analysis for the Global Burden of Disease </span></p>
<p style="top:216.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Study 2016. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Lancet Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">18</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 56&#x2013;87. https://doi.org/10.1016/</span></p>
<p style="top:226.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">S1474 -4422(18)30415 -0</span></p>
<p style="top:237.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ji, X., Peng, D., Zhang, Y., Zhang, J., Wang, Y., Gao, Y., Lu, N., &amp; Tang, P. </span></p>
<p style="top:247.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2017). Astaxanthin improves cognitive performance in mice follow-</span></p>
<p style="top:258.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing mild traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">1659</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 88&#x2013;95. https://</span></p>
<p style="top:268.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1016/j.brain res.2016.12.031</span></p>
<p style="top:279.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jiang, Z., Zhang, J., Cai, Y., Huang, J., &amp; You, L. (2017). Catechin attenu-</span></p>
<p style="top:289.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ates traumatic brain injury-induced blood&#x2013;brain barrier damage and </span></p>
<p style="top:300.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">improves longer-term neurological outcomes in rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Experimental </span></i></p>
<p style="top:310.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Physiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">102</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(10), 1269&#x2013;1277. https://doi.org/10.1113/EP086520</span></p>
<p style="top:321.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Jordan, S., Tung, N., Casanova-Acebes, M., Chang, C., Cantoni, C., Zhang, </span></p>
<p style="top:331.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">D., Wirtz, T. H., Naik, S., Rose, S. A., Brocker, C. N., Gainullina, </span></p>
<p style="top:342.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A., Hornburg, D., Horng, S., Maier, B. B., Cravedi, P., LeRoith, D., </span></p>
<p style="top:352.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Gonzalez, F. J., Meissner, F., Ochando, J., &#x2026; Merad, M. (2019). Dietary </span></p>
<p style="top:363.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">intake regulates the circulating inflammatory monocyte pool. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Cell</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:373.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">178</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), 1102&#x2013;1114.e1117. https://doi.org/10.1016/j.cell.2019.07.050</span></p>
<p style="top:384.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kannan, K., &amp; Jain, S. K. (2000). Oxidative stress and apoptosis. </span></p>
<p style="top:394.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Pathophysiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:394.7pt;left:383.1pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), </span></p>
<p style="top:394.7pt;left:406.0pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">153&#x2013;163. </span></p>
<p style="top:394.7pt;left:446.3pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/s0928 </span></p>
<p style="top:405.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">-4680(00)00053 -5</span></p>
<p style="top:415.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kenzie, E. S., Parks, E. L., Bigler, E. D., Wright, D. W., Lim, M. M., Chesnutt, </span></p>
<p style="top:426.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">J. C., Hawryluk, G. W. J., Gordon, W., &amp; Wakeland, W. (2018). The </span></p>
<p style="top:436.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dynamics of concussion: Mapping pathophysiology, persistence, and </span></p>
<p style="top:447.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">recovery with causal-loop diagramming. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:457.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">203. https://doi.org/10.3389/fneur.2018.00203</span></p>
<p style="top:468.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., Altman, D. G., &amp; </span></p>
<p style="top:478.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">NC3Rs Reporting Guidelines Working Group. (2010). Animal re-</span></p>
<p style="top:489.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">search: Reporting in vivo experiments: The ARRIVE guidelines. </span></p>
<p style="top:499.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">British Journal of Pharmacology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">160</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7), 1577&#x2013;1579. https://doi.</span></p>
<p style="top:510.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1111/j.1476-5381.2010.00872.x</span></p>
<p style="top:520.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Krishna, G., Ying, Z., &amp; Gomez-Pinilla, F. (2019). Blueberry supplemen</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:531.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tation mitigates altered brain plasticity and behavior after traumatic </span></p>
<p style="top:541.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury in rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Molecular Nutrition and Food Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">63</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(15), </span></p>
<p style="top:552.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">1801055. https://doi.org/10.1002/mnfr.20180 1055</span></p>
<p style="top:562.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kumar, A., Rinwa, P., &amp; Dhar, H. (2014). Microglial inhibitory effect of gin</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:573.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">seng ameliorates cognitive deficits and neuroinflammation following </span></p>
<p style="top:583.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">traumatic head injury in rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Inflammopharmacology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 155&#x2013;167. </span></p>
<p style="top:594.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1007/s1078 7-013-0187-3</span></p>
<p style="top:604.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Kuriakose, M., Younger, D., Ravula, A. R., Alay, E., Rama Rao, K. V., &amp; </span></p>
<p style="top:615.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Chandra, N. (2019). Synergistic role of oxidative stress and blood-</span></p>
<p style="top:625.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain barrier permeability as injury mechanisms in the acute patho-</span></p>
<p style="top:636.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">physiology of blast-induced neurotrauma. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Scientific Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), </span></p>
<p style="top:646.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">7717. https://doi.org/10.1038/s4159 8-019-44147 -w</span></p>
<p style="top:657.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Landis, S. C., Amara, S. G., Asadullah, K., Austin, C. P., Blumenstein, R., </span></p>
<p style="top:667.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Bradley, E. W., Crystal, R. G., Darnell, R. B., Ferrante, R. J., Fillit, H., </span></p>
<p style="top:678.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Finkelstein, R., Fisher, M., Gendelman, H. E., Golub, R. M., Goudreau, </span></p>
<p style="top:688.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">J. L., Gross, R. A., Gubitz, A. K., Hesterlee, S. E., Howells, D. W., &#x2026; </span></p>
<p style="top:699.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Silberberg, S. D. (2012). A call for transparent reporting to optimize </span></p>
<p style="top:709.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the predictive value of preclinical research. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Nature</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">490</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7419), 187&#x2013;</span></p>
<p style="top:720.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">191. https://doi.org/10.1038/natur e11556</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;601</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:48.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Leddy, J. J., Baker, J. G., &amp; Willer, B. (2016). Active rehabilitation of </span></p>
<p style="top:58.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">concussion and post-concussion syndrome. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Physical Medicine and </span></i></p>
<p style="top:69.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Rehabilitation Clinics of North America</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">27</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 437&#x2013;454. https://doi.</span></p>
<p style="top:79.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.pmr.2015.12.003</span></p>
<p style="top:90.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Leddy, J. J., Cox, J. L., Baker, J. G., Wack, D. S., Pendergast, D. R., </span></p>
<p style="top:100.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zivadinov, R., &amp; Willer, B. (2013). Exercise treatment for postcon-</span></p>
<p style="top:111.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cussion syndrome: A pilot study of changes in functional magnetic </span></p>
<p style="top:121.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">resonance imaging activation, physiology, and symptoms. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of </span></i></p>
<p style="top:132.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Head Trauma Rehabilitation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 241&#x2013;249. https://doi.org/10.1097/</span></p>
<p style="top:142.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">HTR.0b013 e3182 6da964</span></p>
<p style="top:153.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Leddy, J. J., Kozlowski, K., Fung, M., Pendergast, D. R., &amp; Willer, B. </span></p>
<p style="top:163.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2007). Regulatory and autoregulatory physiological dysfunction as </span></p>
<p style="top:174.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">a primary characteristic of post concussion syndrome: Implications </span></p>
<p style="top:184.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for treatment. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">NeuroRehabilitation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 199&#x2013;205. https://doi.</span></p>
<p style="top:195.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.3233/NRE-2007-22306</span></p>
<p style="top:205.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lewis, M. D. (2016). Concussions, traumatic brain injury, and the inno-</span></p>
<p style="top:216.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vative use of omega-3s. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of the American College of Nutrition</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:226.7pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">35</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), 469&#x2013;475. https://doi.org/10.1080/07315 724.2016.1150796</span></p>
<p style="top:237.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lim, M. M., Elkind, J., Xiong, G., Galante, R., Zhu, J., Zhang, L., Lian, J., </span></p>
<p style="top:247.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rodin, J., Kuzma, N. N., Pack, A. I., &amp; Cohen, A. S. (2013). Dietary </span></p>
<p style="top:258.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">therapy mitigates persistent wake deficits caused by mild traumatic </span></p>
<p style="top:268.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Science Translational Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">5</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(215), 215ra173. https://</span></p>
<p style="top:279.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1126/scitr anslm ed.3007092</span></p>
<p style="top:289.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liu, Q., Li, R., Qu, W., Li, B., Yang, W., &amp; Cui, R. (2019). Pharmacological </span></p>
<p style="top:300.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and non-pharmacological interventions of depression after traumatic </span></p>
<p style="top:310.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury: A systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European Journal of Pharmacology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:321.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">865</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 172775. https://doi.org/10.1016/j.ejphar.2019.172775</span></p>
<p style="top:331.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Liu, Y., Wang, R., Zhao, Z., Dong, W., Zhang, X., Chen, X., &amp; Ma, L. (2017). </span></p>
<p style="top:342.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Short-term caloric restriction exerts neuroprotective effects follow-</span></p>
<p style="top:352.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing mild traumatic brain injury by promoting autophagy and inhibit-</span></p>
<p style="top:363.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ing astrocyte activation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Behavioural Brain Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">331</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 135&#x2013;142. </span></p>
<p style="top:373.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/j.bbr.2017.04.024</span></p>
<p style="top:384.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ljubisavljevic, S. (2016). Oxidative stress and neurobiology of de</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:394.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">myelination. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Molecular Neurobiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">53</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 744&#x2013;758. https://doi.</span></p>
<p style="top:405.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1007/s1203 5-014-9041-x</span></p>
<p style="top:415.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lo Van, A., Sakayori, N., Hachem, M., Belkouch, M., Picq, M., Lagarde, </span></p>
<p style="top:426.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M., Osumi, N., &amp; Bernoud-Hubac, N. (2016). Mechanisms of DHA </span></p>
<p style="top:436.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">transport to the brain and potential therapy to neurodegenera-</span></p>
<p style="top:447.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tive diseases. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Biochimie</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">130</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 163&#x2013;167. https://doi.org/10.1016/j.</span></p>
<p style="top:457.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">biochi.2016.07.011</span></p>
<p style="top:468.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Luissint, A.-C., Artus, C., Glacial, F., Ganeshamoorthy, K., &amp; Couraud, P.-</span></p>
<p style="top:478.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">O. (2012). Tight junctions at the blood brain barrier: Physiological </span></p>
<p style="top:489.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">architecture and disease-associated dysregulation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Fluids and Barriers </span></i></p>
<p style="top:499.7pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">of the CNS</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 23. https://doi.org/10.1186/2045-8118-9-23</span></p>
<p style="top:510.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lukaski, H. C., &amp; Hardy, G. (2013). Micronutrients in brain function, </span></p>
<p style="top:520.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">and traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Opinion in Clinical Nutrition and </span></i></p>
<p style="top:531.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Metabolic Care</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(6), 700&#x2013;702. https://doi.org/10.1097/MCO.0b013 </span></p>
<p style="top:541.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">e3283 65a2ce</span></p>
<p style="top:552.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ma, X., Aravind, A., Pfister, B. J., Chandra, N., &amp; Haorah, J. (2019). Animal </span></p>
<p style="top:562.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">models of traumatic brain injury and assessment of injury severity. </span></p>
<p style="top:573.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Molecular Neurobiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">56</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(8), 5332&#x2013;5345. https://doi.org/10.1007/</span></p>
<p style="top:583.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">s1203 5-018-1454-5</span></p>
<p style="top:594.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mathias, J. L., &amp; Alvaro, P. K. (2012). Prevalence of sleep disturbances, dis</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:604.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">orders, and problems following traumatic brain injury: A meta-anal-</span></p>
<p style="top:615.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ysis. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Sleep Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">13</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7), 898&#x2013;905. https://doi.org/10.1016/j.</span></p>
<p style="top:625.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sleep.2012.04.006</span></p>
<p style="top:636.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">McDougall, A., Bayley, M., &amp; Munce, S. E. (2018). The ketogenic diet as </span></p>
<p style="top:646.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">a treatment for traumatic brain injury: A scoping review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Injury</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:657.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">32</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 416&#x2013;422. https://doi.org/10.1080/02699 052.2018.1429025</span></p>
<p style="top:667.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Meehan, W. P., 3rd. (2011). Medical therapies for concussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinics </span></i></p>
<p style="top:678.2pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">in Sports Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">30</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 115&#x2013;124. https://doi.org/10.1016/j.</span></p>
<p style="top:688.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">csm.2010.08.003</span></p>
<p style="top:699.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Merritt, V. C., Padgett, C. R., &amp; Jak, A. J. (2019). A systematic review of </span></p>
<p style="top:709.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">sex differences in concussion outcome: What do we know? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinical </span></i></p>
<p style="top:48.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuropsychologist</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">33</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(6), 1016&#x2013;1043. https://doi.org/10.1080/13854 </span></p>
<p style="top:58.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">046.2018.1508616</span></p>
<p style="top:69.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Michael-Titus, A. T., &amp; Priestley, J. V. (2014). Omega-3 fatty acids and </span></p>
<p style="top:79.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">traumatic neurological injury: From neuroprotection to neuroplasti-</span></p>
<p style="top:90.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">city? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Trends in Neurosciences</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">37</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 30&#x2013;38. https://doi.org/10.1016/j.</span></p>
<p style="top:100.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tins.2013.10.005</span></p>
<p style="top:111.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Miller Phillips, M., &amp; Reddy, C. C. (2016). Managing patients with pro-</span></p>
<p style="top:121.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">longed recovery following concussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Physical Medicine and </span></i></p>
<p style="top:132.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Rehabilitation Clinics of North America</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">27</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 455&#x2013;474. https://doi.</span></p>
<p style="top:142.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.pmr.2015.12.005</span></p>
<p style="top:153.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mills, J. D., Bailes, J. E., Sedney, C. L., Hutchins, H., &amp; Sears, B. (2011). </span></p>
<p style="top:163.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Omega-3 fatty acid supplementation and reduction of trau</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:174.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matic axonal injury in a rodent head injury model: Laboratory in-</span></p>
<p style="top:184.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vestigation. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurosurgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">114</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 77&#x2013;84. https://doi.</span></p>
<p style="top:195.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.3171/2010.5.JNS08914</span></p>
<p style="top:205.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Mohamadpour, M., Whitney, K., &amp; Bergold, P. J. (2019). The importance </span></p>
<p style="top:216.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of therapeutic time window in the treatment of traumatic brain </span></p>
<p style="top:226.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Neuroscience</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">13</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 7. https://doi.org/10.3389/</span></p>
<p style="top:237.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fnins.2019.00007</span></p>
<p style="top:247.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Noguchi, H., Nishi, D., Matsumura, K., Hamazaki, K., Hamazaki, T., &amp; </span></p>
<p style="top:258.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Matsuoka, Y. J. (2017). Limited effect of omega-3 fatty acids on the </span></p>
<p style="top:268.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">quality of life in survivors of traumatic injury: A randomized, place-</span></p>
<p style="top:279.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">bo-controlled trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Prostaglandins Leukotrienes and Essential Fatty </span></i></p>
<p style="top:289.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Acids</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">127</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1&#x2013;5. https://doi.org/10.1016/j.plefa.2017.09.018</span></p>
<p style="top:300.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Oliver, J. M., Anzalone, A. J., Jones, M. T., Kirk, K. M., Gable, D. A., Gao, </span></p>
<p style="top:310.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Y., Harris, W. S., &amp; Zetterberg, H. (2018). Nutritional supplements for </span></p>
<p style="top:321.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">the treatment and prevention of sports-related concussion&#x2014;Omega </span></p>
<p style="top:331.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3 fatty acids: evidence still lacking? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Sports Medicine Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:342.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">17</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 103&#x2013;104. https://doi.org/10.1249/JSR.00000 00000 000465</span></p>
<p style="top:352.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., </span></p>
<p style="top:363.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, </span></p>
<p style="top:373.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">K., Smith, P., Berger, B., &amp; Heller, A. (2000). Concordance of the </span></p>
<p style="top:384.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">toxicity of pharmaceuticals in humans and in animals. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Regulatory </span></i></p>
<p style="top:394.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Toxicology and Pharmacology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">32</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 56&#x2013;67. https://doi.org/10.1006/</span></p>
<p style="top:405.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rtph.2000.1399</span></p>
<p style="top:415.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Ozbal, S., Cankurt, U., Tugyan, K., Pekcetin, C., Sisman, A. R., Gunduz, </span></p>
<p style="top:426.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">K., &amp; Micili, S. C. (2015). The effects of </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b1;</span><span style="font-family:Lato,serif;font-size:7.5pt">-lipoic acid on immature </span></p>
<p style="top:436.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rats with traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Biotechnic and Histochemistry</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">90</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), </span></p>
<p style="top:447.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">206&#x2013;215. https://doi.org/10.3109/10520 295.2014.977950</span></p>
<p style="top:457.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&#xd6;zevren, H., Irteg&#xfc;n, S., Ekingen, A., Cudi Tuncer, M., G&#xf6;kalp &#xd6;zkorkmaz, </span></p>
<p style="top:468.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">E., Deveci, E., &amp; Deveci, S. (2018). Immunoexpression of vascular en</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:478.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dothelial growth factor, </span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:Lato,serif;font-size:7.5pt">-cell lymphoma 2 and cluster of differentia-</span></p>
<p style="top:489.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion 68 in cerebellar tissue of rats treated with Ganoderma lucidum. </span></p>
<p style="top:499.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Morphology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">36</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 1453&#x2013;1462. https://doi.</span></p>
<p style="top:510.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.4067/S0717 -95022 01800 0401453</span></p>
<p style="top:520.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Perel, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C., Sandercock, </span></p>
<p style="top:531.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P., Macleod, M., Mignini, L. E., Jayaram, P., &amp; Khan, K. S. (2007). </span></p>
<p style="top:541.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Comparison of treatment effects between animal experiments and </span></p>
<p style="top:552.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">clinical trials: Systematic review. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BMJ</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">334</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7586), 197. https://doi.</span></p>
<p style="top:562.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1136/bmj.39048.407928.BE</span></p>
<p style="top:573.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Plantier, D., &amp; Luaut&#xe9;, J. (2016). Drugs for behavior disorders after trau-</span></p>
<p style="top:583.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matic brain injury: Systematic review and expert consensus leading </span></p>
<p style="top:594.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">to French recommendations for good practice. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Annals of Physical </span></i></p>
<p style="top:604.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">and Rehabilitation Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">59</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 42&#x2013;57. https://doi.org/10.1016/j.</span></p>
<p style="top:615.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rehab.2015.10.003</span></p>
<p style="top:625.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Polinder, S., Cnossen, M. C., Real, R. G. L., Covic, A., Gorbunova, A., </span></p>
<p style="top:636.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Voormolen, D. C., Master, C. L., Haagsma, J. A., Diaz-Arrastia, R., </span></p>
<p style="top:646.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; von Steinbuechel, N. (2018). A multidimensional approach to </span></p>
<p style="top:657.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">post-concussion symptoms in mild traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in </span></i></p>
<p style="top:667.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1113. https://doi.org/10.3389/fneur.2018.01113</span></p>
<p style="top:678.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prendergast, B. J., Onishi, K. G., &amp; Zucker, I. (2014). Female mice liberated </span></p>
<p style="top:688.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for inclusion in neuroscience and biomedical research. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience </span></i></p>
<p style="top:699.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Biobehavioral Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">40</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 1&#x2013;5. https://doi.org/10.1016/j.neubi </span></p>
<p style="top:709.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">orev.2014.01.001</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:46.5pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">602&#x2003; </span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;&#x2002;</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,-62.206254,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.8pt;left:494.2pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:48.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins, M. L., Fujima, L. S., &amp; Hovda, D. A. (2005). Age-dependent reduc-</span></p>
<p style="top:58.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion of cortical contusion volume by ketones after traumatic brain </span></p>
<p style="top:69.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neuroscience Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">82</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 413&#x2013;420. https://doi.</span></p>
<p style="top:79.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1002/jnr.20633</span></p>
<p style="top:90.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Prins, M. L., &amp; Hovda, D. A. (2009). The effects of age and ketogenic diet </span></p>
<p style="top:100.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">on local cerebral metabolic rates of glucose after controlled corti-</span></p>
<p style="top:111.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cal impact injury in rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">26</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7), 1083&#x2013;1093. </span></p>
<p style="top:121.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1089/neu.2008-0769</span></p>
<p style="top:132.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Quain, A. M., &amp; Khardori, N. M. (2015). Nutrition in wound care manage</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:142.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ment: A comprehensive overview. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Wounds</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">27</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(12), 327&#x2013;335.</span></p>
<p style="top:153.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Romeu-Mejia, R., Giza, C. C., &amp; Goldman, J. T. (2019). Concussion </span></p>
<p style="top:163.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pathophysiology and injury biomechanics. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Reviews in </span></i></p>
<p style="top:174.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Musculoskeletal Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">12</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 105&#x2013;116. https://doi.org/10.1007/</span></p>
<p style="top:184.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">s1217 8-019-09536 -8</span></p>
<p style="top:195.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rubovitch, V., Pharayra, A., Har-Even, M., Dvir, O., Mattson, M. P., &amp; Pick, </span></p>
<p style="top:205.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">C. G. (2019). Dietary energy restriction ameliorates cognitive impair-</span></p>
<p style="top:216.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ment in a mouse model of traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Molecular </span></i></p>
<p style="top:226.7pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">67</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 613&#x2013;621. https://doi.org/10.1007/s1203 1-019-</span></p>
<p style="top:237.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">01271 -6</span></p>
<p style="top:247.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rusnak, M. (2013). Giving voice to a silent epidemic. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Nature  </span></i></p>
<p style="top:258.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Reviews Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 186&#x2013;187. https://doi.org/10.1038/nrneu </span></p>
<p style="top:268.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rol.2013.38</span></p>
<p style="top:279.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Saatman, K. E., Duhaime, A.-C., Bullock, R., Maas, A. I. R., Valadka, A., </span></p>
<p style="top:289.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Manley, G. T., &amp; Workshop Scientific Team and Advisory Panel </span></p>
<p style="top:300.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Members. (2008). Classification of traumatic brain injury for tar</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:310.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">geted therapies. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7), 719&#x2013;738. https://doi.</span></p>
<p style="top:321.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1089/neu.2008.0586</span></p>
<p style="top:331.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sakellaris, G., Kotsiou, M., Tamiolaki, M., Kalostos, G., Tsapaki, E., Spanaki, </span></p>
<p style="top:342.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">M., Spilioti, M., Charissis, G., &amp; Evangeliou, A. (2006). Prevention of </span></p>
<p style="top:352.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">complications related to traumatic brain injury in children and ado-</span></p>
<p style="top:363.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">lescents with creatine administration: An open label randomized pilot </span></p>
<p style="top:373.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Trauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">61</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 322&#x2013;329. https://doi.org/10.1097/01.</span></p>
<p style="top:384.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ta.00002 30269.46108.d5</span></p>
<p style="top:394.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sakellaris, G., Nasis, G., Kotsiou, M., Tamiolaki, M., Charissis, G., &amp; </span></p>
<p style="top:405.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Evangeliou, A. (2008). Prevention of traumatic headache, dizziness and </span></p>
<p style="top:415.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fatigue with creatine administration. A pilot study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Acta Paediatrica</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:426.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">97</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 31&#x2013;34. https://doi.org/10.1111/j.1651-2227.2007.00529.x</span></p>
<p style="top:436.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Saraiva, A. L. L., Ferreira, A. P. O., Silva, L. F. A., Hoffmann, M. S., Dutra, </span></p>
<p style="top:447.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">F. D., Furian, A. F., Oliveira, M. S., Fighera, M. R., &amp; Royes, L. F. F. </span></p>
<p style="top:457.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2012). Creatine reduces oxidative stress markers but does not pro-</span></p>
<p style="top:468.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tect against seizure susceptibility after severe traumatic brain injury. </span></p>
<p style="top:478.7pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Research Bulletin</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">87</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2&#x2013;3), 180&#x2013;186. https://doi.org/10.1016/j.</span></p>
<p style="top:489.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain resbu ll.2011.10.010</span></p>
<p style="top:499.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schober, M. E., Requena, D. F., Abdullah, O. M., Casper, T., Beachy, J., </span></p>
<p style="top:510.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Malleske, D., &amp; Pauly, J. R. (2016). Dietary docosahexaenoic acid im-</span></p>
<p style="top:520.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">proves cognitive function, tissue sparing, and magnetic resonance </span></p>
<p style="top:531.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">imaging indices of edema and white matter injury in the immature rat </span></p>
<p style="top:541.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">after traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">33</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 390&#x2013;402. </span></p>
<p style="top:552.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1089/neu.2015.3945</span></p>
<p style="top:562.7pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Schwartzkroin, P. A., Wenzel, H. J., Lyeth, B. G., Poon, C. C., DeLance, </span></p>
<p style="top:573.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A., Van, K. C., Campos, L., &amp; Nguyen, D. V. (2010). Does ketogenic </span></p>
<p style="top:583.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diet alter seizure sensitivity and cell loss following fluid percussion </span></p>
<p style="top:594.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury? </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Epilepsy Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">92</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 74&#x2013;84. https://doi.org/10.1016/j.</span></p>
<p style="top:604.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">eplep syres.2010.08.009</span></p>
<p style="top:615.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sharma, B., Lawrence, D. W., &amp; Hutchison, M. G. (2018). Branched chain </span></p>
<p style="top:625.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">amino acids (BCAAs) and traumatic brain injury: A systematic re-</span></p>
<p style="top:636.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">view. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Head Trauma Rehabilitation</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">33</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 33&#x2013;45. https://doi.</span></p>
<p style="top:646.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1097/HTR.00000 00000 000280</span></p>
<p style="top:657.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Sharma, S., Ying, Z., &amp; Gomez-Pinilla, F. (2010). A pyrazole curcumin deriv-</span></p>
<p style="top:667.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ative restores membrane homeostasis disrupted after brain trauma. </span></p>
<p style="top:678.2pt;left:59.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Experimental Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">226</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 191&#x2013;199. https://doi.org/10.1016/j.</span></p>
<p style="top:688.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">expne urol.2010.08.027</span></p>
<p style="top:699.2pt;left:46.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shichiri, M. (2014). The role of lipid peroxidation in neurological disor</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:709.7pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ders. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Clinical Biochemistry and Nutrition</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">54</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 151&#x2013;160. </span></p>
<p style="top:720.2pt;left:59.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.3164/jcbn.14-10</span></p>
<p style="top:48.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shin, S. S., &amp; Dixon, C. E. (2011). Oral fish oil restores striatal dopamine </span></p>
<p style="top:58.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">release after traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience Letters</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">496</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 168&#x2013;</span></p>
<p style="top:69.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">171. https://doi.org/10.1016/j.neulet.2011.04.009</span></p>
<p style="top:79.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shrey, D. W., Griesbach, G. S., &amp; Giza, C. C. (2011). The pathophysiol-</span></p>
<p style="top:90.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ogy of concussions in youth. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Physical Medicine and Rehabilitation </span></i></p>
<p style="top:100.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Clinics of North America</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">22</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 577&#x2013;602. https://doi.org/10.1016/j.</span></p>
<p style="top:111.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">pmr.2011.08.002</span></p>
<p style="top:121.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Shultz, S. R., McDonald, S. J., Vonder Haar, C., Meconi, A., Vink, R., van </span></p>
<p style="top:132.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Donkelaar, P., Taneja, C., Iverson, G. L., &amp; Christie, B. R. (2017). The </span></p>
<p style="top:142.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">potential for animal models to provide insight into mild traumatic </span></p>
<p style="top:153.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury: Translational challenges and strategies. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience and </span></i></p>
<p style="top:163.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Biobehavioral Reviews</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">76</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Pt B), 396&#x2013;414. https://doi.org/10.1016/j.</span></p>
<p style="top:174.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">neubi orev.2016.09.014</span></p>
<p style="top:184.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Siebold, L., Obenaus, A., &amp; Goyal, R. (2018). Criteria to define mild, mod</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:195.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">erate, and severe traumatic brain injury in the mouse controlled cor-</span></p>
<p style="top:205.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tical impact model. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Experimental Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">310</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 48&#x2013;57. https://doi.</span></p>
<p style="top:216.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.expne urol.2018.07.004</span></p>
<p style="top:226.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Snilstveit, B., Oliver, S., &amp; Vojtkova, M. (2012). Narrative approaches to </span></p>
<p style="top:237.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">systematic review and synthesis of evidence for international de-</span></p>
<p style="top:247.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">velopment policy and practice. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Development Effectiveness</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:258.2pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">4</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 409&#x2013;429. https://doi.org/10.1080/19439 342.2012.710641</span></p>
<p style="top:268.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Solomito, M. J., Reuman, H., &amp; Wang, D. H. (2018). Sex differences in </span></p>
<p style="top:279.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">concussion: A review of brain anatomy, function, and biomechani-</span></p>
<p style="top:289.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cal response to impact. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Brain Injury</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">33</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 105&#x2013;110. https://doi.</span></p>
<p style="top:300.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1080/02699 052.2018.1542507</span></p>
<p style="top:310.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Stoica, B. A., &amp; Faden, A. I. (2010). Cell death mechanisms and modula-</span></p>
<p style="top:321.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion in traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurotherapeutics</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">7</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 3&#x2013;12. https://</span></p>
<p style="top:331.7pt;left:320.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1016/j.nurt.2009.10.023</span></p>
<p style="top:342.2pt;left:307.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Storey, E. P., Wiebe, D. J., D&#x2bc;Alonzo, B. A., Nixon-Cave, K., Jackson-Coty, </span></p>
<p style="top:352.7pt;left:320.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">J., Goodman, A. M., Grady, M. F., &amp; Master, C. L. (2018). Vestibular </span></p>
<p style="top:363.2pt;left:320.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rehabilitation is associated with visuovestibular improvement in pe-</span></p>
<p style="top:373.7pt;left:320.6pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">diatric concussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurologic Physical Therapy</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">42</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 134&#x2013;</span></p>
<p style="top:384.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">141. https://doi.org/10.1097/NPT.00000 00000 000228</span></p>
<p style="top:394.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Su, J., Quan, K., Fan, K., Zhang, J., Liu, J., Hua, W., &amp; Mao, Y. (2016). High </span></p>
<p style="top:405.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-3/</span><span style="font-family:STIX,serif;font-size:7.5pt">&#x3c9;</span><span style="font-family:Lato,serif;font-size:7.5pt">-6 ratio diet could alleviate blood-brain barrier dysfunction in </span></p>
<p style="top:415.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rat model with traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">International Journal of Clinical </span></i></p>
<p style="top:426.2pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">and Experimental Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">9</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(11), 21270&#x2013;21279.</span></p>
<p style="top:436.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Thau-Zuchman, O., Gomes, R. N., Dyall, S. C., Davies, M., Priestley, J. V., </span></p>
<p style="top:447.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Groenendijk, M., De Wilde, M. C., Tremoleda, J. L., &amp; Michael-Titus, </span></p>
<p style="top:457.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. T. (2019). Brain phospholipid precursors administered post-injury </span></p>
<p style="top:468.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">reduce tissue damage and improve neurological outcome in experi-</span></p>
<p style="top:478.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mental traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">36</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 25&#x2013;42. </span></p>
<p style="top:489.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1089/neu.2017.5579</span></p>
<p style="top:499.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Theadom, A., Barker-Collo, S., Jones, K. M., Parmar, P., Bhattacharjee, </span></p>
<p style="top:510.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">R., &amp; Feigin, V. L. (2018). MLC901 (NeuroAiD II) for cognition after </span></p>
<p style="top:520.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">traumatic brain injury: A pilot randomized clinical trial. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European </span></i></p>
<p style="top:531.2pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">25</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(8), 1055-e1082. https://doi.org/10.1111/</span></p>
<p style="top:541.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ene.13653</span></p>
<p style="top:552.2pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Theadom, A., Mahon, S., Barker-Collo, S., McPherson, K., Rush, E., Vandal, </span></p>
<p style="top:562.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">A. C., &amp; Feigin, V. L. (2013). Enzogenol for cognitive functioning in </span></p>
<p style="top:573.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">traumatic brain injury: A pilot placebo-controlled RCT. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">European </span></i></p>
<p style="top:583.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">20</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(8), 1135&#x2013;1144. https://doi.org/10.1111/</span></p>
<p style="top:594.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ene.12099</span></p>
<p style="top:604.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Theadom, A., Mahon, S., Feigin, V., Barker-Collo, S., &amp; Rush, E. (2012). </span></p>
<p style="top:615.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Enzogenol supplementation for improving cognitive function </span></p>
<p style="top:625.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">post-traumatic brain injury: A pilot study. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurorehabilitation and </span></i></p>
<p style="top:636.2pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neural Repair</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">26</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(6), 780. https://doi.org/10.1177/15459 68312 </span></p>
<p style="top:646.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">449454. </span></p>
<p style="top:646.7pt;left:362.2pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">http://cochr aneli brary -wiley.com/o/cochr ane/clcen tral/</span></p>
<p style="top:657.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">artic les/863/CN-01004 863/frame.html</span></p>
<p style="top:667.7pt;left:307.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Theadom, A., Parag, V., Dowell, T., McPherson, K., Starkey, N., Barker-</span></p>
<p style="top:678.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Collo, S., Jones, K., Ameratunga, S., Feigin, V. L., &amp; BIONIC Research </span></p>
<p style="top:688.7pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Group. (2016). Persistent problems 1 year after mild traumatic brain </span></p>
<p style="top:699.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury: A longitudinal population study in New Zealand. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">British Journal </span></i></p>
<p style="top:709.7pt;left:320.5pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">of General Practice</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">66</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(642), e16&#x2013;e23. https://doi.org/10.3399/bjgp1 </span></p>
<p style="top:720.2pt;left:320.5pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">6X683161</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>


<p style="top:23.8pt;left:511.2pt;line-height:7.0pt"><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;&#x2002; </span></b><b><span style="font-family:Lato,serif;font-size:7.0pt">&#x2003;</span></b><b><span style="font-family:Lato,serif;font-size:9.1pt">|</span></b><b><span style="font-family:Lato,serif;font-size:7.0pt"> &#x2003;603</span></b></p>
<img style="position:absolute;transform:matrix(.31959243,0,-0,.31685127,375.44148,21.744347)" src="data:image/jpeg;base64,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">
<p style="top:23.9pt;left:44.8pt;line-height:7.0pt"><span style="font-family:Lato-Regular,serif;font-size:7.0pt">MCGEOWN </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">Et</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt"> </span><span style="font-family:Lato-Regular,serif;font-size:4.9pt">al</span><span style="font-family:Lato-Regular,serif;font-size:7.0pt">.</span></p>
<p style="top:48.2pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Tipton, K. D. (2015). Nutritional support for exercise-induced injuries. </span></p>
<p style="top:58.7pt;left:57.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Sports Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">45</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(Suppl. 1), S93&#x2013;S104. https://doi.org/10.1007/</span></p>
<p style="top:69.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">s4027 9-015-0398-4</span></p>
<p style="top:79.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Toklu, H. Z., Hakan, T., Biber, N., Solako&#x11f;lu, S., O&#x11f;&#xfc;n&#xe7;, A. V., &amp; Sener, G. </span></p>
<p style="top:90.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2009). The protective effect of alpha lipoic acid against traumatic </span></p>
<p style="top:100.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury in rats. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Free Radical Research</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">43</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7), 658&#x2013;667. https://doi.</span></p>
<p style="top:111.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1080/10715 76090 2988843</span></p>
<p style="top:121.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Trojian, T. H., Wang, D. H., &amp; Leddy, J. J. (2017). Nutritional supplements </span></p>
<p style="top:132.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">for the treatment and prevention of sports-related concussion-evi-</span></p>
<p style="top:142.7pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dence still lacking. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Current Sports Medicine Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">16</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), 247&#x2013;255. </span></p>
<p style="top:153.2pt;left:57.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1249/JSR.00000 00000 000387</span></p>
<p style="top:163.7pt;left:44.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Walter, A., Finelli, K., Bai, X., Arnett, P., Bream, T., Seidenberg, P., &amp; </span></p>
<p style="top:174.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Slobounov, S. (2017). Effect of enzogenol(R) supplementation on </span></p>
<p style="top:184.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cognitive, executive, and vestibular/balance functioning in chronic </span></p>
<p style="top:195.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">phase of concussion. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Developmental Neuropsychology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">42</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 93&#x2013;103. </span></p>
<p style="top:205.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1080/87565 641.2016.1256404</span></p>
<p style="top:216.2pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, H. C., Wang, B. D., Chen, M. S., Chen, H., Sun, C. F., Shen, G., </span></p>
<p style="top:226.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">&amp; Zhang, J. M. (2018). Neuroprotective effect of berberine against </span></p>
<p style="top:237.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">learning and memory deficits in diffuse axonal injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Experimental </span></i></p>
<p style="top:247.7pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">and Therapeutic Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">15</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 1129&#x2013;1135. https://doi.org/10.3892/</span></p>
<p style="top:258.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">etm.2017.5496</span></p>
<p style="top:268.7pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, K., Cui, D., &amp; Gao, L. (2016). Traumatic brain injury: A review </span></p>
<p style="top:279.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">of characteristics, molecular basis and management. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in </span></i></p>
<p style="top:289.7pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Bioscience - Landmark</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">21</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), 890&#x2013;899. https://doi.org/10.2741/4426</span></p>
<p style="top:300.2pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, W., Li, H., Yu, J., Hong, M., Zhou, J., Zhu, L., Wang, Y., Luo, M., </span></p>
<p style="top:310.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xia, Z., Yang, Z.-J., Tang, T., Ren, P., Huang, X. I., &amp; Wang, J. (2016). </span></p>
<p style="top:321.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Protective effects of Chinese herbal medicine Rhizoma drynar-</span></p>
<p style="top:331.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">iae in rats after traumatic brain injury and identification of active </span></p>
<p style="top:342.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">compound. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Molecular Neurobiology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">53</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(7), 4809&#x2013;4820. https://doi.</span></p>
<p style="top:352.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1007/s1203 5-015-9385-x</span></p>
<p style="top:363.2pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Y., Fan, X., Tang, T., Fan, R., Zhang, C., Huang, Z., Peng, W., Gan, </span></p>
<p style="top:373.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">P., Xiong, X., Huang, W., &amp; Huang, X. I. (2016). Rhein and rhubarb </span></p>
<p style="top:384.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">similarly protect the blood-brain barrier after experimental traumatic </span></p>
<p style="top:394.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury via gp91phox subunit of NADPH oxidase/ROS/ERK/</span></p>
<p style="top:405.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">MMP-9 signaling pathway. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Scientific Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 37098. https://doi.</span></p>
<p style="top:415.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1038/srep3 7098</span></p>
<p style="top:426.2pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wang, Y., Zhang, C., Peng, W., Xia, Z., Gan, P., Huang, W., Shi, Y., &amp; Fan, </span></p>
<p style="top:436.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">R. (2016). Hydroxysafflor yellow A exerts antioxidant effects in a rat </span></p>
<p style="top:447.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">model of traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Molecular Medicine Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(4), </span></p>
<p style="top:457.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">3690&#x2013;3696. https://doi.org/10.3892/mmr.2016.5720</span></p>
<p style="top:468.2pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wei, W., Wang, H., Wu, Y., Ding, K. E., Li, T., Cong, Z., Xu, J., Zhou, M., </span></p>
<p style="top:478.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Huang, L., Ding, H., &amp; Wu, H. (2015). Alpha lipoic acid inhibits neu-</span></p>
<p style="top:489.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ral apoptosis via a mitochondrial pathway in rats following traumatic </span></p>
<p style="top:499.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurochemistry International</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">87</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 85&#x2013;91. https://doi.</span></p>
<p style="top:510.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.neuint.2015.06.003</span></p>
<p style="top:520.7pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">White, H., &amp; Venkatesh, B. (2011). Clinical review: Ketones and brain in</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:531.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">jury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Critical Care</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">15</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 219. https://doi.org/10.1186/cc10020</span></p>
<p style="top:541.7pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wild, T., Rahbarnia, A., Kellner, M., Sobotka, L., &amp; Eberlein, T. (2010). </span></p>
<p style="top:552.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Basics in nutrition and wound healing. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Nutrition</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">26</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(9), 862&#x2013;866. </span></p>
<p style="top:562.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">https://doi.org/10.1016/j.nut.2010.05.008</span></p>
<p style="top:573.2pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wojnarowicz, M. W., Fisher, A. M., Minaeva, O., &amp; Goldstein, L. E. (2017). </span></p>
<p style="top:583.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Considerations for experimental animal models of concussion, trau-</span></p>
<p style="top:594.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">matic brain injury, and chronic traumatic encephalopathy-these mat-</span></p>
<p style="top:604.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ters matter. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Frontiers in Neurology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">8</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 240. https://doi.org/10.3389/</span></p>
<p style="top:615.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">fneur.2017.00240</span></p>
<p style="top:625.7pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu, A., Ying, Z., &amp; Gomez-Pinilla, F. (2011). The salutary effects of </span></p>
<p style="top:636.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">DHA dietary supplementation on cognition, neuroplasticity, and </span></p>
<p style="top:646.7pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">membrane homeostasis after brain trauma. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Neurotrauma</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:657.2pt;left:57.7pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(10), 2113&#x2013;2122. https://doi.org/10.1089/neu.2011.1872</span></p>
<p style="top:667.7pt;left:44.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu, A., Ying, Z., &amp; Gomez-Pinilla, F. (2013). Exercise facilitates the ac-</span></p>
<p style="top:678.2pt;left:57.7pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tion of dietary DHA on functional recovery after brain trauma. </span></p>
<p style="top:48.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Neuroscience</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">248</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 655&#x2013;663. https://doi.org/10.1016/j.neuro scien </span></p>
<p style="top:58.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">ce.2013.06.041</span></p>
<p style="top:69.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Wu, A., Ying, Z., &amp; Gomez-Pinilla, F. (2014). Dietary strategy to repair </span></p>
<p style="top:79.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">plasma membrane after brain trauma: Implications for plasticity and </span></p>
<p style="top:90.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">cognition. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Neurorehabilitation and Neural Repair</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">28</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 75&#x2013;84. https://</span></p>
<p style="top:100.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">doi.org/10.1177/15459 68313 498650</span></p>
<p style="top:111.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xie, G., Peng, W., Li, P., Xia, Z., Zhong, Y., He, F., &amp; Xing, Z. (2018). A </span></p>
<p style="top:121.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">network pharmacology analysis to explore the effect of astragali ra-</span></p>
<p style="top:132.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">dix-radix angelica sinensis on traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BioMed Research </span></i></p>
<p style="top:142.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">International</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">2018</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 3951783. https://doi.org/10.1155/2018/3951783</span></p>
<p style="top:153.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xing, Z., Xia, Z., Peng, W., Li, J., Zhang, C., Fu, C., Tang, T., Luo, J., Zou, Y., </span></p>
<p style="top:163.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Fan, R., Liu, W., Xiong, X., Huang, W., Sheng, C., Gan, P., &amp; Wang, Y. </span></p>
<p style="top:174.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">(2016). Xuefu Zhuyu decoction, a traditional Chinese medicine, pro</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:184.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">vides neuroprotection in a rat model of traumatic brain injury via an </span></p>
<p style="top:195.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">anti-inflammatory pathway. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Scientific Reports</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">6</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, 20040. https://doi.</span></p>
<p style="top:205.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1038/srep2 0040</span></p>
<p style="top:216.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xiong, Y., Mahmood, A., &amp; Chopp, M. (2013). Animal models of traumatic </span></p>
<p style="top:226.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Nature Reviews Neuroscience</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(2), 128&#x2013;142. https://doi.</span></p>
<p style="top:237.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1038/nrn3407</span></p>
<p style="top:247.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Xu, X., Lv, H., Xia, Z., Fan, R., Zhang, C., Wang, Y., &amp; Wang, D. (2017). </span></p>
<p style="top:258.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Rhein exhibits antioxidative effects similar to Rhubarb in a rat </span></p>
<p style="top:268.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">model of traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">BMC Complementary and Alternative </span></i></p>
<p style="top:279.2pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">17</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 1&#x2013;9. https://doi.org/10.1186/s1290 6-017-1655-x</span></p>
<p style="top:289.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Yang, D. L., &amp; Xu, J. F. (2007). Effect of dipeptide of glutamine and alanine </span></p>
<p style="top:300.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">on severe traumatic brain injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Chinese Journal of Traumatology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span></p>
<p style="top:310.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">10</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(3), 145&#x2013;149.</span></p>
<p style="top:321.2pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhang, F., Wu, H., Jin, Y., &amp; Zhang, X. (2018). Proton magnetic resonance </span></p>
<p style="top:331.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">spectroscopy (H1-MRS) study of the ketogenic diet on repetitive </span></p>
<p style="top:342.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">mild traumatic brain injury in adolescent rats and its effect on neu-</span></p>
<p style="top:352.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">rodegeneration. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">World Neurosurgery</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">120</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, e1193&#x2013;e1202. https://doi.</span></p>
<p style="top:363.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.wneu.2018.09.037</span></p>
<p style="top:373.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhao, G.-W., Wang, Y., Li, Y.-C., Jiang, Z.-L., Sun, L. I., Xi, X., He, P., Wang, </span></p>
<p style="top:384.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">G.-H., Xu, S.-H., Ma, D.-M., &amp; Ke, K.-F. (2014). The neuroprotec</span><span style="font-family:Lato,serif;font-size:7.5pt">-</span></p>
<p style="top:394.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">tive effect of modified &#x201c;Shengyu&#x201d; decoction is mediated through </span></p>
<p style="top:405.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">an anti-inflammatory mechanism in the rat after traumatic brain </span></p>
<p style="top:415.7pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">injury. </span><i><span style="font-family:Lato,serif;font-size:7.5pt">Journal of Ethnopharmacology</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">151</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(1), 694&#x2013;703. https://doi.</span></p>
<p style="top:426.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.1016/j.jep.2013.11.041</span></p>
<p style="top:436.7pt;left:305.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Zhu, W., Chi, N., Zou, P., Chen, H., Tang, G., &amp; Zhao, W. (2017). </span></p>
<p style="top:447.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">Effect of docosahexaenoic acid on traumatic brain injury in rats. </span></p>
<p style="top:457.7pt;left:318.8pt;line-height:7.5pt"><i><span style="font-family:Lato,serif;font-size:7.5pt">Experimental and Therapeutic Medicine</span></i><span style="font-family:Lato,serif;font-size:7.5pt">, </span><i><span style="font-family:Lato,serif;font-size:7.5pt">14</span></i><span style="font-family:Lato,serif;font-size:7.5pt">(5), 4411&#x2013;4416. https://doi.</span></p>
<p style="top:468.2pt;left:318.8pt;line-height:7.5pt"><span style="font-family:Lato,serif;font-size:7.5pt">org/10.3892/etm.2017.5054</span></p>
<p style="top:504.4pt;left:305.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">SUPPORTING INFORMATION</span></b></p>
<p style="top:517.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Additional supporting information may be found online in the </span></p>
<p style="top:530.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Supporting Information section.</span></p>
<p style="top:543.4pt;left:305.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TABLE S1</span></b><span style="font-family:Lato,serif;font-size:8.0pt"> Expanded outcomes</span></p>
<p style="top:556.4pt;left:305.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">TABLE S2</span></b><span style="font-family:Lato,serif;font-size:8.0pt"> Abbreviation glossary</span></p>
<p style="top:569.4pt;left:305.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Transparent Peer Review Report</span></p>
<p style="top:604.9pt;left:317.8pt;line-height:8.0pt"><b><span style="font-family:Lato,serif;font-size:8.0pt">How to cite this article:</span></b><span style="font-family:Lato,serif;font-size:8.0pt"> McGeown JP, Hume PA, Theadom A, </span></p>
<p style="top:617.9pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">Quarrie KL, Borotkanics R. Nutritional interventions </span><span style="font-family:Lato,serif;font-size:8.0pt"> </span></p>
<p style="top:630.9pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">to improve neurophysiological impairments following </span></p>
<p style="top:643.9pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">traumatic brain injury: A systematic review. </span><i><span style="font-family:Lato,serif;font-size:8.0pt">J Neurosci Res</span></i><span style="font-family:Lato,serif;font-size:8.0pt">. </span></p>
<p style="top:656.9pt;left:317.8pt;line-height:8.0pt"><span style="font-family:Lato,serif;font-size:8.0pt">2021;99:573&#x2013;603. </span><span style="font-family:Lato,serif;font-size:8.0pt;color:#0000ff">https://doi.org/10.1002/jnr.24746</span></p>
<p style="top:11.4pt;left:578.5pt;line-height:5.3pt"><span style="font-family:Times New Roman,serif;font-size:5.3pt"> 10974547, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/jnr.24746 by University Zurich, Wiley Online Library on [31/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</span></p>

</div>
